{
  "usdmVersion": "4.0",
  "generatedAt": "2026-01-23T04:37:44.299835",
  "generator": "Protocol2USDM v6.5.0",
  "study": {
    "id": "30ca1e5f-1859-47fe-b880-b638f2f72a9e",
    "instanceType": "Study",
    "versions": [
      {
        "id": "62956fe2-1482-4ba0-9fe3-6e3cd508d275",
        "instanceType": "StudyVersion",
        "versionIdentifier": "1.0",
        "studyDesigns": [
          {
            "id": "3d9e5943-abfb-4161-b375-134c10ce28c1",
            "name": "Study Design",
            "rationale": "Protocol-defined study design for investigating efficacy and safety",
            "instanceType": "InterventionalStudyDesign",
            "blindingSchema": {
              "id": "b3604f4b-e49c-4bfb-a0ab-b92b45e33f9e",
              "standardCode": {
                "id": "57412e96-b952-4665-9ccb-fe137c25ab87",
                "code": "Open Label",
                "codeSystem": "http://www.cdisc.org",
                "codeSystemVersion": "2024-09-27",
                "decode": "Open Label",
                "instanceType": "Code"
              },
              "instanceType": "AliasCode"
            },
            "randomizationType": {
              "code": "Non-Randomized"
            },
            "arms": [
              {
                "id": "3833c737-bde4-40ca-8325-4515f879792b",
                "name": "ABBV-951 Treatment Arm",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "All subjects receive an oral loading dose of LD+DDCI followed by a 24-hour daily continuous subcutaneous infusion (CSCI) of ABBV-951. The dose is individualized and titrated during an Optimization Period to achieve optimal clinical response.",
                "type": {
                  "id": "C174266",
                  "code": "C174266",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Investigational Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "5f1521a6-43a1-4d49-8b21-4b450603e6e2",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              }
            ],
            "studyCohorts": [],
            "studyCells": [
              {
                "id": "16a6aa07-7502-4511-a791-8984614fb6c7",
                "armId": "3833c737-bde4-40ca-8325-4515f879792b",
                "epochId": "a5ef4e3c-0fe3-42a1-9624-886d45ddfc6b",
                "elementIds": [
                  "d0ce3157-a764-4c61-9a6a-bb026bfa965c"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "ae0fff0a-fbca-4622-8692-91eb72748f69",
                "armId": "3833c737-bde4-40ca-8325-4515f879792b",
                "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4",
                "elementIds": [
                  "67fa64f5-0c8d-488d-a618-687d9c0f717d"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "1aaae46f-f024-4f43-afc8-0755f3eb5ed0",
                "armId": "3833c737-bde4-40ca-8325-4515f879792b",
                "epochId": "21c5409b-d548-4a70-b46c-32f5e3d92523",
                "elementIds": [
                  "8cbf10d1-0b46-4928-9fa4-0099fd0a331b"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "78946e58-ac87-4213-96dd-9ca601d258e9",
                "armId": "3833c737-bde4-40ca-8325-4515f879792b",
                "epochId": "84081714-d5e0-47df-af23-b37bc8a9df57",
                "elementIds": [
                  "d69bd834-4939-4bb3-bdb1-22364968daf9"
                ],
                "instanceType": "StudyCell"
              }
            ],
            "studyElements": [
              {
                "id": "d0ce3157-a764-4c61-9a6a-bb026bfa965c",
                "name": "ABBV-951 Treatment Arm - Screening Period",
                "instanceType": "StudyElement",
                "description": "Treatment period for ABBV-951 Treatment Arm during Screening Period"
              },
              {
                "id": "67fa64f5-0c8d-488d-a618-687d9c0f717d",
                "name": "ABBV-951 Treatment Arm - Optimization Period",
                "instanceType": "StudyElement",
                "description": "Treatment period for ABBV-951 Treatment Arm during Optimization Period"
              },
              {
                "id": "8cbf10d1-0b46-4928-9fa4-0099fd0a331b",
                "name": "ABBV-951 Treatment Arm - Maintenance Period",
                "instanceType": "StudyElement",
                "description": "Treatment period for ABBV-951 Treatment Arm during Maintenance Period"
              },
              {
                "id": "d69bd834-4939-4bb3-bdb1-22364968daf9",
                "name": "ABBV-951 Treatment Arm - Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for ABBV-951 Treatment Arm during Follow-up"
              }
            ],
            "maskingRoles": [
              {
                "id": "d192b127-807c-4cb8-97ed-777aa2a3e325",
                "text": "This is an Open Label study with no masking",
                "isMasked": false,
                "instanceType": "Masking"
              }
            ],
            "eligibilityCriteria": [
              {
                "id": "04bbe120-0cbc-4d9f-ae24-161b26ef8092",
                "identifier": "1",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "14d17986-e18e-42db-bdbc-6b493aaf7dc9",
                "instanceType": "EligibilityCriterion",
                "name": "Informed Consent Understanding",
                "nextId": "8d43c7a9-5d39-432b-9ea3-27559ba78f81"
              },
              {
                "id": "8d43c7a9-5d39-432b-9ea3-27559ba78f81",
                "identifier": "2",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "0e12b510-9dd8-4a9e-88a7-b7df70799447",
                "instanceType": "EligibilityCriterion",
                "name": "Informed Consent Signature",
                "previousId": "04bbe120-0cbc-4d9f-ae24-161b26ef8092",
                "nextId": "80befee1-3de4-4abc-b682-8a7ad635fffe"
              },
              {
                "id": "80befee1-3de4-4abc-b682-8a7ad635fffe",
                "identifier": "3",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "80fa8a05-5d5c-4845-b057-2deeb59c16ff",
                "instanceType": "EligibilityCriterion",
                "name": "Age Requirement",
                "previousId": "8d43c7a9-5d39-432b-9ea3-27559ba78f81",
                "nextId": "b7a8faa1-dc9f-4c50-abc8-392312fbdb35"
              },
              {
                "id": "b7a8faa1-dc9f-4c50-abc8-392312fbdb35",
                "identifier": "4",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "2c407aad-11fd-418a-8d1d-0254ae5e4168",
                "instanceType": "EligibilityCriterion",
                "name": "Compliance",
                "previousId": "80befee1-3de4-4abc-b682-8a7ad635fffe",
                "nextId": "cb57180c-6f4d-4086-b77d-55d89e01886c"
              },
              {
                "id": "cb57180c-6f4d-4086-b77d-55d89e01886c",
                "identifier": "5",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "66b729bd-50e8-4fc6-b5d0-5cdd925b16a5",
                "instanceType": "EligibilityCriterion",
                "name": "Vitamin B12 Levels",
                "previousId": "b7a8faa1-dc9f-4c50-abc8-392312fbdb35",
                "nextId": "8e28438f-4fd2-4d1a-8c3b-5b0055b49ce5"
              },
              {
                "id": "8e28438f-4fd2-4d1a-8c3b-5b0055b49ce5",
                "identifier": "6",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "41803854-3c11-4261-80ae-7107f0f639dd",
                "instanceType": "EligibilityCriterion",
                "name": "Cognitive Function",
                "previousId": "cb57180c-6f4d-4086-b77d-55d89e01886c",
                "nextId": "163629f1-c45d-4e7d-8e46-369b8af39828"
              },
              {
                "id": "163629f1-c45d-4e7d-8e46-369b8af39828",
                "identifier": "7",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "c35f50e9-726a-4f45-84db-31996d19fb29",
                "instanceType": "EligibilityCriterion",
                "name": "Investigator Suitability",
                "previousId": "8e28438f-4fd2-4d1a-8c3b-5b0055b49ce5",
                "nextId": "e02bb070-8e84-46ea-89d3-4c0bdd293336"
              },
              {
                "id": "e02bb070-8e84-46ea-89d3-4c0bdd293336",
                "identifier": "8",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "6681a2aa-374d-42a8-9dce-9a6974267c9a",
                "instanceType": "EligibilityCriterion",
                "name": "Parkinson's Diagnosis",
                "previousId": "163629f1-c45d-4e7d-8e46-369b8af39828",
                "nextId": "08c855dd-f376-4694-b164-d9b64c5aee51"
              },
              {
                "id": "08c855dd-f376-4694-b164-d9b64c5aee51",
                "identifier": "9",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "102a173e-24bc-448e-8a3d-3eb28757a87a",
                "instanceType": "EligibilityCriterion",
                "name": "Disease Activity and Medication",
                "previousId": "e02bb070-8e84-46ea-89d3-4c0bdd293336",
                "nextId": "1c51fcc5-58b0-4046-b9de-b19c7959a16a"
              },
              {
                "id": "1c51fcc5-58b0-4046-b9de-b19c7959a16a",
                "identifier": "10",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "310f8e99-dc00-42a3-9125-60a23b2141ce",
                "instanceType": "EligibilityCriterion",
                "name": "Off Time Requirement",
                "previousId": "08c855dd-f376-4694-b164-d9b64c5aee51",
                "nextId": "46ed3d89-ee0e-4c5f-ab22-0d48beae0b32"
              },
              {
                "id": "6d6ef11d-9f4f-4a5f-8edd-7ea85106cade",
                "identifier": "11",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "25e99789-e458-421a-8c29-c40bb794f4b0",
                "instanceType": "EligibilityCriterion",
                "name": "Skin Conditions Exclusion",
                "nextId": "7b7eb2be-b4f6-478d-b6c8-25c5380e5bae"
              },
              {
                "id": "7b7eb2be-b4f6-478d-b6c8-25c5380e5bae",
                "identifier": "12",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "e8004d64-9d49-445c-8a11-2e5b27899bfa",
                "instanceType": "EligibilityCriterion",
                "name": "Substance Abuse Exclusion",
                "previousId": "6d6ef11d-9f4f-4a5f-8edd-7ea85106cade",
                "nextId": "14d09dd3-a30b-48bf-831d-fd8a64839159"
              },
              {
                "id": "14d09dd3-a30b-48bf-831d-fd8a64839159",
                "identifier": "13",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "ecb4c3c6-0f46-4da0-8596-28ca28eaf151",
                "instanceType": "EligibilityCriterion",
                "name": "Suicidal Ideation Exclusion",
                "previousId": "7b7eb2be-b4f6-478d-b6c8-25c5380e5bae",
                "nextId": "1457924e-54f8-4f26-9a04-7264c5ab230e"
              },
              {
                "id": "1457924e-54f8-4f26-9a04-7264c5ab230e",
                "identifier": "14",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "3a0f9b1c-8494-4e25-95f4-c60ad8c592f7",
                "instanceType": "EligibilityCriterion",
                "name": "Psychotic Episodes Exclusion",
                "previousId": "14d09dd3-a30b-48bf-831d-fd8a64839159",
                "nextId": "b430ff97-f4fe-48b5-8db8-6962604806e1"
              },
              {
                "id": "b430ff97-f4fe-48b5-8db8-6962604806e1",
                "identifier": "15",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "d56ccff6-a37e-4178-a4be-310c0a2d1ed3",
                "instanceType": "EligibilityCriterion",
                "name": "Unstable Medical Conditions Exclusion",
                "previousId": "1457924e-54f8-4f26-9a04-7264c5ab230e",
                "nextId": "3a6396c7-bb8c-43b8-b129-d11f4fca6c92"
              },
              {
                "id": "3a6396c7-bb8c-43b8-b129-d11f4fca6c92",
                "identifier": "16",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "0f63fd19-358e-4c54-9580-ed13641a32b3",
                "instanceType": "EligibilityCriterion",
                "name": "Allergic Reaction Exclusion",
                "previousId": "b430ff97-f4fe-48b5-8db8-6962604806e1",
                "nextId": "bd25c9e0-1e31-4386-827f-485789d7b4f3"
              },
              {
                "id": "bd25c9e0-1e31-4386-827f-485789d7b4f3",
                "identifier": "17",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "2907bb0f-57c9-4aec-8cd9-793244624841",
                "instanceType": "EligibilityCriterion",
                "name": "Levodopa Contraindications Exclusion",
                "previousId": "3a6396c7-bb8c-43b8-b129-d11f4fca6c92",
                "nextId": "0966314d-6e6c-4005-9108-6344cf1f185f"
              },
              {
                "id": "0966314d-6e6c-4005-9108-6344cf1f185f",
                "identifier": "18",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "232dae9e-8576-4fac-8d06-b14060499cda",
                "instanceType": "EligibilityCriterion",
                "name": "Blood Donation Exclusion",
                "previousId": "bd25c9e0-1e31-4386-827f-485789d7b4f3",
                "nextId": "41755b5e-5cd6-4688-bc38-c4dfae6c68f6"
              },
              {
                "id": "41755b5e-5cd6-4688-bc38-c4dfae6c68f6",
                "identifier": "19",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "d2d2f6fa-45a9-47a4-9177-57e83e60450d",
                "instanceType": "EligibilityCriterion",
                "name": "COVID-19 Exclusion",
                "previousId": "0966314d-6e6c-4005-9108-6344cf1f185f",
                "nextId": "5aa19952-0724-4128-bda3-59c28f0d47b5"
              },
              {
                "id": "46ed3d89-ee0e-4c5f-ab22-0d48beae0b32",
                "identifier": "20",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "fc85a01b-26d1-4e47-be23-5d566f76b55f",
                "instanceType": "EligibilityCriterion",
                "name": "Pregnancy Test Requirement",
                "previousId": "1c51fcc5-58b0-4046-b9de-b19c7959a16a",
                "nextId": "7456affd-a706-4d97-a558-23499614dabb"
              },
              {
                "id": "7456affd-a706-4d97-a558-23499614dabb",
                "identifier": "21",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "bf4769e9-be24-48c5-88c8-96a4a2237299",
                "instanceType": "EligibilityCriterion",
                "name": "Female Contraception",
                "previousId": "46ed3d89-ee0e-4c5f-ab22-0d48beae0b32",
                "nextId": "32e83d74-a8f1-41ac-a48e-3c761b940342"
              },
              {
                "id": "32e83d74-a8f1-41ac-a48e-3c761b940342",
                "identifier": "22",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "717ad803-8376-47d2-b8e1-e104e15ae1e5",
                "instanceType": "EligibilityCriterion",
                "name": "Male Contraception",
                "previousId": "7456affd-a706-4d97-a558-23499614dabb"
              },
              {
                "id": "5aa19952-0724-4128-bda3-59c28f0d47b5",
                "identifier": "23",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "64322fe7-dca1-4af8-88f1-fe801a2f58f7",
                "instanceType": "EligibilityCriterion",
                "name": "Pregnancy/Breastfeeding Exclusion",
                "previousId": "41755b5e-5cd6-4688-bc38-c4dfae6c68f6",
                "nextId": "ce9e230c-4f0a-4aee-8976-f523d80922e4"
              },
              {
                "id": "ce9e230c-4f0a-4aee-8976-f523d80922e4",
                "identifier": "24",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "7a9efe64-de08-4337-9437-03e0ecb0c93c",
                "instanceType": "EligibilityCriterion",
                "name": "Male Procreation Exclusion",
                "previousId": "5aa19952-0724-4128-bda3-59c28f0d47b5",
                "nextId": "a2999ed3-ee7d-4275-a7c3-9b3321fd733c"
              },
              {
                "id": "a2999ed3-ee7d-4275-a7c3-9b3321fd733c",
                "identifier": "25",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "16c5dcdc-86c8-4150-b51d-9684abc15766",
                "instanceType": "EligibilityCriterion",
                "name": "Investigational Product Exclusion",
                "previousId": "ce9e230c-4f0a-4aee-8976-f523d80922e4"
              }
            ],
            "population": {
              "id": "d62c1a27-1291-4de4-ae11-52e5815c3219",
              "name": "Study Population",
              "includesHealthySubjects": false,
              "criterionIds": [
                "04bbe120-0cbc-4d9f-ae24-161b26ef8092",
                "8d43c7a9-5d39-432b-9ea3-27559ba78f81",
                "80befee1-3de4-4abc-b682-8a7ad635fffe",
                "b7a8faa1-dc9f-4c50-abc8-392312fbdb35",
                "cb57180c-6f4d-4086-b77d-55d89e01886c",
                "8e28438f-4fd2-4d1a-8c3b-5b0055b49ce5",
                "163629f1-c45d-4e7d-8e46-369b8af39828",
                "e02bb070-8e84-46ea-89d3-4c0bdd293336",
                "08c855dd-f376-4694-b164-d9b64c5aee51",
                "1c51fcc5-58b0-4046-b9de-b19c7959a16a",
                "6d6ef11d-9f4f-4a5f-8edd-7ea85106cade",
                "7b7eb2be-b4f6-478d-b6c8-25c5380e5bae",
                "14d09dd3-a30b-48bf-831d-fd8a64839159",
                "1457924e-54f8-4f26-9a04-7264c5ab230e",
                "b430ff97-f4fe-48b5-8db8-6962604806e1",
                "3a6396c7-bb8c-43b8-b129-d11f4fca6c92",
                "bd25c9e0-1e31-4386-827f-485789d7b4f3",
                "0966314d-6e6c-4005-9108-6344cf1f185f",
                "41755b5e-5cd6-4688-bc38-c4dfae6c68f6",
                "46ed3d89-ee0e-4c5f-ab22-0d48beae0b32",
                "7456affd-a706-4d97-a558-23499614dabb",
                "32e83d74-a8f1-41ac-a48e-3c761b940342",
                "5aa19952-0724-4128-bda3-59c28f0d47b5",
                "ce9e230c-4f0a-4aee-8976-f523d80922e4",
                "a2999ed3-ee7d-4275-a7c3-9b3321fd733c"
              ],
              "instanceType": "StudyDesignPopulation",
              "description": "Target population defined by eligibility criteria"
            },
            "objectives": [
              {
                "id": "065c8606-7e78-4280-aa2a-2b1612776d46",
                "name": "Primary Safety and Tolerability Objective",
                "text": "To assess the local and systemic safety and tolerability of ABBV-951 delivered as a CSCI for 24 hours daily for up to 52 weeks.",
                "level": {
                  "id": "C85826",
                  "code": "C85826",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Primary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "21875b0b-c9e7-4923-9c7b-8ee50ebf7007",
                  "1317959c-6079-45be-a1e0-fbddffd0681b",
                  "5894b017-a5c6-4543-b142-650ca7d69c39",
                  "926c22b9-7d8e-4d6e-a493-a24cf4e7552b",
                  "e9b9a26d-ce11-4193-bb79-bbc5ceae0df8",
                  "f8505bc0-fae2-4461-8c9d-55eb2326823b"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "80ce718f-800c-447d-9964-ac65585942e4",
                "name": "Secondary Efficacy Objective",
                "text": "To assess the efficacy of ABBV-951 as measured by patient-reported and rater-measured efficacy endpoints.",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "1306c360-eb18-475d-8e73-dac037684db1",
                  "b5f2b080-6c8e-47a4-94c9-ad6fa93ce254",
                  "75f9d7c3-1e8d-4ffb-bda6-5af6f1b3525d",
                  "93ff16e6-9610-4591-905a-66e8017b6fe3",
                  "11b066c6-4a42-4b34-ab0a-36ed165ede8d"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "61bb986d-1ceb-4e97-baea-d5fe526456ec",
                "name": "Exploratory Objective",
                "text": "To evaluate PD symptoms via wearable device and biomarker research.",
                "level": {
                  "id": "C163559",
                  "code": "C163559",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Exploratory Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "f96af887-f9af-43b9-b025-d25393539ac8",
                  "c0ec2701-4d4e-481b-b136-da4902a459ce"
                ],
                "instanceType": "Objective"
              }
            ],
            "endpoints": [
              {
                "id": "21875b0b-c9e7-4923-9c7b-8ee50ebf7007",
                "name": "Adverse Events",
                "text": "Percentage of subjects with adverse events (AEs) and serious adverse events (SAEs) during the study",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "1317959c-6079-45be-a1e0-fbddffd0681b",
                "name": "Adverse Events of Special Interest",
                "text": "Percentage of subjects with AEs of special interest (AESIs) during the study",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "5894b017-a5c6-4543-b142-650ca7d69c39",
                "name": "Infusion Site Evaluation Scale",
                "text": "Percentage of subjects with numeric grade equal to or higher than 5 and percentage of subjects with letter grade equal to or higher than D on the Infusion Site Evaluation Scale at any time during the study",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Tolerability"
              },
              {
                "id": "926c22b9-7d8e-4d6e-a493-a24cf4e7552b",
                "name": "Clinical Laboratory Test Data",
                "text": "Change in clinical laboratory test data from Baseline to end of study",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "e9b9a26d-ce11-4193-bb79-bbc5ceae0df8",
                "name": "Vital Sign Measurements",
                "text": "Change in vital sign measurements from Baseline to end of study",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "f8505bc0-fae2-4461-8c9d-55eb2326823b",
                "name": "Electrocardiograms (ECGs)",
                "text": "Change in electrocardiograms (ECGs) from Baseline to end of study",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "1306c360-eb18-475d-8e73-dac037684db1",
                "name": "PD Diary Off and On Times",
                "text": "Average normalized daily \"Off\" time and \"On\" times as assessed by the PD Diary",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "b5f2b080-6c8e-47a4-94c9-ad6fa93ce254",
                "name": "MDS-UPDRS Parts I-IV",
                "text": "PD symptoms as assessed by the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Parts I-IV (or the UPDRS Parts I-V in countries where a validated translation of the MDS-UPDRS is not available)",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "75f9d7c3-1e8d-4ffb-bda6-5af6f1b3525d",
                "name": "PDSS-2",
                "text": "Sleep symptoms as assessed by the PD Sleep Scale-2 (PDSS-2)",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "93ff16e6-9610-4591-905a-66e8017b6fe3",
                "name": "PDQ-39",
                "text": "Quality of life as assessed by the PD Questionnaire-39 items (PDQ-39)",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "QualityOfLife"
              },
              {
                "id": "11b066c6-4a42-4b34-ab0a-36ed165ede8d",
                "name": "EQ-5D-5L",
                "text": "Health-related quality of life as assessed by the EuroQol 5-dimensions questionnaire (EQ-5D-5L)",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "QualityOfLife"
              },
              {
                "id": "f96af887-f9af-43b9-b025-d25393539ac8",
                "name": "PKG Wearable Device",
                "text": "PD symptoms (including tremor, bradykinesia, dyskinesia, daytime somnolence, and indication of propensity for impulsive behaviors) as assessed by the Parkinson's KinetiGraph™/Personal KinetiGraph™ (PKG) wearable device (as allowed by local regulations) from Baseline to the Week 26 Visit.",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "c0ec2701-4d4e-481b-b136-da4902a459ce",
                "name": "Biomarker Research Endpoints",
                "text": "Optional samples will be collected during the study to evaluate known and/or novel biomarkers related to PD, related conditions, ABBV-951, or drugs of a similar class.",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Biomarker"
              }
            ],
            "estimands": [
              {
                "id": "8d33b172-9f85-4857-9183-1b8cd382c54c",
                "name": "Primary Safety Estimand - Adverse Events",
                "populationSummary": "Adult patients with Parkinson's Disease whose motor symptoms are inadequately controlled by current therapy (Safety Population) Summary measure: Percentage (Proportion).",
                "analysisPopulationId": "166b5fa1-a4ad-4a9f-a831-daa94b36b798",
                "variableOfInterestId": "21875b0b-c9e7-4923-9c7b-8ee50ebf7007",
                "interventionIds": [
                  "097a1545-eb9e-487c-a802-b62717762728"
                ],
                "intercurrentEvents": [
                  {
                    "id": "a664e920-ff8a-4b4a-86bb-2d3039dd93df",
                    "name": "Treatment discontinuation",
                    "text": "Subject discontinues ABBV-951 infusion prior to Week 52",
                    "strategy": "While on Treatment",
                    "instanceType": "IntercurrentEvent"
                  },
                  {
                    "id": "23215605-7f3c-46b1-ba6a-2a36096321c2",
                    "name": "Death",
                    "text": "Death of the subject during the 52-week study period",
                    "strategy": "While on Treatment",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "ABBV-951 continuous subcutaneous infusion (CSCI) for 24 hours daily",
                "analysisPopulation": "Adult patients with Parkinson's Disease whose motor symptoms are inadequately controlled by current therapy (Safety Population)",
                "variableOfInterest": "Percentage of subjects with adverse events (AEs) and serious adverse events (SAEs) during the study",
                "summaryMeasure": "Percentage (Proportion)"
              },
              {
                "id": "b8d2205b-ecfa-48d6-9a73-d5532a823a4f",
                "name": "Primary Safety Estimand - Infusion Site Tolerability",
                "populationSummary": "Adult patients with Parkinson's Disease whose motor symptoms are inadequately controlled by current therapy (Safety Population) Summary measure: Percentage (Proportion).",
                "analysisPopulationId": "134af6c9-5538-4a30-8b98-967e6d3cd5db",
                "variableOfInterestId": "5894b017-a5c6-4543-b142-650ca7d69c39",
                "interventionIds": [
                  "261ef62c-bcb1-4e10-a925-cbd0f6589ce2"
                ],
                "intercurrentEvents": [
                  {
                    "id": "a664e920-ff8a-4b4a-86bb-2d3039dd93df",
                    "name": "Treatment discontinuation",
                    "text": "Subject discontinues ABBV-951 infusion prior to Week 52",
                    "strategy": "While on Treatment",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "ABBV-951 continuous subcutaneous infusion (CSCI) for 24 hours daily",
                "analysisPopulation": "Adult patients with Parkinson's Disease whose motor symptoms are inadequately controlled by current therapy (Safety Population)",
                "variableOfInterest": "Percentage of subjects with numeric grade ≥ 5 or letter grade ≥ D on the Infusion Site Evaluation Scale",
                "summaryMeasure": "Percentage (Proportion)"
              },
              {
                "id": "1948554a-adbd-4517-8cf8-dd6ea635f87a",
                "name": "Secondary Efficacy Estimand - Off Time",
                "populationSummary": "Adult patients with Parkinson's Disease whose motor symptoms are inadequately controlled by current therapy (ITT Population) Summary measure: Mean change from baseline.",
                "analysisPopulationId": "7565fe90-7dd4-4709-b149-2a72bd988fed",
                "variableOfInterestId": "1306c360-eb18-475d-8e73-dac037684db1",
                "interventionIds": [
                  "a7fa7f2b-9f8a-46e0-9f35-870bc47f82ea"
                ],
                "intercurrentEvents": [
                  {
                    "id": "a664e920-ff8a-4b4a-86bb-2d3039dd93df",
                    "name": "Treatment discontinuation",
                    "text": "Subject discontinues ABBV-951 infusion prior to Week 52",
                    "strategy": "Treatment Policy",
                    "instanceType": "IntercurrentEvent"
                  },
                  {
                    "id": "679cf20a-b544-414e-beea-5ca1310dce8b",
                    "name": "Use of rescue medication",
                    "text": "Use of prohibited or rescue PD medications during the study",
                    "strategy": "Treatment Policy",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "ABBV-951 continuous subcutaneous infusion (CSCI) for 24 hours daily",
                "analysisPopulation": "Adult patients with Parkinson's Disease whose motor symptoms are inadequately controlled by current therapy (ITT Population)",
                "variableOfInterest": "Change from Baseline to end of study in average normalized daily 'Off' time as assessed by the PD Diary",
                "summaryMeasure": "Mean change from baseline"
              }
            ],
            "scheduleTimelines": [
              {
                "id": "c604cf45-c744-4731-9ccf-007bb9de2714",
                "name": "Main Schedule Timeline",
                "mainTimeline": true,
                "instanceType": "ScheduleTimeline",
                "entryCondition": "Subject enrolled in study",
                "entryId": "73dc688e-235e-4c52-b934-45d0f45224f9",
                "instances": [
                  {
                    "id": "73dc688e-235e-4c52-b934-45d0f45224f9",
                    "activityIds": [
                      "997c6ea0-164b-4c42-8466-719ce4e88cc6"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_1",
                    "encounterId": "23622a73-d6e4-44e5-b311-0da8d29ca480",
                    "epochId": "a5ef4e3c-0fe3-42a1-9624-886d45ddfc6b"
                  },
                  {
                    "id": "5a53aa89-1c72-4df6-bf6e-8a28b9bea451",
                    "activityIds": [
                      "d21fbad9-1c89-45e5-988e-0b8fefcfc9b5"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@enc_1",
                    "encounterId": "23622a73-d6e4-44e5-b311-0da8d29ca480",
                    "epochId": "a5ef4e3c-0fe3-42a1-9624-886d45ddfc6b"
                  },
                  {
                    "id": "10a07b73-ed67-4986-97b4-54c1e0265c4a",
                    "activityIds": [
                      "d21fbad9-1c89-45e5-988e-0b8fefcfc9b5"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@enc_2",
                    "encounterId": "fbdbbed3-aff7-46aa-be3b-0ac929bbadae",
                    "epochId": "a5ef4e3c-0fe3-42a1-9624-886d45ddfc6b"
                  },
                  {
                    "id": "684a4b88-516d-4283-ab4f-a9b2e36576e8",
                    "activityIds": [
                      "d21fbad9-1c89-45e5-988e-0b8fefcfc9b5"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@enc_3",
                    "encounterId": "4070747f-2523-4fd0-80ff-7a391ccca14b",
                    "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4"
                  },
                  {
                    "id": "8c380e72-a68d-4a1d-ac9d-94e74554c510",
                    "activityIds": [
                      "dd134546-bccc-459b-a050-0cccaf5d0f8b"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_1",
                    "encounterId": "23622a73-d6e4-44e5-b311-0da8d29ca480",
                    "epochId": "a5ef4e3c-0fe3-42a1-9624-886d45ddfc6b"
                  },
                  {
                    "id": "11ac11f5-840c-4bc3-87cd-336ebe6f8966",
                    "activityIds": [
                      "b06d1919-ba33-451a-8130-a2f8a1b88192"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_1",
                    "encounterId": "23622a73-d6e4-44e5-b311-0da8d29ca480",
                    "epochId": "a5ef4e3c-0fe3-42a1-9624-886d45ddfc6b"
                  },
                  {
                    "id": "4f91c956-561f-487c-9130-f113c529c658",
                    "activityIds": [
                      "066a5196-e9a8-423b-ba4b-b248bd970a13"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_1",
                    "encounterId": "23622a73-d6e4-44e5-b311-0da8d29ca480",
                    "epochId": "a5ef4e3c-0fe3-42a1-9624-886d45ddfc6b"
                  },
                  {
                    "id": "d9f59dc4-99a6-4e15-9c8a-2174ea85304a",
                    "activityIds": [
                      "3f579363-98a6-44ae-9b78-b7e7d8f0f21f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@enc_1",
                    "encounterId": "23622a73-d6e4-44e5-b311-0da8d29ca480",
                    "epochId": "a5ef4e3c-0fe3-42a1-9624-886d45ddfc6b"
                  },
                  {
                    "id": "c8735e6f-476a-4d24-a3a8-485cae79e16f",
                    "activityIds": [
                      "3f579363-98a6-44ae-9b78-b7e7d8f0f21f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@enc_3",
                    "encounterId": "4070747f-2523-4fd0-80ff-7a391ccca14b",
                    "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4"
                  },
                  {
                    "id": "c7302567-f5a5-48c1-b980-d4e66118ab0a",
                    "activityIds": [
                      "c02ecd9a-5c29-48f7-b747-f1ee09df452e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@enc_1",
                    "encounterId": "23622a73-d6e4-44e5-b311-0da8d29ca480",
                    "epochId": "a5ef4e3c-0fe3-42a1-9624-886d45ddfc6b"
                  },
                  {
                    "id": "e50eb5de-149a-4abf-b68a-2f920d8f7432",
                    "activityIds": [
                      "c02ecd9a-5c29-48f7-b747-f1ee09df452e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@enc_2",
                    "encounterId": "fbdbbed3-aff7-46aa-be3b-0ac929bbadae",
                    "epochId": "a5ef4e3c-0fe3-42a1-9624-886d45ddfc6b"
                  },
                  {
                    "id": "72e0bcd6-011b-431b-ad24-b448835f1873",
                    "activityIds": [
                      "9b4d4200-62bc-44ff-95e9-460308cd7d55"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_1",
                    "encounterId": "23622a73-d6e4-44e5-b311-0da8d29ca480",
                    "epochId": "a5ef4e3c-0fe3-42a1-9624-886d45ddfc6b"
                  },
                  {
                    "id": "fd6080a4-4e40-40b3-b1e3-d62dc4ffa79d",
                    "activityIds": [
                      "3f6a9dd3-d1bc-43bd-81f9-f21bad2a42f8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_1",
                    "encounterId": "23622a73-d6e4-44e5-b311-0da8d29ca480",
                    "epochId": "a5ef4e3c-0fe3-42a1-9624-886d45ddfc6b"
                  },
                  {
                    "id": "b1fd8b79-be51-4700-b21c-3b48ab13aa0f",
                    "activityIds": [
                      "3f6a9dd3-d1bc-43bd-81f9-f21bad2a42f8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_3",
                    "encounterId": "4070747f-2523-4fd0-80ff-7a391ccca14b",
                    "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4"
                  },
                  {
                    "id": "22614d70-f202-4246-9915-66c4ed20ff22",
                    "activityIds": [
                      "3f6a9dd3-d1bc-43bd-81f9-f21bad2a42f8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_9",
                    "encounterId": "c8b75252-b2fe-4424-9300-12faff10f74f",
                    "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4"
                  },
                  {
                    "id": "43bbc783-dec0-467c-a277-50c4a1634565",
                    "activityIds": [
                      "3f6a9dd3-d1bc-43bd-81f9-f21bad2a42f8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_11",
                    "encounterId": "698b51e5-afe5-4834-ae7b-9ee7bb3ab676",
                    "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4"
                  },
                  {
                    "id": "2ee0f62c-e38b-4009-84fe-e38b714f47fc",
                    "activityIds": [
                      "3f6a9dd3-d1bc-43bd-81f9-f21bad2a42f8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_13",
                    "encounterId": "e11c956e-1329-432d-b320-05889756e974",
                    "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4"
                  },
                  {
                    "id": "543585a0-0fa0-44c2-af1b-105fb80813c0",
                    "activityIds": [
                      "b7fb4f45-db24-4aa8-8ef3-e5fa83d7689c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_1",
                    "encounterId": "23622a73-d6e4-44e5-b311-0da8d29ca480",
                    "epochId": "a5ef4e3c-0fe3-42a1-9624-886d45ddfc6b"
                  },
                  {
                    "id": "1347a7c0-ce4a-40ce-b3c9-e433ef35ea4c",
                    "activityIds": [
                      "b7fb4f45-db24-4aa8-8ef3-e5fa83d7689c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_3",
                    "encounterId": "4070747f-2523-4fd0-80ff-7a391ccca14b",
                    "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4"
                  },
                  {
                    "id": "0580ebc7-cb49-4957-9595-488da64b4ce8",
                    "activityIds": [
                      "ad760990-7420-4ca5-a41a-77e594a7b611"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_12@enc_1",
                    "encounterId": "23622a73-d6e4-44e5-b311-0da8d29ca480",
                    "epochId": "a5ef4e3c-0fe3-42a1-9624-886d45ddfc6b"
                  },
                  {
                    "id": "e111354d-ce05-461c-ad32-82801a5f4bed",
                    "activityIds": [
                      "d93761fc-70b6-45de-9685-84551422e5c3"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_1",
                    "encounterId": "23622a73-d6e4-44e5-b311-0da8d29ca480",
                    "epochId": "a5ef4e3c-0fe3-42a1-9624-886d45ddfc6b"
                  },
                  {
                    "id": "aa4feb02-2285-4f1f-84bf-31502448135f",
                    "activityIds": [
                      "d93761fc-70b6-45de-9685-84551422e5c3"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_3",
                    "encounterId": "4070747f-2523-4fd0-80ff-7a391ccca14b",
                    "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4"
                  },
                  {
                    "id": "2c31c6dc-755c-48ff-a57d-083fa491d57d",
                    "activityIds": [
                      "d93761fc-70b6-45de-9685-84551422e5c3"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_9",
                    "encounterId": "c8b75252-b2fe-4424-9300-12faff10f74f",
                    "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4"
                  },
                  {
                    "id": "5a80722b-2409-4617-abb8-a67fa6ca31ea",
                    "activityIds": [
                      "d93761fc-70b6-45de-9685-84551422e5c3"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_11",
                    "encounterId": "698b51e5-afe5-4834-ae7b-9ee7bb3ab676",
                    "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4"
                  },
                  {
                    "id": "2bb26fc2-6869-4efa-bb20-ce3548d840eb",
                    "activityIds": [
                      "d93761fc-70b6-45de-9685-84551422e5c3"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_13",
                    "encounterId": "e11c956e-1329-432d-b320-05889756e974",
                    "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4"
                  },
                  {
                    "id": "4c87cb5b-48b0-4f4c-acba-f1734a0ae6c8",
                    "activityIds": [
                      "5e3f0364-bce1-481d-a93b-228ded4799ea"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_1",
                    "encounterId": "23622a73-d6e4-44e5-b311-0da8d29ca480",
                    "epochId": "a5ef4e3c-0fe3-42a1-9624-886d45ddfc6b"
                  },
                  {
                    "id": "21e75204-a6f3-4945-aa4d-edf27180216d",
                    "activityIds": [
                      "5e3f0364-bce1-481d-a93b-228ded4799ea"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_3",
                    "encounterId": "4070747f-2523-4fd0-80ff-7a391ccca14b",
                    "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4"
                  },
                  {
                    "id": "11a7d0d9-5bd2-48c3-9a98-750630e9b3b3",
                    "activityIds": [
                      "18ca9b30-6135-4749-8a2b-1a94c9b67415"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_21@enc_3",
                    "encounterId": "4070747f-2523-4fd0-80ff-7a391ccca14b",
                    "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4"
                  },
                  {
                    "id": "436d903f-4e22-4d01-b024-0a045c4fe41b",
                    "name": "Screening",
                    "description": "Visit anchor: Screening",
                    "encounterId": "4070747f-2523-4fd0-80ff-7a391ccca14b",
                    "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4",
                    "activityIds": [],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "f0a1079b-103f-4e5b-8f33-924de3496c95",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      },
                      {
                        "id": "3859253e-b150-49eb-901c-02a4bf188031",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 20
                      }
                    ],
                    "scheduledDay": 1
                  },
                  {
                    "id": "02be48d2-136d-49aa-90f1-b29e3e447277",
                    "name": "FirstDose",
                    "description": "Event anchor: FirstDose",
                    "activityIds": [
                      "b7fb4f45-db24-4aa8-8ef3-e5fa83d7689c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "f0a1079b-103f-4e5b-8f33-924de3496c95",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Event"
                      },
                      {
                        "id": "3859253e-b150-49eb-901c-02a4bf188031",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 60
                      }
                    ],
                    "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4",
                    "scheduledDay": 1
                  },
                  {
                    "id": "bc4dd93d-35ba-4439-a391-d9021c8cf59c",
                    "name": "Day1",
                    "description": "Visit anchor: Day1",
                    "encounterId": "4070747f-2523-4fd0-80ff-7a391ccca14b",
                    "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4",
                    "activityIds": [],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "f0a1079b-103f-4e5b-8f33-924de3496c95",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      },
                      {
                        "id": "3859253e-b150-49eb-901c-02a4bf188031",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 80
                      }
                    ],
                    "scheduledDay": 1
                  },
                  {
                    "id": "158b803b-b842-48c6-b90b-12f3191fd3ff",
                    "name": "Anchor: Standard Visit Window",
                    "activityIds": [],
                    "encounterId": "4070747f-2523-4fd0-80ff-7a391ccca14b",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "8ad2d0c6-c80f-4b5d-b051-4ac1f87af992",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "86b77dd8-cb02-4081-9fd1-f4119a55ec37",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4"
                  },
                  {
                    "id": "573bfff4-dad4-4e71-baf2-b3b082c556b6",
                    "name": "Anchor: Post-Study Follow-up Call",
                    "activityIds": [],
                    "encounterId": "4070747f-2523-4fd0-80ff-7a391ccca14b",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "6f74ca18-2490-4c5e-89bc-8ff41daf79d7",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "9d5018ca-8316-44ab-8e1b-519735c6e4fe",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4"
                  }
                ],
                "timings": [
                  {
                    "id": "0c62bb2e-99cb-4bbd-b9a8-66a7cbfa198a",
                    "name": "Screening Period",
                    "type": {
                      "id": "601354b7-c241-4684-a35d-9d97cf73c631",
                      "code": "C71151",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Within",
                      "instanceType": "Code"
                    },
                    "value": "P42D",
                    "valueLabel": "Day 42",
                    "relativeToFrom": {
                      "id": "c45f786f-6ca5-4b01-b537-d693d5982c74",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "436d903f-4e22-4d01-b024-0a045c4fe41b",
                    "instanceType": "Timing",
                    "windowLower": "-P42D",
                    "windowUpper": "-P10D"
                  },
                  {
                    "id": "2a58a964-bffc-422a-993f-b8b531fe7fb5",
                    "name": "Extended Screening Window",
                    "type": {
                      "id": "90c1123c-e0a3-48ef-96b7-043f513372df",
                      "code": "C71151",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Within",
                      "instanceType": "Code"
                    },
                    "value": "P90D",
                    "valueLabel": "Day 90",
                    "relativeToFrom": {
                      "id": "8c790133-c578-4440-9c26-3db981b24864",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "436d903f-4e22-4d01-b024-0a045c4fe41b",
                    "instanceType": "Timing",
                    "windowLower": "-P90D",
                    "windowUpper": "-P1D"
                  },
                  {
                    "id": "b390279b-c95a-422d-a403-269469ff2b2c",
                    "name": "Monitoring Period",
                    "type": {
                      "id": "c74484f2-8d51-4c1f-9359-37063cba5aaf",
                      "code": "C71149",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Before",
                      "instanceType": "Code"
                    },
                    "value": "P6D",
                    "valueLabel": "Day 6",
                    "relativeToFrom": {
                      "id": "b1d8cba8-4e8a-4272-85a4-7866ed25ab04",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "2bc90d4f-9f52-40b7-9903-30b0688965c8",
                    "instanceType": "Timing",
                    "windowLower": "-P6D",
                    "windowUpper": "-P1D"
                  },
                  {
                    "id": "55abf4e1-d89e-436f-8728-b955deb843f3",
                    "name": "Stable Oral PD Medication",
                    "type": {
                      "id": "9de2af1b-04f9-4436-b494-b41b973ee252",
                      "code": "C71149",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Before",
                      "instanceType": "Code"
                    },
                    "value": "P30D",
                    "valueLabel": "Day 30",
                    "relativeToFrom": {
                      "id": "6e9f5b13-6c56-49e6-a518-104554aa6b76",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "7ff20e96-183b-42c2-9cfd-c75c5343f7b5",
                    "instanceType": "Timing",
                    "windowLower": "-P30D",
                    "windowUpper": "-P30D"
                  },
                  {
                    "id": "19028a21-3710-4e00-ae43-685342cd8421",
                    "name": "Prohibited Medication Washout",
                    "type": {
                      "id": "3f9430e7-6808-4efb-ba64-93d4f40634e5",
                      "code": "C71149",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Before",
                      "instanceType": "Code"
                    },
                    "value": "P30D",
                    "valueLabel": "Day 30",
                    "relativeToFrom": {
                      "id": "ed94934d-1554-4a13-b853-a841b2a83dac",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "d6e9eed4-782d-4636-97c2-5383a103c35e",
                    "instanceType": "Timing",
                    "windowLower": "-P30D",
                    "windowUpper": "-P30D"
                  },
                  {
                    "id": "35bdce64-8cb8-4fe2-9b9b-05d3c75196b2",
                    "name": "Levodopa/COMT Discontinuation",
                    "type": {
                      "id": "3fc332c9-b881-41b0-af3b-9ee10dced199",
                      "code": "C71149",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Before",
                      "instanceType": "Code"
                    },
                    "value": "PT12H",
                    "valueLabel": "12 hours",
                    "relativeToFrom": {
                      "id": "307debb3-2a22-4e00-a6ab-35dceff89938",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "5854c31a-56ba-4c40-a9ed-f4369514aaff",
                    "instanceType": "Timing",
                    "windowLower": "-PT12H",
                    "windowUpper": "-PT12H"
                  },
                  {
                    "id": "742a93f2-2ad9-41df-8014-df12dc96d421",
                    "name": "Standard Visit Window",
                    "type": {
                      "id": "2e715850-28b2-4bb6-9cfc-3e5ba49528bd",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P0D",
                    "valueLabel": "Day 0",
                    "relativeToFrom": {
                      "id": "93f63a9b-b71b-4ea5-b0fe-6b064a6ea2e2",
                      "code": "C71157",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Previous Visit",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "158b803b-b842-48c6-b90b-12f3191fd3ff",
                    "instanceType": "Timing",
                    "windowLower": "-P3D",
                    "windowUpper": "P3D"
                  },
                  {
                    "id": "14a2e81d-2afa-4089-ab35-472da4548069",
                    "name": "Post-Study Follow-up Call",
                    "type": {
                      "id": "67489ab4-bb6b-48f8-b362-f8f7e6b98138",
                      "code": "C71150",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "After",
                      "instanceType": "Code"
                    },
                    "value": "P30D",
                    "valueLabel": "Day 30",
                    "relativeToFrom": {
                      "id": "03faff07-3810-40ee-a01e-0aafad2f76ac",
                      "code": "C71156",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Last Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "573bfff4-dad4-4e71-baf2-b3b082c556b6",
                    "instanceType": "Timing",
                    "windowLower": "P30D",
                    "windowUpper": "P30D"
                  }
                ],
                "exits": [
                  {
                    "id": "78ad63a5-d0ee-47cd-b810-1347e1724c6e",
                    "name": "Pregnancy Discontinuation",
                    "exitType": "Early Termination",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Subject becomes pregnant while on study drug"
                  },
                  {
                    "id": "a83ee750-c097-44e6-91ea-addb3fab5c41",
                    "name": "Safety Discontinuation",
                    "exitType": "Early Termination",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Clinically significant abnormal laboratory results or AEs"
                  },
                  {
                    "id": "a3010f43-0cd1-4981-9642-30ee11c7d42c",
                    "name": "Study Completion",
                    "exitType": "Completion",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Completion of Week 52 (V13) visit"
                  }
                ]
              }
            ],
            "encounters": [
              {
                "id": "4070747f-2523-4fd0-80ff-7a391ccca14b",
                "name": "Day 1 (V3)",
                "instanceType": "Encounter",
                "type": {
                  "id": "50014faf-e0d0-43e0-a65a-aba269536a8f",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4",
                "extensionAttributes": [
                  {
                    "id": "7aac53e3-d9e1-46e1-8eba-55b9c24f76b9",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "4471855e-d9b4-4ecb-9c11-304fbfae009a",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "92f1075c-0109-44aa-a641-aab6f093dec3",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 1
                  }
                ]
              },
              {
                "id": "bfec5dba-1a85-486d-a90b-e1ddbea381e1",
                "name": "Day 2 (V4)",
                "instanceType": "Encounter",
                "type": {
                  "id": "415b62b6-47e2-4cef-afe4-d357437be7e5",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4",
                "extensionAttributes": [
                  {
                    "id": "4721731b-73d2-4e15-a72c-b6cb60b8cff2",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "72a4f32d-c844-4927-a1b8-85bc2d5d19ea",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "9a509ff0-f401-49c3-b16d-4b79493550d1",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 2
                  }
                ]
              },
              {
                "id": "a2a6ed1c-29fb-4506-b131-d1f37f651ec2",
                "name": "Week 1 (V5)",
                "instanceType": "Encounter",
                "type": {
                  "id": "dc47dd23-08b9-4a6e-991d-d0b623f90b9f",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4",
                "extensionAttributes": [
                  {
                    "id": "0419d0e7-1ac1-490f-bf8f-56d9492848b9",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "126a22df-0edc-4bbb-96d2-71ce68af9e0b",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "4b8bbe20-8519-41b7-8da8-17c7b225e0b8",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 1
                  }
                ]
              },
              {
                "id": "fa9c2c01-0be2-4528-aa45-c82e35be0e9b",
                "name": "Week 2 (V6)",
                "instanceType": "Encounter",
                "type": {
                  "id": "1df4ca36-a256-455a-9f29-a386141b073f",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4",
                "extensionAttributes": [
                  {
                    "id": "a3f701b0-da70-4650-8e72-2d010bca3084",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "8a339ec2-0b60-475c-87cb-b63e691bac37",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "297e892f-91ed-43ff-a155-4ac40682293f",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 2
                  }
                ]
              },
              {
                "id": "dda248db-8660-4fd2-9d4a-4a466f308380",
                "name": "Week 3 (V7)",
                "instanceType": "Encounter",
                "type": {
                  "id": "b3d7cd24-268c-4a0c-8d4b-40344ad5ea90",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4",
                "extensionAttributes": [
                  {
                    "id": "70b55164-1a56-41d5-bdae-a9967d0e0cf0",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "1bc8e5c7-d400-4adc-bf26-60bebed3df47",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "2002af9a-d314-403d-aa9e-b20a356cefb2",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 3
                  }
                ]
              },
              {
                "id": "944eec81-afa7-4740-9983-aafb275ec931",
                "name": "Week 4 (V8)",
                "instanceType": "Encounter",
                "type": {
                  "id": "85ab33cf-3225-4252-b0e0-027b5e6ddffd",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4",
                "extensionAttributes": [
                  {
                    "id": "8bc4847e-ab56-4bc8-805b-dc9a1de3e433",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "3478eeed-7190-495f-8754-a3080cf8181b",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "a290c5f4-3f0b-4dec-8736-7c4a2dfa1bf4",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 4
                  }
                ]
              },
              {
                "id": "c8b75252-b2fe-4424-9300-12faff10f74f",
                "name": "Week 6 (V9)",
                "instanceType": "Encounter",
                "type": {
                  "id": "57454c47-2869-4781-894b-fe52e8a0c746",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4",
                "extensionAttributes": [
                  {
                    "id": "884cfeee-5d54-451a-ac51-48c0a379bbd9",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "31d6c256-c690-4716-aed7-4503b6e73835",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "4e739145-2911-43da-8e70-831dc5713435",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 6
                  }
                ]
              },
              {
                "id": "61950618-3c53-4c07-9df0-5bf6d10b994c",
                "name": "Week 13 (V10)",
                "instanceType": "Encounter",
                "type": {
                  "id": "968c15c4-6990-4a8a-ab10-f24752b7ac19",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4",
                "extensionAttributes": [
                  {
                    "id": "1cde824d-acae-4243-95f2-08369c5b834b",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "ef42d45c-c5ef-478c-bd94-b83bc4ed2805",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "296c2879-6c13-443f-b9c1-eb2bb695a29e",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 13
                  }
                ]
              },
              {
                "id": "698b51e5-afe5-4834-ae7b-9ee7bb3ab676",
                "name": "Week 26 (V11)",
                "instanceType": "Encounter",
                "type": {
                  "id": "5f1c4be4-d0dc-4b4b-81f3-b86fa6fee35f",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4",
                "extensionAttributes": [
                  {
                    "id": "046d3b8d-0ce3-47af-922b-b666528059d1",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "85b9429b-fd60-4c36-8ef5-bdab8f546fc5",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "de1a097f-7fae-4415-9b54-2fbd7ff4c9a3",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 26
                  }
                ]
              },
              {
                "id": "ea510aa3-89e6-4c4d-9ed9-a40c2439c079",
                "name": "Week 39 (V12)",
                "instanceType": "Encounter",
                "type": {
                  "id": "64aa4730-7dad-4918-b583-66fd3ae4871d",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4",
                "extensionAttributes": [
                  {
                    "id": "70c2b5f1-5eaf-4b65-a16e-15a13c083d3a",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "80b5d8d3-0327-4b51-9737-4988336e6abf",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "96666b48-001f-43e4-aed8-2746154ad41c",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 39
                  }
                ]
              },
              {
                "id": "e11c956e-1329-432d-b320-05889756e974",
                "name": "Week 52 (V13)",
                "instanceType": "Encounter",
                "type": {
                  "id": "a0122ba3-dc6a-40c3-a7c1-6d1a7aea2596",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a3d29481-61ef-4d69-a082-74fa363d99e4",
                "extensionAttributes": [
                  {
                    "id": "2edff6bb-dbf2-4bfb-8693-069d0570f951",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "4225fdf0-a5db-476e-bf5b-3b9bc1b6f756",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "4d18af0a-c8d1-49e3-bcd1-584f84def197",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 52
                  }
                ]
              },
              {
                "id": "23622a73-d6e4-44e5-b311-0da8d29ca480",
                "name": "Visit 1 (V1)",
                "instanceType": "Encounter",
                "type": {
                  "id": "8a954740-1c62-408c-811e-cdcd5dcaff41",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a5ef4e3c-0fe3-42a1-9624-886d45ddfc6b",
                "extensionAttributes": [
                  {
                    "id": "0ab2d317-a552-4d57-9270-6552e083bf3a",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "032b4d59-1380-454b-af6c-981d62edb65f",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "fbdbbed3-aff7-46aa-be3b-0ac929bbadae",
                "name": "Visit 2 (V2)",
                "instanceType": "Encounter",
                "type": {
                  "id": "0fc767f4-f162-4bd4-8b46-af782ff10b5e",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a5ef4e3c-0fe3-42a1-9624-886d45ddfc6b",
                "extensionAttributes": [
                  {
                    "id": "729920ef-72e8-450e-84c2-48dfd5878c8f",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "6f271c4e-a03c-4573-8fdf-2b203b3a9379",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              }
            ],
            "activities": [
              {
                "id": "ddccffde-42c2-45ce-a852-a60d8a60ce13",
                "name": "12-Lead ECG",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "c445f6cd-a283-49ba-abc0-85a88980dc67",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "ac18fc21-34a0-47fb-a281-afb904f53018",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "68680297-477b-409e-baf8-8ae04a4405f9",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "066a5196-e9a8-423b-ba4b-b248bd970a13",
                "name": "Advanced Parkinson's Disease (aPD) Clinician Assessment",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "911591c3-018f-431d-b3cc-2de8be889c2e",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "9b052435-ef43-471e-a94c-4deee75b20e7",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "da0de10f-12ae-4c04-898a-0e04bb693718",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "43a9db09-d928-4f77-9572-3ae15639a432",
                "name": "Adverse Event Monitoring",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "4e69ecbc-f46a-4ad8-9563-b99d572245fa",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "fa8aac96-15a3-4e1e-aa6f-b5005302dd38",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "865e4318-8731-484f-835f-5cc067d8907e",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "d249c90d-39af-4efa-9fb3-5da5a3de0c34",
                "name": "Clinical Chemistry",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "a1e96665-e820-4ccc-8447-1ac523924ec9",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "c639168a-f47c-42dd-99c3-0c2e92ba4997",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "lab"
                  },
                  {
                    "id": "d46c6741-be71-4a52-a4b6-a5e80fba5ce1",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "7d308b67-4cf1-4bf3-b8ff-c906fa94ef01",
                "name": "Clinical laboratory test",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "7d308b67-4cf1-4bf3-b8ff-c906fa94ef01",
                    "name": "Clinical laboratory test",
                    "procedureType": "Biospecimen Collection",
                    "code": {
                      "id": "c0118ca0-5ce6-4686-b11b-c9c43d5afa38",
                      "code": "C70793",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Biospecimen Collection",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Laboratory Testing",
                    "description": "Collection and analysis of clinical laboratory data from baseline to end of study"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "ffb997c3-6ac5-4719-9590-ae632032ad27",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "53161d7f-5e2b-475c-aea5-650b0cc43a59",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "fa9f1048-792c-40fc-a89a-61ce7cefc0aa",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "9b605766-f564-44fd-84d6-d7c6c2ad9eeb",
                "name": "Concomitant Medication Review",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "35d99955-52c3-47eb-a017-cb00b194b7fd",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "6a7d86c7-f276-47ad-badb-b97118534dd6",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "f90e373e-d5a8-4e0d-8d56-ebda885adbf5",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "da03f49a-f996-4df9-8d65-858b4c175ff8",
                "name": "Continuous subcutaneous infusion",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "da03f49a-f996-4df9-8d65-858b4c175ff8",
                    "name": "Continuous subcutaneous infusion",
                    "procedureType": "Therapeutic Procedure",
                    "code": {
                      "id": "ff2285b6-013d-455f-b602-43b0b661b8f7",
                      "code": "C49236",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Therapeutic Procedure",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "CSCI",
                    "description": "Continuous delivery of ABBV-951 via a subcutaneous pump"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "211ae4b5-26f9-40cf-abce-05217eed8d2f",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "208085b0-5f4e-4345-999b-297aabdaea61",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "c72771db-57a7-43a1-a320-4ae260e9321a",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "50e6df08-1993-4ea8-8150-a58f41a27da4",
                "name": "DNA sampling",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "50e6df08-1993-4ea8-8150-a58f41a27da4",
                    "name": "DNA sampling",
                    "procedureType": "Biospecimen Collection",
                    "code": {
                      "id": "7b7c0b48-9bf4-4e25-86a4-5fdaae66a476",
                      "code": "C70793",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Biospecimen Collection",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Genetic Sampling",
                    "description": "Collection of samples for genetic markers and biomarker research"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "14af3413-3c9d-446d-8bf6-178c67332472",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "be5b9810-8f10-41bc-9256-5c139ddff618",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "e55b176e-9228-417a-94f0-d85da299597c",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "430f854e-63f9-4ea8-b1a3-795f6788216a",
                "name": "Electrocardiogram",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "430f854e-63f9-4ea8-b1a3-795f6788216a",
                    "name": "Electrocardiogram",
                    "procedureType": "Imaging Technique",
                    "code": {
                      "id": "6d775178-a27c-41ad-ae14-f139bfd54a81",
                      "code": "93000",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Electrocardiogram, routine ECG with at least 12 leads",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "ECG",
                    "description": "Recording of the electrical activity of the heart"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "b00a2e22-62cd-4920-a6da-b10098a198fc",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "b0d6a4d7-4aa9-4d9b-928c-26fb278513e7",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "f77f1ce4-560e-4c77-a397-541e8275eca9",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "d21fbad9-1c89-45e5-988e-0b8fefcfc9b5",
                "name": "Eligibility Criteria",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "b9dd01e6-bd47-429e-a6bd-e6e2e52e8f6e",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "3681ea19-6113-4379-98b9-9919031df82a",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "31c1c498-2f4c-41d0-b755-ed3f57275a00",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "e2280080-1fec-493c-90a0-53ac6cc3fe68",
                "name": "EuroQol 5-Dimension Questionnaire (EQ-5D-5L)",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "14b46b71-91d4-4da5-baa2-1e18edb812ef",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "48545ea3-ec08-4a58-94fb-d005735e1248",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "assessment"
                  },
                  {
                    "id": "7811d251-46f4-443f-aa71-e7d6a6908cf7",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "ad760990-7420-4ca5-a41a-77e594a7b611",
                "name": "Height and Weight",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "34580f80-6db8-454f-964d-ac5a86acdb76",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "4d800cd5-a858-48dc-b306-a6f8073b994a",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "cc7d506c-4b9e-4590-a7e7-7a391e61db47",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "82d25c8c-81f1-4bf7-8ff8-0b8a8f9f871c",
                "name": "Hematology",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "86660350-3616-4d2d-836e-11e0b7793b3f",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "db698e7f-869d-4b0d-811f-a80a35598962",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "lab"
                  },
                  {
                    "id": "59c9c779-a460-467b-82ad-e459909fd37d",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "997c6ea0-164b-4c42-8466-719ce4e88cc6",
                "name": "Informed Consent",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "ba352bf3-1774-4a6f-9e3d-6a793ef8d671",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "408071d9-9c11-4128-bcaa-57a9d77a7d0b",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "documentation"
                  },
                  {
                    "id": "ece05aaf-3ff4-45a5-9442-10c8995c749c",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "dd134546-bccc-459b-a050-0cccaf5d0f8b",
                "name": "Medical History",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "d8d464b5-6f39-4d67-ba72-7daf74f96fac",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "38e1996f-27c2-437a-b381-da8058eeb57f",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "348f845d-5ee4-483f-886c-39d12dc8f046",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "ee601acb-1172-4ae1-89cb-cde204582a90",
                "name": "Neurologic examination",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "ee601acb-1172-4ae1-89cb-cde204582a90",
                    "name": "Neurologic examination",
                    "procedureType": "Assessment",
                    "code": {
                      "id": "306f048f-575a-494a-aaf6-691bc9357b9c",
                      "code": "C25218",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Assessment",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Neurological Exam",
                    "description": "Assessment of PD symptoms by interview and physical examination"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "dd3255ba-c542-4e3c-984b-fa8ea209f6d9",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "184d4b78-bae3-418e-9ddc-522ecee99aed",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "f88c311b-2d05-412a-b67b-c876ff641f52",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "b7fb4f45-db24-4aa8-8ef3-e5fa83d7689c",
                "name": "Neurological Examination",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "23910fe6-0296-41e0-b23a-762b84bb3422",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "b881a09a-97bc-4f6f-811a-5db61ce8e534",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "694fb0c9-f0a3-449f-aade-fa15b77db1d4",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "045c840a-e27f-497c-b45f-c45385c2b145",
                "name": "Oral loading dose administration",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "045c840a-e27f-497c-b45f-c45385c2b145",
                    "name": "Oral loading dose administration",
                    "procedureType": "Therapeutic Procedure",
                    "code": {
                      "id": "a8e9ead3-9f84-4868-9315-d2826d1bdb82",
                      "code": "C49236",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Therapeutic Procedure",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Loading Dose",
                    "description": "Administration of oral LD+DDCI at the initiation of treatment"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "08cca0a8-9b20-468f-a070-b3e2aa74e7ce",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "a4550a0c-15d8-401a-a4ec-aec2167e9c22",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "08549b77-8abd-4399-afc7-5c3438649649",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "3f579363-98a6-44ae-9b78-b7e7d8f0f21f",
                "name": "PD Diary",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "90b6a8ea-145c-4309-bfa8-6cffb6ef2fe6",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "60481314-c3be-45c4-b6e5-c877b5c45a36",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "assessment"
                  },
                  {
                    "id": "5c0395f5-cab9-4a69-ba27-fba82207af17",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "c02ecd9a-5c29-48f7-b747-f1ee09df452e",
                "name": "PD Diary Concordance Assessment",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "805a4656-764c-4d1b-9b4d-441f079e5142",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "82fe6854-dbd3-4658-a2e8-f94452030c35",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "assessment"
                  },
                  {
                    "id": "1b0f0477-d5ae-4b15-acb3-4dae0f623618",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "b06d1919-ba33-451a-8130-a2f8a1b88192",
                "name": "PD Treatment History",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "9e690a97-5254-49bb-8b04-abc6d0a335a3",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "b9fb3267-208a-43a3-8547-009123f6c250",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "90663a80-5fed-4d10-885f-fefc56efc531",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "9b4d4200-62bc-44ff-95e9-460308cd7d55",
                "name": "Parkinson's KinetiGraph (PKG) Wearable Device",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "cb5b231d-9d48-46f4-95a3-2dbdd6b00051",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "741a2541-d31d-4882-92f3-55061adfbada",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "a72890c2-854b-4755-be5c-e5b8d9e581ca",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "3f6a9dd3-d1bc-43bd-81f9-f21bad2a42f8",
                "name": "Physical Examination",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "307fb5a7-94c8-4b56-8dcd-292c2d8b1729",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "491f4714-207c-4277-ba47-bd9b458cc078",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "6fc2a8eb-faa7-457d-8842-2f0e2e8afae4",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "5e3f0364-bce1-481d-a93b-228ded4799ea",
                "name": "Pregnancy Test",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "239a8ee6-4ce9-40af-9b10-bb768c51509a",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "4fcc2d5b-b368-4c2f-a579-edd54044a06a",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "9f1c53db-6ba0-4001-a724-543e85f649bb",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "e77e3925-9360-45be-8055-d6b89f9b607e",
                "name": "Pump Settings Record",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "37c99676-d453-4e10-9901-137bbe665007",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "6ca2f2a0-d6fa-4869-9d86-c52ec027c00d",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "b8a4b9aa-2505-4eaa-b8d3-f42175db9b12",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "7b6dabe8-bc1e-4bdd-8efb-646cd9458fae",
                "name": "Skin biopsy",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "7b6dabe8-bc1e-4bdd-8efb-646cd9458fae",
                    "name": "Skin biopsy",
                    "procedureType": "Biospecimen Collection",
                    "code": {
                      "id": "87655996-bc2f-46a0-bc37-b3cefbd55653",
                      "code": "C70793",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Biospecimen Collection",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Biopsy",
                    "description": "Optional collection of skin tissue for comprehensive evaluation by a dermatologist"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "51a2f13a-cdb4-4a2e-8bdd-15c26dae0bf3",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "2791a720-87cc-4ec7-ae32-a3e18605e8ef",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "4636ddf0-2320-49cb-9a62-c2e05ab675b9",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "d93761fc-70b6-45de-9685-84551422e5c3",
                "name": "Special Laboratory Tests (Vitamin B6, B12, Folic Acid, MMA, Homocysteine)",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "57f5de9f-e8c7-4dc4-8ed0-4ed67fd1ce44",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "f5ecd107-53c8-4688-9e4b-308c88a4fdf2",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "ea83a36d-fcba-43f0-a03f-675f1ab9d242",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "18ca9b30-6135-4749-8a2b-1a94c9b67415",
                "name": "Study Drug Prescription Record",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "9f380baa-c329-471f-9faf-b3f87022cc0a",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "e8846e68-85fe-40e5-9c4c-c696f51470f6",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "e1c724ab-2bf8-41a5-b4e9-5345aec63ac9",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "444e6dc0-24c9-4dea-aa52-6495ce882375",
                "name": "Urinalysis",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "1c24c7e7-3d5f-42f1-9138-137a15cebedf",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "357f824b-560e-4108-9756-d2bf4e8d01a9",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "lab"
                  },
                  {
                    "id": "c4bce418-89df-4cd7-839b-d4cafbeeddfd",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "76fe83b3-d1a5-42c8-912c-4d30c37c69ef",
                "name": "Vital Signs",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "d2ecc847-5c55-4c65-b5e6-558ce1afc9bf",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "d143a3a8-1e23-4d6c-ace9-f69b3ed47174",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "b0977161-5e04-4db7-9561-9e8bca5ac057",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "b6412614-bb1c-455f-a674-b8a28d1124b0",
                "name": "Vital sign measurements",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "b6412614-bb1c-455f-a674-b8a28d1124b0",
                    "name": "Vital sign measurements",
                    "procedureType": "Monitoring",
                    "code": {
                      "id": "4abd7fb8-b1e5-4f16-8b69-bc9cced4b0d6",
                      "code": "C25548",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Monitoring",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Vital Signs",
                    "description": "Monitoring of blood pressure, heart rate, and other vital signs"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "95586136-29db-4a2b-a7a9-15b95ff0a93d",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "e160f397-046b-4b6e-92cf-250ffae7bfb8",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "73bb0058-ff0e-4e6c-b475-4ca11bf865db",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              }
            ],
            "epochs": [
              {
                "id": "a5ef4e3c-0fe3-42a1-9624-886d45ddfc6b",
                "name": "Screening Period",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "ed6f650e-b95b-42a4-be98-ad8084f0f35c",
                  "code": "C98779",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Screening Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "a9d5f73b-9dd6-4a4d-aa0e-c021fc1cd491",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa,traversal"
                  },
                  {
                    "id": "3b880719-9107-433e-9806-ac0d2b63d7e9",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "0397860c-8cd5-4aa3-9790-09e65fbef9ff",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "1"
                  }
                ]
              },
              {
                "id": "a3d29481-61ef-4d69-a082-74fa363d99e4",
                "name": "Treatment Period",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "086ed97c-9182-4b40-be32-5f26e498a157",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "54bb751c-e3c8-4e2b-98f9-d9a2d7f5ec14",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa,traversal"
                  },
                  {
                    "id": "57b4aac1-39a2-474d-b400-137b5a188fec",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "5d5d890d-cdff-41a9-85e9-04b5acdcdb4d",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "2"
                  }
                ]
              }
            ],
            "activityGroups": [
              {
                "id": "408358b1-3c4b-490d-b15a-0ea5591c723c",
                "name": "Eligibility and History",
                "description": null,
                "childIds": [
                  "997c6ea0-164b-4c42-8466-719ce4e88cc6",
                  "d21fbad9-1c89-45e5-988e-0b8fefcfc9b5",
                  "dd134546-bccc-459b-a050-0cccaf5d0f8b",
                  "b06d1919-ba33-451a-8130-a2f8a1b88192"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Informed Consent",
                  "Eligibility Criteria",
                  "Medical History",
                  "PD Treatment History"
                ]
              },
              {
                "id": "f37349ad-ab2a-4ab1-9dc8-29b89e57825f",
                "name": "Clinical Assessments",
                "description": null,
                "childIds": [
                  "066a5196-e9a8-423b-ba4b-b248bd970a13",
                  "3f579363-98a6-44ae-9b78-b7e7d8f0f21f",
                  "c02ecd9a-5c29-48f7-b747-f1ee09df452e",
                  "9b4d4200-62bc-44ff-95e9-460308cd7d55"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Advanced Parkinson's Disease (aPD) Clinician Assessment",
                  "PD Diary",
                  "PD Diary Concordance Assessment",
                  "EuroQol 5-Dimension Questionnaire (EQ-5D-5L)",
                  "Parkinson's KinetiGraph (PKG) Wearable Device"
                ]
              },
              {
                "id": "a97e8ebe-3dc5-43d6-be9d-32aa04ee539b",
                "name": "Safety Assessments",
                "description": null,
                "childIds": [
                  "3f6a9dd3-d1bc-43bd-81f9-f21bad2a42f8",
                  "b7fb4f45-db24-4aa8-8ef3-e5fa83d7689c",
                  "ad760990-7420-4ca5-a41a-77e594a7b611"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Physical Examination",
                  "Neurological Examination",
                  "Height and Weight",
                  "Vital Signs",
                  "12-Lead ECG",
                  "Adverse Event Monitoring"
                ]
              },
              {
                "id": "bdc32de2-9649-4044-bdae-40e25ec8dc36",
                "name": "Laboratory Assessments",
                "description": null,
                "childIds": [
                  "d93761fc-70b6-45de-9685-84551422e5c3",
                  "5e3f0364-bce1-481d-a93b-228ded4799ea"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Hematology",
                  "Clinical Chemistry",
                  "Urinalysis",
                  "Special Laboratory Tests (Vitamin B6, B12, Folic Acid, MMA, Homocysteine)",
                  "Pregnancy Test"
                ]
              },
              {
                "id": "cd1cc56c-a6fe-48c1-95a8-4923d1675660",
                "name": "Study Drug Administration",
                "description": null,
                "childIds": [
                  "18ca9b30-6135-4749-8a2b-1a94c9b67415"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Study Drug Prescription Record",
                  "Pump Settings Record",
                  "Concomitant Medication Review"
                ]
              }
            ],
            "notes": [
              {
                "id": "d9bc1182-ba92-401d-ae37-90cfd4c1a57d",
                "text": "a. The Screening Period may be extended up to a total of 90 days for extenuating circumstances, e.g., supply constraints.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "5c9beb77-b6cc-4ef5-85d1-533c74162722",
                "text": "b. The Monitoring Period can occur any time before V3, as long as it lasts for 6 consecutive days. PD Diaries will also be collected for at least 2 consecutive days during the Monitoring Period.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "25690578-7bf4-43d3-aec8-bd491912fdf0",
                "text": "a. GFR will be calculated one time at Screening Visit 1 (V1) according to the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "0dd9c2be-6f7e-4186-bbc7-a3369329506d",
                "text": "b. Special laboratory tests to detect vitamin deficiencies, i.e., vitamin B12, vitamin B6, folic acid, homocysteine, and MMA levels will be performed at Screening Visit 1 (V1), on Day 1 (V3), and at Week 6 (V9), Week 26 (V11), and Week 52 (V13).",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "6d8f3a12-337f-4f1a-b832-e409313fc27d",
                "text": "a. Subjects with a low vitamin B12 or low-normal vitamin B12 and high MMA plasma level may undergo supplemental vitamin therapy.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "34a45b5b-70f2-4252-95dd-fdea88984512",
                "text": "b. The PD diary concordance test may be omitted for subjects previously enrolled in Study M15-739, for whom recognizable/identifiable \"Off\" and \"On\" state (motor fluctuations) have been already established and confirmed.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "00d395cd-ab15-4b40-a572-d3c09d5b4f2f",
                "text": "c. Subjects with evidence of transient skin conditions such as recent sunburn or open wound that resolved within the Screening Period are eligible for enrollment.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "33405f29-7215-4b5a-9646-0e3f8d44d06b",
                "text": "a. The Screening Period may be extended up to a total of 90 days for extenuating circumstances, e.g., supply constraints.",
                "instanceType": "Note"
              },
              {
                "id": "070fa2c9-c63c-4cb2-831a-90510f20c198",
                "text": "a. Subjects with a low vitamin B12 or low-normal vitamin B12 and high MMA plasma level may undergo supplemental vitamin therapy.",
                "instanceType": "Note"
              },
              {
                "id": "559ab5d3-993e-4ca4-b023-5f19fe5beaa0",
                "text": "c. Subjects with evidence of transient skin conditions such as recent sunburn or open wound that resolved within the Screening Period are eligible for enrollment.",
                "instanceType": "Note"
              },
              {
                "id": "f3f2b4da-226e-49df-ae7a-30e2abea691e",
                "text": "8. Subject must have a diagnosis of levodopa-responsive idiopathic PD.",
                "instanceType": "Note"
              }
            ],
            "model": {
              "id": "c14e2635-ab2f-4401-a2a7-d21eb4641feb",
              "code": "C82638",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Single Group Study",
              "instanceType": "Code"
            },
            "indications": [
              {
                "id": "8ba0807d-8705-49ce-b343-6e7c1f1323b6",
                "name": "Parkinson's Disease",
                "isRareDisease": false,
                "instanceType": "Indication",
                "description": "Treatment involving ABBV-951 and Levodopa equivalent doses"
              }
            ],
            "procedures": [
              {
                "id": "7d308b67-4cf1-4bf3-b8ff-c906fa94ef01",
                "name": "Clinical laboratory test",
                "procedureType": "Biospecimen Collection",
                "code": {
                  "id": "c0118ca0-5ce6-4686-b11b-c9c43d5afa38",
                  "code": "C70793",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Biospecimen Collection",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Laboratory Testing",
                "description": "Collection and analysis of clinical laboratory data from baseline to end of study"
              },
              {
                "id": "b6412614-bb1c-455f-a674-b8a28d1124b0",
                "name": "Vital sign measurements",
                "procedureType": "Monitoring",
                "code": {
                  "id": "4abd7fb8-b1e5-4f16-8b69-bc9cced4b0d6",
                  "code": "C25548",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Monitoring",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Vital Signs",
                "description": "Monitoring of blood pressure, heart rate, and other vital signs"
              },
              {
                "id": "430f854e-63f9-4ea8-b1a3-795f6788216a",
                "name": "Electrocardiogram",
                "procedureType": "Imaging Technique",
                "code": {
                  "id": "6d775178-a27c-41ad-ae14-f139bfd54a81",
                  "code": "93000",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Electrocardiogram, routine ECG with at least 12 leads",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "ECG",
                "description": "Recording of the electrical activity of the heart"
              },
              {
                "id": "ee601acb-1172-4ae1-89cb-cde204582a90",
                "name": "Neurologic examination",
                "procedureType": "Assessment",
                "code": {
                  "id": "306f048f-575a-494a-aaf6-691bc9357b9c",
                  "code": "C25218",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Assessment",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Neurological Exam",
                "description": "Assessment of PD symptoms by interview and physical examination"
              },
              {
                "id": "da03f49a-f996-4df9-8d65-858b4c175ff8",
                "name": "Continuous subcutaneous infusion",
                "procedureType": "Therapeutic Procedure",
                "code": {
                  "id": "ff2285b6-013d-455f-b602-43b0b661b8f7",
                  "code": "C49236",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Therapeutic Procedure",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "CSCI",
                "description": "Continuous delivery of ABBV-951 via a subcutaneous pump"
              },
              {
                "id": "7b6dabe8-bc1e-4bdd-8efb-646cd9458fae",
                "name": "Skin biopsy",
                "procedureType": "Biospecimen Collection",
                "code": {
                  "id": "87655996-bc2f-46a0-bc37-b3cefbd55653",
                  "code": "C70793",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Biospecimen Collection",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Biopsy",
                "description": "Optional collection of skin tissue for comprehensive evaluation by a dermatologist"
              },
              {
                "id": "50e6df08-1993-4ea8-8150-a58f41a27da4",
                "name": "DNA sampling",
                "procedureType": "Biospecimen Collection",
                "code": {
                  "id": "7b7c0b48-9bf4-4e25-86a4-5fdaae66a476",
                  "code": "C70793",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Biospecimen Collection",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Genetic Sampling",
                "description": "Collection of samples for genetic markers and biomarker research"
              },
              {
                "id": "045c840a-e27f-497c-b45f-c45385c2b145",
                "name": "Oral loading dose administration",
                "procedureType": "Therapeutic Procedure",
                "code": {
                  "id": "a8e9ead3-9f84-4868-9315-d2826d1bdb82",
                  "code": "C49236",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Therapeutic Procedure",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Loading Dose",
                "description": "Administration of oral LD+DDCI at the initiation of treatment"
              }
            ],
            "analysisPopulations": [
              {
                "id": "d62c1a27-1291-4de4-ae11-52e5815c3219",
                "name": "",
                "text": "",
                "populationType": "Analysis",
                "instanceType": "AnalysisPopulation"
              }
            ],
            "extensionAttributes": [
              {
                "id": "137028fc-60ca-4546-a2fb-390cc05ee02a",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-entityMaps",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"epochAliases\": {\"SCREENING PERIOD\": \"epoch_1\", \"SCREENING_PERIOD\": \"epoch_1\", \"SCREENING\": \"epoch_1\", \"TREATMENT PERIOD\": \"epoch_2\", \"TREATMENT_PERIOD\": \"epoch_2\", \"TREATMENT\": \"epoch_2\", \"TREATMENT_MAINTENANCE\": \"epoch_2\", \"TREATMENT_OPTIMIZATION\": \"epoch_2\"}, \"visitAliases\": {\"VISIT 1 (V1)\": \"enc_1\", \"VISIT_1_(V1)\": \"enc_1\", \"VISIT 2 (V2)\": \"enc_2\", \"VISIT_2_(V2)\": \"enc_2\", \"DAY 1 (V3)\": \"enc_3\", \"DAY_1_(V3)\": \"enc_3\", \"DAY 2 (V4)\": \"enc_4\", \"DAY_2_(V4)\": \"enc_4\", \"WEEK 1 (V5)\": \"enc_5\", \"WEEK_1_(V5)\": \"enc_5\", \"WEEK 2 (V6)\": \"enc_6\", \"WEEK_2_(V6)\": \"enc_6\", \"WEEK 3 (V7)\": \"enc_7\", \"WEEK_3_(V7)\": \"enc_7\", \"WEEK 4 (V8)\": \"enc_8\", \"WEEK_4_(V8)\": \"enc_8\", \"WEEK 6 (V9)\": \"enc_9\", \"WEEK_6_(V9)\": \"enc_9\", \"WEEK 13 (V10)\": \"enc_10\", \"WEEK_13_(V10)\": \"enc_10\", \"WEEK 26 (V11)\": \"enc_11\", \"WEEK_26_(V11)\": \"enc_11\", \"WEEK 39 (V12)\": \"enc_12\", \"WEEK_39_(V12)\": \"enc_12\", \"WEEK 52 (V13)\": \"enc_13\", \"WEEK_52_(V13)\": \"enc_13\", \"Visit 12\": \"enc_3\", \"Visit 4\": \"enc_4\", \"Week 39\": \"enc_12\", \"Week 52\": \"enc_13\"}}"
              },
              {
                "id": "b3ea8185-53f2-434c-95c5-cc29f0dde417",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-classifiedIssues",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"severity\": \"warning\", \"category\": \"traversal_resolution\", \"message\": \"Traversal step 'MONITORING_PERIOD' could not be resolved to an epoch ID\", \"affectedPath\": \"$.traversalConstraints[].requiredSequence\", \"affectedIds\": [\"25f62be7-0ce9-46f8-ab97-415ced1db3e7\"], \"suggestion\": \"Create epoch for 'MONITORING_PERIOD' or map to existing epoch\"}, {\"severity\": \"warning\", \"category\": \"traversal_resolution\", \"message\": \"Traversal step 'FOLLOW_UP' could not be resolved to an epoch ID\", \"affectedPath\": \"$.traversalConstraints[].requiredSequence\", \"affectedIds\": [\"25f62be7-0ce9-46f8-ab97-415ced1db3e7\"], \"suggestion\": \"Create epoch for 'FOLLOW_UP' or map to existing epoch\"}]"
              },
              {
                "id": "ext_conceptual_afe4e4d0-3ce4-433e-8354-90caeeba40cc",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-conceptualAnchors",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"2bc90d4f-9f52-40b7-9903-30b0688965c8\", \"name\": \"Monitoring Period\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}, {\"id\": \"7ff20e96-183b-42c2-9cfd-c75c5343f7b5\", \"name\": \"Stable Oral PD Medication\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}, {\"id\": \"d6e9eed4-782d-4636-97c2-5383a103c35e\", \"name\": \"Prohibited Medication Washout\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}, {\"id\": \"5854c31a-56ba-4c40-a9ed-f4369514aaff\", \"name\": \"Levodopa/COMT Discontinuation\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}]"
              },
              {
                "id": "d56db8f5-592f-4d78-bb3a-69d32b21607b",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-promotionIssues",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"severity\": \"warning\", \"category\": \"timing_reference_remapped\", \"message\": \"Timing 'Screening Period' reference remapped: 38f75ad4-0432-413e-a6ff-fc09b8d145e1 \\u2192 anchor_inst_anchor_2\", \"affectedPath\": \"$.timings[?(@.id=='timing_1')]\"}, {\"severity\": \"warning\", \"category\": \"timing_reference_remapped\", \"message\": \"Timing 'Extended Screening Window' reference remapped: 5007b3f1-fdba-470b-a074-6be16fd51aa1 \\u2192 anchor_inst_anchor_2\", \"affectedPath\": \"$.timings[?(@.id=='timing_2')]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'Monitoring Period' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'Stable Oral PD Medication' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'Prohibited Medication Washout' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'Levodopa/COMT Discontinuation' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: 158b803b-b842-48c6-b90b-12f3191fd3ff (encounter: enc_3)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: 573bfff4-dad4-4e71-baf2-b3b082c556b6 (encounter: enc_3)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}]"
              },
              {
                "id": "84f6e59a-abc8-4e98-baf8-763116685b9a",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-timeAnchors",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"37befd42-7708-4097-bb38-6a75618442df\", \"definition\": \"First administration of investigational product\", \"anchorType\": \"FirstDose\", \"classification\": \"Event\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 60, \"sourceText\": \"initiation of treatment\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"786e2c1c-794b-4635-9c54-edf4324d7f16\", \"definition\": \"The initiation of ABBV-951 (study drug) administration\", \"anchorType\": \"Day1\", \"classification\": \"Visit\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 80, \"sourceText\": \"The Treatment Period starts with the initiation of ABBV-951... On the morning of Day 1 (V3) subjects will need to be in a clinically defined \\\"Off\\\" state (i.e., no PD medications for at least 12 hours before initiation of study drug).\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"e52b4ef4-7f1b-49f6-8441-ccd836de992f\", \"definition\": \"Screening visit\", \"anchorType\": \"Screening\", \"classification\": \"Visit\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 20, \"sourceText\": \"Screening \\nPeriod\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"dc4a3628-7cc3-4b77-a215-b19e4da1a4fa\", \"definition\": \"procedure\", \"anchorType\": \"Custom\", \"classification\": \"Conceptual\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 100, \"sourceText\": \"procedure\", \"encounterId\": null, \"activityId\": null}]"
              },
              {
                "id": "2faba4d8-7f6e-496c-9c63-e4ae571de7d4",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-repetitions",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"1954f42f-79b2-4cfa-8bcb-d2a0cb8d32f8\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"OD\"}, {\"id\": \"cc1d58ca-74af-42ba-94c7-a2a88233e0bf\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"od\"}, {\"id\": \"937dbf8a-c231-49fe-ac0a-872f95b095f8\", \"type\": \"Interval\", \"sourceText\": \"bid\"}, {\"id\": \"02180bff-8535-47c6-8d05-7213c301be2f\", \"type\": \"Continuous\", \"sourceText\": \"Screening \\nPeriod\"}, {\"id\": \"0abd7051-291e-44bb-a8e2-84cc6c306f7e\", \"type\": \"Continuous\", \"sourceText\": \"Screening Period\"}, {\"id\": \"dce83350-9c1f-4b01-899d-8ec3c7b17a2b\", \"type\": \"Continuous\", \"sourceText\": \"Treatment Period\"}, {\"id\": \"e8f05a9a-d813-4d61-9e5a-2c4281a363dd\", \"type\": \"Continuous\", \"sourceText\": \"treatment period\"}, {\"id\": \"acddbb91-6c45-4b50-b08d-908570a58bca\", \"type\": \"Continuous\", \"sourceText\": \"treatment \\nperiod\"}, {\"id\": \"07370040-af09-470c-8f61-2fdacfe28377\", \"type\": \"Continuous\", \"sourceText\": \"12 hours before\"}, {\"id\": \"1449e851-01a6-4670-a426-f59a4ad9ad2f\", \"type\": \"Continuous\", \"sourceText\": \"30 days after\"}, {\"id\": \"0aaf9951-e816-4993-abb3-ad7d0e08c6a2\", \"type\": \"Continuous\", \"startOffset\": \"P0D\", \"endOffset\": \"P28D\", \"interval\": \"P1D\", \"minObservations\": 28, \"exitCondition\": \"Completion of 28-day infusion period\", \"sourceText\": \"following CSCI for 28 days with a fixed indwelling catheter at a rate of 0.1 or 0.25 mL/hour\"}, {\"id\": \"efa6d8e1-b9c3-46a4-96a6-493a0016236c\", \"type\": \"Continuous\", \"startOffset\": \"P0D\", \"endOffset\": \"PT72H\", \"interval\": \"PT1H\", \"minObservations\": 72, \"exitCondition\": \"Completion of 72-hour infusion\", \"sourceText\": \"ABBV-951 was administered as a loading dose followed by a continuous infusion for up to 72 hours\"}, {\"id\": \"ee103f53-dd8d-43c4-b8c4-2425c0b3b164\", \"type\": \"Continuous\", \"startOffset\": \"P0D\", \"endOffset\": \"P5D\", \"interval\": \"P1D\", \"minObservations\": 5, \"exitCondition\": \"Completion of 5-day infusion\", \"sourceText\": \"infusion of ABBV-951 at the same concentration (50/200 mg/mL), but at a higher infusion rate (0.5 mL/hour) for fewer days (5 days) was well tolerated\"}]"
              },
              {
                "id": "df1ed016-dcee-4296-a4d6-963204252d98",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-traversalConstraints",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"25f62be7-0ce9-46f8-ab97-415ced1db3e7\", \"requiredSequence\": [\"epoch_1\", \"epoch_2\", \"epoch_2\"], \"allowEarlyExit\": true, \"exitEpochIds\": [], \"mandatoryVisits\": [\"enc_3\", \"enc_1\", \"enc_1\", \"enc_2\", \"enc_8\", \"enc_13\"], \"sourceText\": \"[{'condition': 'If subject experiences AE requiring discontinuation', 'path': ['EARLY_TERMINATION', 'FOLLOW_UP']}, {'condition': 'In countries where PKG watch is not approved', 'path': ['REDUCED_MONITORING_PERIOD']}]\"}]"
              },
              {
                "id": "1aac4ae4-7ba8-4958-a2fc-68839fcf81ff",
                "url": "https://protocol2usdm.io/extensions/x-footnoteConditions",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"2be4b0f3-628d-4dc3-96cd-5e4ec2c24256\", \"conditionType\": \"general\", \"text\": \"a. The Screening Period may be extended up to a total of 90 days for extenuating circumstances, e.g., supply constraints.\", \"footnoteId\": \"d4a2742a-1252-423a-a1c4-b537785b5e91\", \"structuredCondition\": \"period.duration.max(Screening, P90D)\", \"appliesToActivityIds\": [\"Screening Period\"], \"sourceText\": \"a. The Screening Period may be extended up to a total of 90 days for extenuating circumstances, e.g.\"}, {\"id\": \"1337a16a-575e-4514-84a7-2867799918f0\", \"conditionType\": \"timing_before\", \"text\": \"b. The Monitoring Period can occur any time before V3, as long as it lasts for 6 consecutive days. PD Diaries will also be collected for at least 2 consecutive days during the Monitoring Period.\", \"footnoteId\": \"29af93fc-ba1f-467e-a60c-09f14af8e98b\", \"structuredCondition\": \"timing.before(MonitoringPeriod, V3) && duration(MonitoringPeriod, P6D) && duration(PD_Diaries, P2D)\", \"appliesToActivityIds\": [\"43a9db09-d928-4f77-9572-3ae15639a432\"], \"sourceText\": \"b. The Monitoring Period can occur any time before V3, as long as it lasts for 6 consecutive days. P\"}, {\"id\": \"905c47b7-8b1e-4efa-a618-0076135c07db\", \"conditionType\": \"general\", \"text\": \"a. GFR will be calculated one time at Screening Visit 1 (V1) according to the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation.\", \"footnoteId\": \"1710b877-0951-44d2-a0ce-f3f370c4e51f\", \"structuredCondition\": \"occurrence.count(GFR, 1) && timing.at(V1)\", \"appliesToActivityIds\": [\"066a5196-e9a8-423b-ba4b-b248bd970a13\"], \"sourceText\": \"a. GFR will be calculated one time at Screening Visit 1 (V1) according to the Chronic Kidney Disease\"}, {\"id\": \"803d6c5a-f2d3-45b8-bd3b-ac53e3f2698d\", \"conditionType\": \"timing_at\", \"text\": \"b. Special laboratory tests to detect vitamin deficiencies, i.e., vitamin B12, vitamin B6, folic acid, homocysteine, and MMA levels will be performed at Screening Visit 1 (V1), on Day 1 (V3), and at Week 6 (V9), Week 26 (V11), and Week 52 (V13).\", \"footnoteId\": \"54c74f61-b043-4555-8f58-5908ee4b9d4f\", \"structuredCondition\": \"timing.at([V1, V3, V9, V11, V13])\", \"appliesToActivityIds\": [\"d93761fc-70b6-45de-9685-84551422e5c3\"], \"sourceText\": \"b. Special laboratory tests to detect vitamin deficiencies, i.e., vitamin B12, vitamin B6, folic aci\"}, {\"id\": \"d571a2fc-60c5-4fad-a1c0-8c9fccf5fe21\", \"conditionType\": \"general\", \"text\": \"a. Subjects with a low vitamin B12 or low-normal vitamin B12 and high MMA plasma level may undergo supplemental vitamin therapy.\", \"footnoteId\": \"6ed3d5a1-4b30-4f93-b9f4-0f4db345aacc\", \"structuredCondition\": \"if(lab.B12 == low || (lab.B12 == low-normal && lab.MMA == high)) then(supplemental_vitamin_therapy)\", \"appliesToActivityIds\": [\"Supplemental vitamin therapy\"], \"sourceText\": \"a. Subjects with a low vitamin B12 or low-normal vitamin B12 and high MMA plasma level may undergo s\"}, {\"id\": \"e83fc045-70a1-472d-8e73-334a09e2e2cc\", \"conditionType\": \"general\", \"text\": \"b. The PD diary concordance test may be omitted for subjects previously enrolled in Study M15-739, for whom recognizable/identifiable \\\"Off\\\" and \\\"On\\\" state (motor fluctuations) have been already established and confirmed.\", \"footnoteId\": \"466728f7-773e-4ec4-8078-7e006c2e9491\", \"structuredCondition\": \"if(subject.prior_enrollment == 'M15-739' && subject.motor_fluctuations == established) then(omit(PD_diary_concordance_test))\", \"appliesToActivityIds\": [\"3f579363-98a6-44ae-9b78-b7e7d8f0f21f\"], \"sourceText\": \"b. The PD diary concordance test may be omitted for subjects previously enrolled in Study M15-739, f\"}, {\"id\": \"ec4da8e0-8398-4fc4-abc2-e4a08f453957\", \"conditionType\": \"general\", \"text\": \"c. Subjects with evidence of transient skin conditions such as recent sunburn or open wound that resolved within the Screening Period are eligible for enrollment.\", \"footnoteId\": \"01833b41-bae7-41aa-8257-1a41cae49f61\", \"structuredCondition\": \"if(skin_condition.status == resolved && skin_condition.timing == ScreeningPeriod) then(eligible)\", \"appliesToActivityIds\": [\"Enrollment\"], \"sourceText\": \"c. Subjects with evidence of transient skin conditions such as recent sunburn or open wound that res\"}, {\"id\": \"b1ef8c81-3427-4a80-8354-f5ba5b6057f8\", \"conditionType\": \"timing_after\", \"text\": \"p. 4 of 46 OPERATIONS MANUAL FOR CLINICAL STUDY PROTOCOL M15-741 VERSION 7.0 CONFIDENTIAL INFORMATION No use or disclosure outside AbbVie is permitted without prior written authorization from AbbVie. 4.2 REPORTING ADVERSE EVENTS AND INTERCURRENT ILLNESSES 37 4.3 PRODUCT COMPLAINT REPORTING 39 5 COUNTRY-SPECIFIC REQUIREMENTS 39 5.1 SAMPLE RETENTION REQUIREMENTS 39 5.2 SUSAR REPORTING 39 5.3 TREATMENT AFTER END OF STUDY 40 6 REFERENCES 40 LIST OF APPENDICES APPENDIX A. NEUROLOGY LABORATORY GRADING 41 APPENDIX B. CRITERIA FOR POTENTIALLY CLINICALLY SIGNIFICANT VITAL SIGN VALUES AND WEIGHT VALUES 46 Page 65 of 107 --- Page 66 ---\", \"footnoteId\": \"e92409b6-9e9a-4d49-9ff8-6f6025f96dc7\", \"sourceText\": \"p. 4 of 46 OPERATIONS MANUAL FOR CLINICAL STUDY PROTOCOL M15-741 VERSION 7.0 CONFIDENTIAL INFORMATIO\", \"appliesToActivityIds\": [\"ad760990-7420-4ca5-a41a-77e594a7b611\", \"43a9db09-d928-4f77-9572-3ae15639a432\", \"76fe83b3-d1a5-42c8-912c-4d30c37c69ef\", \"bdc32de2-9649-4044-bdae-40e25ec8dc36\", \"d21fbad9-1c89-45e5-988e-0b8fefcfc9b5\", \"b06d1919-ba33-451a-8130-a2f8a1b88192\", \"f37349ad-ab2a-4ab1-9dc8-29b89e57825f\", \"cd1cc56c-a6fe-48c1-95a8-4923d1675660\"]}, {\"id\": \"10b015ff-37f1-46f1-a3d1-c04aefb0e6e3\", \"conditionType\": \"general\", \"text\": \"1. Percentage of subjects with adverse events (AEs) and serious adverse events (SAEs) during the study\", \"footnoteId\": \"bad884e4-116f-427d-9b2c-275f7ec38cd7\", \"sourceText\": \"1. Percentage of subjects with adverse events (AEs) and serious adverse events (SAEs) during the stu\", \"appliesToActivityIds\": [\"cd1cc56c-a6fe-48c1-95a8-4923d1675660\", \"43a9db09-d928-4f77-9572-3ae15639a432\"]}, {\"id\": \"67bfcd11-ac48-44f3-a423-2daa4fb1f191\", \"conditionType\": \"general\", \"text\": \"2. Percentage of subjects with AEs of special interest (AESIs) during the study\", \"footnoteId\": \"46e0e8a7-cb17-433d-a920-31f3f043e431\", \"sourceText\": \"2. Percentage of subjects with AEs of special interest (AESIs) during the study\", \"appliesToActivityIds\": [\"cd1cc56c-a6fe-48c1-95a8-4923d1675660\", \"d93761fc-70b6-45de-9685-84551422e5c3\"]}, {\"id\": \"cad5294b-3e1f-4a1a-a8d8-d0e66b49d672\", \"conditionType\": \"general\", \"text\": \"3. Percentage of subjects with numeric grade equal to or higher than 5 and percentage of subjects with letter grade equal to or higher than D on the Infusion Site Evaluation Scale at any time during the study\", \"footnoteId\": \"647da999-0e95-4b30-95c8-a0b92fc497f2\", \"sourceText\": \"3. Percentage of subjects with numeric grade equal to or higher than 5 and percentage of subjects wi\", \"appliesToActivityIds\": [\"cd1cc56c-a6fe-48c1-95a8-4923d1675660\"]}, {\"id\": \"7aefed1e-1754-418e-bf36-cc3a3d80aaba\", \"conditionType\": \"general\", \"text\": \"4. Change in clinical laboratory test data from Baseline to end of study\", \"footnoteId\": \"4499a344-3c64-462d-9aab-b6f0c41864a4\", \"sourceText\": \"4. Change in clinical laboratory test data from Baseline to end of study\", \"appliesToActivityIds\": [\"f37349ad-ab2a-4ab1-9dc8-29b89e57825f\", \"cd1cc56c-a6fe-48c1-95a8-4923d1675660\", \"bdc32de2-9649-4044-bdae-40e25ec8dc36\", \"5e3f0364-bce1-481d-a93b-228ded4799ea\"]}, {\"id\": \"c115f99f-3779-44f0-b9d6-d14c5ceac0a3\", \"conditionType\": \"general\", \"text\": \"5. Change in vital sign measurements from Baseline to end of study\", \"footnoteId\": \"771ccb41-e178-4069-a4ae-3a5a27fb8a50\", \"sourceText\": \"5. Change in vital sign measurements from Baseline to end of study\", \"appliesToActivityIds\": [\"cd1cc56c-a6fe-48c1-95a8-4923d1675660\", \"76fe83b3-d1a5-42c8-912c-4d30c37c69ef\"]}, {\"id\": \"60c10e28-e713-40ed-a228-a62ac4ccca32\", \"conditionType\": \"general\", \"text\": \"6. Change in electrocardiograms (ECGs) from Baseline to end of study\", \"footnoteId\": \"2c33dbf3-6df8-4a03-a700-035bd11c31cf\", \"sourceText\": \"6. Change in electrocardiograms (ECGs) from Baseline to end of study\", \"appliesToActivityIds\": [\"cd1cc56c-a6fe-48c1-95a8-4923d1675660\"]}, {\"id\": \"3cf35b70-055b-4464-95ce-31b1f7430492\", \"conditionType\": \"general\", \"text\": \"7. Subject is not considered by the investigator to be an unsuitable candidate to receive ABBV-951 for any reason. Disease Activity\", \"footnoteId\": \"7d528954-0984-4bae-bceb-8519b170de5b\", \"structuredCondition\": \"investigator.assessment == suitable\", \"appliesToActivityIds\": [\"066a5196-e9a8-423b-ba4b-b248bd970a13\"], \"sourceText\": \"7. Subject is not considered by the investigator to be an unsuitable candidate to receive ABBV-951 f\"}, {\"id\": \"40479a40-c0be-4082-b2f4-1570a769015b\", \"conditionType\": \"general\", \"text\": \"8. Subject must have a diagnosis of levodopa-responsive idiopathic PD.\", \"footnoteId\": \"92d6dd22-d177-4964-beba-b21f076fd3da\", \"structuredCondition\": \"subject.diagnosis == 'levodopa-responsive idiopathic PD'\", \"appliesToActivityIds\": [\"Enrollment\"], \"sourceText\": \"8. Subject must have a diagnosis of levodopa-responsive idiopathic PD.\"}, {\"id\": \"52121c6a-a6ce-437f-9f57-100551695b72\", \"conditionType\": \"timing_before\", \"text\": \"9. Subject must meet the following disease activity criteria: \\uf0b7 Must be taking a regimen of oral medications for PD that has remained unchanged for at least 30 days before commencing ABBV-951 (rescue medications taken \\\"as needed\\\" may be disregarded when assessing whether the regimen of oral medications has remained unchanged); this regimen must include levodopa-containing formulations such as CD/LD IR (e.g., Sinemet, Madopar), CD/LD-CR (e.g., Sinemet controlled release [CR]), CD/LD extended release (e.g., Rytary), CD/LD/entacapone (e.g., Stalevo). \\uf0b7 Must have a recognizable/identifiable \\\"Off\\\" and \\\"On\\\" state (motor fluctuations) as established through investigator observation and confirmed by PD diary entries recorded during the concordance test performed during the Screening Period.b\", \"footnoteId\": \"bc67a517-1704-4f3a-a6f7-b39cc2e623b4\", \"structuredCondition\": \"medication.PD_regimen.stable_duration >= P30D && subject.motor_fluctuations == confirmed\", \"appliesToActivityIds\": [\"3f579363-98a6-44ae-9b78-b7e7d8f0f21f\", \"9b605766-f564-44fd-84d6-d7c6c2ad9eeb\", \"5e3f0364-bce1-481d-a93b-228ded4799ea\", \"d21fbad9-1c89-45e5-988e-0b8fefcfc9b5\", \"c02ecd9a-5c29-48f7-b747-f1ee09df452e\", \"066a5196-e9a8-423b-ba4b-b248bd970a13\", \"18ca9b30-6135-4749-8a2b-1a94c9b67415\"], \"sourceText\": \"9. Subject must meet the following disease activity criteria: \\uf0b7 Must be taking a regimen of oral med\"}]"
              },
              {
                "id": "25160e01-2183-4143-a197-d25aabbf4212",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-endpointAlgorithms",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"21875b0b-c9e7-4923-9c7b-8ee50ebf7007\", \"name\": \"Primary: Adverse Event Incidence\", \"endpointType\": \"Primary\", \"inputs\": [\"AE\", \"SAE\", \"AESI\"], \"timeWindow\": {\"reference\": \"First infusion to end of study\", \"duration\": \"P52W\"}, \"algorithm\": \"(Count of subjects with >= 1 event / Total subjects in Safety Analysis Set) * 100\", \"successCriteria\": \"Descriptive summary of percentage of subjects with AEs, SAEs, and AESIs\", \"sourceText\": \"Percentage of subjects with adverse events (AEs) and serious adverse events (SAEs) during the study; Percentage of subjects with AEs of special interest (AESIs) during the study\"}, {\"id\": \"1317959c-6079-45be-a1e0-fbddffd0681b\", \"name\": \"Primary: Infusion Site Tolerability\", \"endpointType\": \"Primary\", \"inputs\": [\"Infusion Site Evaluation Scale numeric grade\", \"Infusion Site Evaluation Scale letter grade\"], \"timeWindow\": {\"reference\": \"Any time during study\", \"duration\": \"P52W\"}, \"algorithm\": \"Percentage of subjects with numeric grade >= 5 OR letter grade >= D\", \"successCriteria\": \"Descriptive summary of high-grade site reactions\", \"sourceText\": \"Percentage of subjects with numeric grade equal to or higher than 5 and percentage of subjects with letter grade equal to or higher than D on the Infusion Site Evaluation Scale at any time during the \"}, {\"id\": \"5894b017-a5c6-4543-b142-650ca7d69c39\", \"name\": \"Primary: Safety Parameter Change from Baseline\", \"endpointType\": \"Primary\", \"inputs\": [\"Clinical laboratory data\", \"Vital signs\", \"ECG\"], \"timeWindow\": {\"reference\": \"Baseline to end of study\", \"duration\": \"P52W\"}, \"algorithm\": \"Post-baseline value - Baseline value\", \"successCriteria\": \"Descriptive statistics (mean, SD, min, median, max) of change\", \"sourceText\": \"Change in clinical laboratory test data from Baseline to end of study; Change in vital sign measurements from Baseline to end of study; Change in electrocardiograms (ECGs) from Baseline to end of stud\"}, {\"id\": \"926c22b9-7d8e-4d6e-a493-a24cf4e7552b\", \"name\": \"Secondary: Normalized Daily Off/On Time\", \"endpointType\": \"Secondary\", \"inputs\": [\"PD Diary Off time\", \"PD Diary On time\", \"Total diary hours\"], \"timeWindow\": {\"reference\": \"Baseline to end of study\", \"duration\": \"P52W\"}, \"algorithm\": \"(Reported hours / Total diary hours) * 24 - Baseline normalized value\", \"successCriteria\": \"Paired-sample t-test for change from Baseline\", \"sourceText\": \"Average normalized daily \\\"Off\\\" time and \\\"On\\\" times as assessed by the PD Diary\"}, {\"id\": \"e9b9a26d-ce11-4193-bb79-bbc5ceae0df8\", \"name\": \"Secondary: PD Symptom Severity (MDS-UPDRS)\", \"endpointType\": \"Secondary\", \"inputs\": [\"MDS-UPDRS Parts I-IV total scores\"], \"timeWindow\": {\"reference\": \"Baseline to end of study\", \"duration\": \"P52W\"}, \"algorithm\": \"End of study score - Baseline score\", \"successCriteria\": \"Paired-sample t-test for change from Baseline\", \"sourceText\": \"PD symptoms as assessed by the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Parts I-IV\"}, {\"id\": \"f8505bc0-fae2-4461-8c9d-55eb2326823b\", \"name\": \"Secondary: Quality of Life and Sleep\", \"endpointType\": \"Secondary\", \"inputs\": [\"PDSS-2 score\", \"PDQ-39 score\", \"EQ-5D-5L score\"], \"timeWindow\": {\"reference\": \"Baseline to end of study\", \"duration\": \"P52W\"}, \"algorithm\": \"End of study score - Baseline score\", \"successCriteria\": \"Paired-sample t-test for change from Baseline\", \"sourceText\": \"Sleep symptoms as assessed by the PD Sleep Scale-2 (PDSS-2); Quality of life as assessed by the PD Questionnaire-39 items (PDQ-39); Health-related quality of life as assessed by the EuroQol 5-dimensio\"}]"
              },
              {
                "id": "9ef7e559-f98e-479e-ba09-baa66beb41b2",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-derivedVariables",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"a9de07eb-b8bb-4d9c-a89e-ca03bd710f7a\", \"name\": \"Percentage of subjects with adverse events (AEs)\", \"variableType\": \"Categorical\", \"sourceVariables\": [\"Adverse Event (AE) occurrence\"], \"derivationRule\": \"(Number of subjects with at least one AE / Total number of subjects) * 100\", \"baselineDefinition\": \"Not applicable\", \"analysisWindow\": \"Up to 52 weeks\", \"imputationRule\": \"None specified\", \"unit\": \"%\"}, {\"id\": \"1ac46b70-d6bf-4290-afe1-72928ff0b613\", \"name\": \"Percentage of subjects with Infusion Site Evaluation Scale numeric grade >= 5\", \"variableType\": \"Categorical\", \"sourceVariables\": [\"Infusion Site Evaluation Scale numeric grade\"], \"derivationRule\": \"(Number of subjects with numeric grade >= 5 at any time / Total number of subjects) * 100\", \"baselineDefinition\": \"Not applicable\", \"analysisWindow\": \"Any time during the study\", \"imputationRule\": \"None specified\", \"unit\": \"%\"}, {\"id\": \"13dee3c4-9f90-4ee4-8c52-2383afce9bb0\", \"name\": \"Change in clinical laboratory test data from Baseline\", \"variableType\": \"ChangeFromBaseline\", \"sourceVariables\": [\"Clinical laboratory test values\"], \"derivationRule\": \"End of study value - Baseline value\", \"baselineDefinition\": \"Last value prior to initial study drug administration\", \"baselineVisit\": \"Baseline\", \"analysisWindow\": \"End of study (Week 52)\", \"imputationRule\": \"None specified\", \"unit\": \"Variable per test\"}, {\"id\": \"62ade9b5-ef97-49aa-9597-be9242da1996\", \"name\": \"Change in vital sign measurements from Baseline\", \"variableType\": \"ChangeFromBaseline\", \"sourceVariables\": [\"Vital sign measurements\"], \"derivationRule\": \"End of study value - Baseline value\", \"baselineDefinition\": \"Last value prior to initial study drug administration\", \"baselineVisit\": \"Baseline\", \"analysisWindow\": \"End of study (Week 52)\", \"imputationRule\": \"None specified\", \"unit\": \"Variable per measurement\"}, {\"id\": \"91945575-644d-468f-8335-8af3f21fc340\", \"name\": \"Average normalized daily Off time\", \"variableType\": \"ChangeFromBaseline\", \"sourceVariables\": [\"PD Diary Off time\"], \"derivationRule\": \"(End of study normalized Off time) - (Baseline normalized Off time)\", \"baselineDefinition\": \"Assessed via PD Diary prior to treatment\", \"baselineVisit\": \"Baseline\", \"analysisWindow\": \"End of study (Week 52)\", \"imputationRule\": \"None specified\", \"unit\": \"Hours\"}, {\"id\": \"4eb3a9c5-71e5-455d-bf4f-31d7a9643671\", \"name\": \"Change in MDS-UPDRS Parts I-IV\", \"variableType\": \"ChangeFromBaseline\", \"sourceVariables\": [\"MDS-UPDRS score\"], \"derivationRule\": \"End of study total score - Baseline total score\", \"baselineDefinition\": \"Last assessment prior to treatment\", \"baselineVisit\": \"Baseline\", \"analysisWindow\": \"End of study (Week 52)\", \"imputationRule\": \"None specified\", \"unit\": \"Score\"}, {\"id\": \"3d13340c-839e-46e8-9ffc-52cb8e61b46b\", \"name\": \"Change in PDSS-2\", \"variableType\": \"ChangeFromBaseline\", \"sourceVariables\": [\"PDSS-2 score\"], \"derivationRule\": \"End of study total score - Baseline total score\", \"baselineDefinition\": \"Last assessment prior to treatment\", \"baselineVisit\": \"Baseline\", \"analysisWindow\": \"End of study (Week 52)\", \"imputationRule\": \"None specified\", \"unit\": \"Score\"}, {\"id\": \"b7c81d90-7745-4ea7-817a-f657b2c6a5d8\", \"name\": \"Change in PDQ-39\", \"variableType\": \"ChangeFromBaseline\", \"sourceVariables\": [\"PDQ-39 score\"], \"derivationRule\": \"End of study total score - Baseline total score\", \"baselineDefinition\": \"Last assessment prior to treatment\", \"baselineVisit\": \"Baseline\", \"analysisWindow\": \"End of study (Week 52)\", \"imputationRule\": \"None specified\", \"unit\": \"Score\"}, {\"id\": \"c93153ac-4a50-4edc-9e16-68254ed3b11b\", \"name\": \"Change in EQ-5D-5L\", \"variableType\": \"ChangeFromBaseline\", \"sourceVariables\": [\"EQ-5D-5L score\"], \"derivationRule\": \"End of study total score - Baseline total score\", \"baselineDefinition\": \"Last assessment prior to treatment\", \"baselineVisit\": \"Baseline\", \"analysisWindow\": \"End of study (Week 52)\", \"imputationRule\": \"None specified\", \"unit\": \"Score\"}, {\"id\": \"8d06517d-c1b4-4513-b8c2-6b4e44cc715a\", \"name\": \"Change in PKG wearable device assessments\", \"variableType\": \"ChangeFromBaseline\", \"sourceVariables\": [\"Tremor\", \"Bradykinesia\", \"Dyskinesia\", \"Daytime somnolence\", \"Impulsive behaviors\"], \"derivationRule\": \"Week 26 value - Baseline value\", \"baselineDefinition\": \"6-Day Monitoring Period prior to Visit 3\", \"baselineVisit\": \"Visit 3\", \"analysisWindow\": \"Week 26\", \"imputationRule\": \"None specified\", \"unit\": \"Variable per metric\"}]"
              },
              {
                "id": "e18442db-7e67-4a42-969a-f920b3272a82",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-stateMachine",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"id\": \"1df0077b-2ecb-47bb-ac8e-c49566378290\", \"initialState\": \"Screening\", \"terminalStates\": [\"Early Termination\", \"Completed\"], \"states\": [\"Screening\", \"Monitoring Period\", \"Treatment Optimization\", \"Treatment Maintenance\", \"Follow Up\", \"Early Termination\"], \"transitions\": [{\"fromState\": \"Screening\", \"toState\": \"Monitoring Period\", \"trigger\": \"Progress to Monitoring Period\"}, {\"fromState\": \"Monitoring Period\", \"toState\": \"Treatment Optimization\", \"trigger\": \"Progress to Treatment Optimization\"}, {\"fromState\": \"Treatment Optimization\", \"toState\": \"Treatment Maintenance\", \"trigger\": \"Progress to Treatment Maintenance\"}, {\"fromState\": \"Treatment Maintenance\", \"toState\": \"Follow Up\", \"trigger\": \"Progress to Follow Up\"}, {\"fromState\": \"Monitoring Period\", \"toState\": \"Early Termination\", \"trigger\": \"Subject exits to Early Termination\"}, {\"fromState\": \"Treatment Optimization\", \"toState\": \"Early Termination\", \"trigger\": \"Subject exits to Early Termination\"}, {\"fromState\": \"Treatment Maintenance\", \"toState\": \"Early Termination\", \"trigger\": \"Subject exits to Early Termination\"}], \"epochIds\": {\"Screening\": \"SCREENING\", \"Monitoring Period\": \"MONITORING_PERIOD\", \"Treatment Optimization\": \"TREATMENT_OPTIMIZATION\", \"Treatment Maintenance\": \"TREATMENT_MAINTENANCE\", \"Follow Up\": \"FOLLOW_UP\", \"Early Termination\": \"EARLY_TERMINATION\"}}"
              },
              {
                "id": "73c0dafd-3d50-48e6-8dc7-0b858e831185",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-dosingRegimens",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"e5217fcd-44ee-460b-9b08-7dde00be85dd\", \"treatmentName\": \"Therapy\", \"frequency\": \"QD\", \"route\": \"Oral\", \"startDay\": 1, \"doseLevels\": [{\"amount\": 100.0, \"unit\": \"mg\"}, {\"amount\": 25.0, \"unit\": \"mg\"}, {\"amount\": 10.0, \"unit\": \"mg\"}, {\"amount\": 84.0, \"unit\": \"mg\"}], \"sourceText\": \"se a. Apomorphine and ergot dopamine agonists (lisuride, bromocriptine, cabergoline, etc.) are NOT allowed. b. Approved in Japan. c. Approved in the United States. Table 7. Allowed Rescue Medications/\"}, {\"id\": \"520fe3f7-0270-4980-9751-8e056c1f3ce8\", \"treatmentName\": \"ABBV-951 (carbidopa phosphate/levodopa phosphate [CDP/LDP])\", \"frequency\": \"Continuous\", \"route\": \"SC\", \"startDay\": 1, \"doseLevels\": [{\"amount\": 50.0, \"unit\": \"mg/mL\", \"description\": \"Concentration of carbidopa phosphate\"}, {\"amount\": 200.0, \"unit\": \"mg/mL\", \"description\": \"Concentration of levodopa phosphate\"}], \"durationDescription\": \"52 weeks\", \"titrationSchedule\": \"Individualized delivery covering a wide range of levodopa doses; includes loading dose and continuous infusion rates based on Levodopa Equivalent Dose.\", \"doseModifications\": [\"Loading dose followed by continuous infusion\", \"Infusion rate adjusted based on individual patient needs\"]}, {\"id\": \"810076a7-9b04-426c-8ec0-a393dac4c536\", \"treatmentName\": \"Levodopa-carbidopa intestinal gel (LCIG / CLES)\", \"frequency\": \"Continuous\", \"route\": \"\", \"startDay\": 1, \"durationDescription\": \"Not specified for this study arm\"}]"
              },
              {
                "id": "005ce1ab-af39-4660-a970-09ec3a5b38f0",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-visitWindows",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"134fb483-e680-4eb2-9e02-a960746063ae\", \"visitName\": \"Screening Visit 1\", \"targetDay\": -42, \"windowBefore\": 0, \"windowAfter\": 32, \"isRequired\": true, \"visitNumber\": 1, \"epoch\": \"Screening\"}, {\"id\": \"6fc744de-a50d-4fc4-a11d-93ef4ae43ca2\", \"visitName\": \"Monitoring Period\", \"targetDay\": -6, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 2.5, \"epoch\": \"Screening\"}, {\"id\": \"56ed456e-fbd7-499c-b253-c60a49da79a0\", \"visitName\": \"Early Termination\", \"targetDay\": null, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 5, \"sourceText\": \"To assess the local and systemic safety and tolerability of ABBV-951 delivered as a CSCI for 24 hours daily for up to 52 weeks. Secondary\"}, {\"id\": \"b9b36511-5cca-4950-aaa4-77185ebd8865\", \"visitName\": \"Baseline\", \"targetDay\": 0, \"windowBefore\": 1, \"windowAfter\": 1, \"isRequired\": true, \"visitNumber\": 6, \"sourceText\": \"Change in clinical laboratory test data from Baseline to end of study 5. Change in vital sign measurements from Baseline to end of study\"}, {\"id\": \"2ed074f8-7a6f-45cd-8632-ef77a701af7b\", \"visitName\": \"end of study\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 7, \"isRequired\": true, \"visitNumber\": 7, \"sourceText\": \"Change in clinical laboratory test data from Baseline to end of study 5. Change in vital sign measurements from Baseline to end of study\"}, {\"id\": \"d7bd37d3-5f2b-4973-a254-97c4607ac6f2\", \"visitName\": \"Visit 3\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 8, \"epoch\": \"Treatment\", \"sourceText\": \"The Monitoring Period can occur any time before V3, as long as it lasts for 6 consecutive days. PD Diaries will also be collected for at least 2 consecutive days during the Monitoring Period. In count\"}, {\"id\": \"a675ebf8-0f1f-440a-b702-e32364df3764\", \"visitName\": \"end of Treatment\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 9, \"sourceText\": \"infusion (end of Treatment Period). 22. If male and sexually active with female partner(s) of childbearing potential, subject must agree, from Day 1 (V3) through 30 days after the end of the infusion \"}, {\"id\": \"b6fe0993-91cf-45c2-85f0-c6e37d6c1d70\", \"visitName\": \"Visit 12\", \"targetDay\": 1, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 10, \"targetWeek\": 39, \"sourceText\": \"Week 39 (V12) Week 52 (V13) or in case of premature discontinuation. All visits, apart from the Screening visits (V1 and V2) and V3 (Day 1), will be allowed a window of\"}, {\"id\": \"deefdd3c-86f4-4695-b753-03c88c8bcdbb\", \"visitName\": \"Visit 4\", \"targetDay\": 2, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 11, \"targetWeek\": 1, \"sourceText\": \"Day 2 (V4) Week 1 (V5) Week 2 (V6)\"}, {\"id\": \"21f57b69-48c2-403f-a520-acbce7fa5911\", \"visitName\": \"Visit 6\", \"targetDay\": 8, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 12, \"targetWeek\": 2, \"sourceText\": \"Week 2 (V6) Week 3 (V7) Week 4 (V8)\"}, {\"id\": \"9fa15e80-ad4f-4601-a9fe-a1efaf439337\", \"visitName\": \"Visit 7\", \"targetDay\": 15, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": false, \"visitNumber\": 13, \"targetWeek\": 3, \"sourceText\": \"Week 3 (V7) Week 4 (V8) The investigator may perform unscheduled visits to make any needed adjustments within the 4-week\"}, {\"id\": \"cfcce98e-8516-49a6-9cc2-66e1ad1c3df8\", \"visitName\": \"Visit 8\", \"targetDay\": 22, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": false, \"visitNumber\": 14, \"targetWeek\": 4, \"sourceText\": \"Week 4 (V8) The investigator may perform unscheduled visits to make any needed adjustments within the 4-week Optimization Period.\"}, {\"id\": \"f278ed44-a6a5-4824-b63b-77e4cedbb0e1\", \"visitName\": \"Visit 9\", \"targetDay\": 36, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 15, \"targetWeek\": 6, \"sourceText\": \"Week 6 (V9) Week 13 (V10) Week 26 (V11)\"}, {\"id\": \"1ea05b11-4b63-4b2d-8696-d167dbf9009a\", \"visitName\": \"Visit 10\", \"targetDay\": 85, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 16, \"targetWeek\": 13, \"sourceText\": \"Week 13 (V10) Week 26 (V11) Week 39 (V12)\"}, {\"id\": \"9ec973c6-d528-4db6-a7b8-f265076970c3\", \"visitName\": \"Visit 11\", \"targetDay\": 176, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": false, \"visitNumber\": 17, \"targetWeek\": 26, \"sourceText\": \"completion of Week 26 (V11); thereafter, wearing of the PKG-watch will be optional. The Monitoring Period consists of at least 6 consecutive days during the Screening Period (prior to V3) where subjec\"}, {\"id\": \"3adc18c5-2c6f-41fc-885c-93346839998e\", \"visitName\": \"Week 39\", \"targetDay\": 267, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 18, \"targetWeek\": 39, \"sourceText\": \"Week 39 (V12) Week 52 (V13) or in case of premature discontinuation. All visits, apart from the Screening visits (V1 and V2) and V3 (Day 1), will be allowed a window of\"}, {\"id\": \"08ac9a35-7780-4e60-9f1a-4ed1246d3733\", \"visitName\": \"Week 52\", \"targetDay\": 358, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 19, \"targetWeek\": 52, \"epoch\": \"Treatment\", \"sourceText\": \"Week 52 (V13) or in case of premature discontinuation. All visits, apart from the Screening visits (V1 and V2) and V3 (Day 1), will be allowed a window of \\u00b1 3 days.\"}, {\"id\": \"91e6ea4c-d566-4acd-81d9-0c4afd7cecbd\", \"visitName\": \"Follow-up\", \"targetDay\": 365, \"windowBefore\": 7, \"windowAfter\": 7, \"isRequired\": true, \"visitNumber\": 20, \"sourceText\": \"applicable), treatment, and follow-up per standard practice. The subject should be referred to a dermatologist within 2 business days after the photographs are taken. The dermatologic visit should be \"}]"
              },
              {
                "id": "ext_execution_model_3e7f1746-6085-4b0c-bfd1-fb59e4882da9",
                "url": "https://protocol2usdm.io/extensions/x-executionModel",
                "instanceType": "ExtensionAttribute",
                "valueObject": {
                  "schemaVersion": "1.0.0",
                  "extractionTimestamp": "2026-01-23T04:38:06.349191",
                  "executionModel": {
                    "timeAnchors": [
                      {
                        "id": "37befd42-7708-4097-bb38-6a75618442df",
                        "definition": "First administration of investigational product",
                        "anchorType": "FirstDose",
                        "classification": "Event",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 60,
                        "sourceText": "initiation of treatment",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "786e2c1c-794b-4635-9c54-edf4324d7f16",
                        "definition": "The initiation of ABBV-951 (study drug) administration",
                        "anchorType": "Day1",
                        "classification": "Visit",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 80,
                        "sourceText": "The Treatment Period starts with the initiation of ABBV-951... On the morning of Day 1 (V3) subjects will need to be in a clinically defined \"Off\" state (i.e., no PD medications for at least 12 hours before initiation of study drug).",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "e52b4ef4-7f1b-49f6-8441-ccd836de992f",
                        "definition": "Screening visit",
                        "anchorType": "Screening",
                        "classification": "Visit",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 20,
                        "sourceText": "Screening \nPeriod",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "dc4a3628-7cc3-4b77-a215-b19e4da1a4fa",
                        "definition": "procedure",
                        "anchorType": "Custom",
                        "classification": "Conceptual",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 100,
                        "sourceText": "procedure",
                        "encounterId": null,
                        "activityId": null
                      }
                    ],
                    "repetitions": [
                      {
                        "id": "1954f42f-79b2-4cfa-8bcb-d2a0cb8d32f8",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "OD"
                      },
                      {
                        "id": "cc1d58ca-74af-42ba-94c7-a2a88233e0bf",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "od"
                      },
                      {
                        "id": "937dbf8a-c231-49fe-ac0a-872f95b095f8",
                        "type": "Interval",
                        "sourceText": "bid"
                      },
                      {
                        "id": "02180bff-8535-47c6-8d05-7213c301be2f",
                        "type": "Continuous",
                        "sourceText": "Screening \nPeriod"
                      },
                      {
                        "id": "0abd7051-291e-44bb-a8e2-84cc6c306f7e",
                        "type": "Continuous",
                        "sourceText": "Screening Period"
                      },
                      {
                        "id": "dce83350-9c1f-4b01-899d-8ec3c7b17a2b",
                        "type": "Continuous",
                        "sourceText": "Treatment Period"
                      },
                      {
                        "id": "e8f05a9a-d813-4d61-9e5a-2c4281a363dd",
                        "type": "Continuous",
                        "sourceText": "treatment period"
                      },
                      {
                        "id": "acddbb91-6c45-4b50-b08d-908570a58bca",
                        "type": "Continuous",
                        "sourceText": "treatment \nperiod"
                      },
                      {
                        "id": "07370040-af09-470c-8f61-2fdacfe28377",
                        "type": "Continuous",
                        "sourceText": "12 hours before"
                      },
                      {
                        "id": "1449e851-01a6-4670-a426-f59a4ad9ad2f",
                        "type": "Continuous",
                        "sourceText": "30 days after"
                      },
                      {
                        "id": "0aaf9951-e816-4993-abb3-ad7d0e08c6a2",
                        "type": "Continuous",
                        "startOffset": "P0D",
                        "endOffset": "P28D",
                        "interval": "P1D",
                        "minObservations": 28,
                        "exitCondition": "Completion of 28-day infusion period",
                        "sourceText": "following CSCI for 28 days with a fixed indwelling catheter at a rate of 0.1 or 0.25 mL/hour"
                      },
                      {
                        "id": "efa6d8e1-b9c3-46a4-96a6-493a0016236c",
                        "type": "Continuous",
                        "startOffset": "P0D",
                        "endOffset": "PT72H",
                        "interval": "PT1H",
                        "minObservations": 72,
                        "exitCondition": "Completion of 72-hour infusion",
                        "sourceText": "ABBV-951 was administered as a loading dose followed by a continuous infusion for up to 72 hours"
                      },
                      {
                        "id": "ee103f53-dd8d-43c4-b8c4-2425c0b3b164",
                        "type": "Continuous",
                        "startOffset": "P0D",
                        "endOffset": "P5D",
                        "interval": "P1D",
                        "minObservations": 5,
                        "exitCondition": "Completion of 5-day infusion",
                        "sourceText": "infusion of ABBV-951 at the same concentration (50/200 mg/mL), but at a higher infusion rate (0.5 mL/hour) for fewer days (5 days) was well tolerated"
                      }
                    ],
                    "samplingConstraints": [],
                    "traversalConstraints": [
                      {
                        "id": "25f62be7-0ce9-46f8-ab97-415ced1db3e7",
                        "requiredSequence": [
                          "epoch_1",
                          "epoch_2",
                          "epoch_2"
                        ],
                        "allowEarlyExit": true,
                        "exitEpochIds": [
                          "33d2fe35-aa30-4f27-9057-1f1436ca129a"
                        ],
                        "mandatoryVisits": [
                          "Day 1",
                          "End of Study",
                          "Visit 1",
                          "Safety Follow-up",
                          "Visit 3 (Day 1)",
                          "Visit 2",
                          "Week 4 (End of Optimization)",
                          "Week 52 (End of Maintenance)",
                          "Screening"
                        ],
                        "sourceText": "[{'condition': 'If subject experiences AE requiring discontinuation', 'path': ['EARLY_TERMINATION', 'FOLLOW_UP']}, {'condition': 'In countries where PKG watch is not approved', 'path': ['REDUCED_MONITORING_PERIOD']}]"
                      }
                    ],
                    "executionTypes": [
                      {
                        "activityId": "Vital Sign",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 1"
                      },
                      {
                        "activityId": "Electrocardiogram",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Pe",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Adverse Events",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Concomitant Medications",
                        "executionType": "Episode",
                        "rationale": "EPISODE signals: 4"
                      },
                      {
                        "activityId": "Laboratory Test",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 1"
                      },
                      {
                        "activityId": "Pharmacokinetic",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Drug Administration",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 1"
                      },
                      {
                        "activityId": "Biopsy",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 3"
                      },
                      {
                        "activityId": "Diary",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 1"
                      },
                      {
                        "activityId": "Eligibility Criteria Assessment",
                        "executionType": "Single",
                        "rationale": "Assessment of eligibility is performed once at the start of the study to determine subject participation."
                      },
                      {
                        "activityId": "Continuous Subcutaneous Infusion (CSCI)",
                        "executionType": "Single",
                        "rationale": "ABBV-951 is delivered via continuous infusion over a period of time to maintain steady levodopa exposure."
                      },
                      {
                        "activityId": "Loading Dose Administration",
                        "executionType": "Single",
                        "rationale": "The loading dose is a one-time administration preceding the start of continuous infusion."
                      },
                      {
                        "activityId": "Titration and Infusion Rate Adjustment",
                        "executionType": "Single",
                        "rationale": "Adjustments to infusion rates and extra doses are based on individual patient needs and clinical response (decision points)."
                      },
                      {
                        "activityId": "Local (Skin) Tolerability Assessment",
                        "executionType": "Single",
                        "rationale": "Infusion site findings and irritation are monitored repeatedly throughout the treatment period."
                      },
                      {
                        "activityId": "Serum Phosphate Monitoring",
                        "executionType": "Single",
                        "rationale": "Laboratory assessments are scheduled at specific intervals to monitor for potential increases in phosphate levels."
                      }
                    ],
                    "footnoteConditions": [
                      {
                        "id": "2be4b0f3-628d-4dc3-96cd-5e4ec2c24256",
                        "conditionType": "general",
                        "text": "a. The Screening Period may be extended up to a total of 90 days for extenuating circumstances, e.g., supply constraints.",
                        "footnoteId": "d4a2742a-1252-423a-a1c4-b537785b5e91",
                        "structuredCondition": "period.duration.max(Screening, P90D)",
                        "appliesToActivityIds": [
                          "Screening Period"
                        ],
                        "sourceText": "a. The Screening Period may be extended up to a total of 90 days for extenuating circumstances, e.g."
                      },
                      {
                        "id": "1337a16a-575e-4514-84a7-2867799918f0",
                        "conditionType": "timing_before",
                        "text": "b. The Monitoring Period can occur any time before V3, as long as it lasts for 6 consecutive days. PD Diaries will also be collected for at least 2 consecutive days during the Monitoring Period.",
                        "footnoteId": "29af93fc-ba1f-467e-a60c-09f14af8e98b",
                        "structuredCondition": "timing.before(MonitoringPeriod, V3) && duration(MonitoringPeriod, P6D) && duration(PD_Diaries, P2D)",
                        "appliesToActivityIds": [
                          "Monitoring Period",
                          "PD Diaries"
                        ],
                        "sourceText": "b. The Monitoring Period can occur any time before V3, as long as it lasts for 6 consecutive days. P"
                      },
                      {
                        "id": "905c47b7-8b1e-4efa-a618-0076135c07db",
                        "conditionType": "general",
                        "text": "a. GFR will be calculated one time at Screening Visit 1 (V1) according to the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation.",
                        "footnoteId": "1710b877-0951-44d2-a0ce-f3f370c4e51f",
                        "structuredCondition": "occurrence.count(GFR, 1) && timing.at(V1)",
                        "appliesToActivityIds": [
                          "GFR calculation"
                        ],
                        "sourceText": "a. GFR will be calculated one time at Screening Visit 1 (V1) according to the Chronic Kidney Disease"
                      },
                      {
                        "id": "803d6c5a-f2d3-45b8-bd3b-ac53e3f2698d",
                        "conditionType": "timing_at",
                        "text": "b. Special laboratory tests to detect vitamin deficiencies, i.e., vitamin B12, vitamin B6, folic acid, homocysteine, and MMA levels will be performed at Screening Visit 1 (V1), on Day 1 (V3), and at Week 6 (V9), Week 26 (V11), and Week 52 (V13).",
                        "footnoteId": "54c74f61-b043-4555-8f58-5908ee4b9d4f",
                        "structuredCondition": "timing.at([V1, V3, V9, V11, V13])",
                        "appliesToActivityIds": [
                          "Special laboratory tests",
                          "Vitamin B12",
                          "Vitamin B6",
                          "Folic acid",
                          "Homocysteine",
                          "MMA levels"
                        ],
                        "sourceText": "b. Special laboratory tests to detect vitamin deficiencies, i.e., vitamin B12, vitamin B6, folic aci"
                      },
                      {
                        "id": "d571a2fc-60c5-4fad-a1c0-8c9fccf5fe21",
                        "conditionType": "general",
                        "text": "a. Subjects with a low vitamin B12 or low-normal vitamin B12 and high MMA plasma level may undergo supplemental vitamin therapy.",
                        "footnoteId": "6ed3d5a1-4b30-4f93-b9f4-0f4db345aacc",
                        "structuredCondition": "if(lab.B12 == low || (lab.B12 == low-normal && lab.MMA == high)) then(supplemental_vitamin_therapy)",
                        "appliesToActivityIds": [
                          "Supplemental vitamin therapy"
                        ],
                        "sourceText": "a. Subjects with a low vitamin B12 or low-normal vitamin B12 and high MMA plasma level may undergo s"
                      },
                      {
                        "id": "e83fc045-70a1-472d-8e73-334a09e2e2cc",
                        "conditionType": "general",
                        "text": "b. The PD diary concordance test may be omitted for subjects previously enrolled in Study M15-739, for whom recognizable/identifiable \"Off\" and \"On\" state (motor fluctuations) have been already established and confirmed.",
                        "footnoteId": "466728f7-773e-4ec4-8078-7e006c2e9491",
                        "structuredCondition": "if(subject.prior_enrollment == 'M15-739' && subject.motor_fluctuations == established) then(omit(PD_diary_concordance_test))",
                        "appliesToActivityIds": [
                          "PD diary concordance test"
                        ],
                        "sourceText": "b. The PD diary concordance test may be omitted for subjects previously enrolled in Study M15-739, f"
                      },
                      {
                        "id": "ec4da8e0-8398-4fc4-abc2-e4a08f453957",
                        "conditionType": "general",
                        "text": "c. Subjects with evidence of transient skin conditions such as recent sunburn or open wound that resolved within the Screening Period are eligible for enrollment.",
                        "footnoteId": "01833b41-bae7-41aa-8257-1a41cae49f61",
                        "structuredCondition": "if(skin_condition.status == resolved && skin_condition.timing == ScreeningPeriod) then(eligible)",
                        "appliesToActivityIds": [
                          "Enrollment"
                        ],
                        "sourceText": "c. Subjects with evidence of transient skin conditions such as recent sunburn or open wound that res"
                      },
                      {
                        "id": "b1ef8c81-3427-4a80-8354-f5ba5b6057f8",
                        "conditionType": "timing_after",
                        "text": "p. 4 of 46 OPERATIONS MANUAL FOR CLINICAL STUDY PROTOCOL M15-741 VERSION 7.0 CONFIDENTIAL INFORMATION No use or disclosure outside AbbVie is permitted without prior written authorization from AbbVie. 4.2 REPORTING ADVERSE EVENTS AND INTERCURRENT ILLNESSES 37 4.3 PRODUCT COMPLAINT REPORTING 39 5 COUNTRY-SPECIFIC REQUIREMENTS 39 5.1 SAMPLE RETENTION REQUIREMENTS 39 5.2 SUSAR REPORTING 39 5.3 TREATMENT AFTER END OF STUDY 40 6 REFERENCES 40 LIST OF APPENDICES APPENDIX A. NEUROLOGY LABORATORY GRADING 41 APPENDIX B. CRITERIA FOR POTENTIALLY CLINICALLY SIGNIFICANT VITAL SIGN VALUES AND WEIGHT VALUES 46 Page 65 of 107 --- Page 66 ---",
                        "footnoteId": "e92409b6-9e9a-4d49-9ff8-6f6025f96dc7",
                        "sourceText": "p. 4 of 46 OPERATIONS MANUAL FOR CLINICAL STUDY PROTOCOL M15-741 VERSION 7.0 CONFIDENTIAL INFORMATIO"
                      },
                      {
                        "id": "10b015ff-37f1-46f1-a3d1-c04aefb0e6e3",
                        "conditionType": "general",
                        "text": "1. Percentage of subjects with adverse events (AEs) and serious adverse events (SAEs) during the study",
                        "footnoteId": "bad884e4-116f-427d-9b2c-275f7ec38cd7",
                        "sourceText": "1. Percentage of subjects with adverse events (AEs) and serious adverse events (SAEs) during the stu"
                      },
                      {
                        "id": "67bfcd11-ac48-44f3-a423-2daa4fb1f191",
                        "conditionType": "general",
                        "text": "2. Percentage of subjects with AEs of special interest (AESIs) during the study",
                        "footnoteId": "46e0e8a7-cb17-433d-a920-31f3f043e431",
                        "sourceText": "2. Percentage of subjects with AEs of special interest (AESIs) during the study"
                      },
                      {
                        "id": "cad5294b-3e1f-4a1a-a8d8-d0e66b49d672",
                        "conditionType": "general",
                        "text": "3. Percentage of subjects with numeric grade equal to or higher than 5 and percentage of subjects with letter grade equal to or higher than D on the Infusion Site Evaluation Scale at any time during the study",
                        "footnoteId": "647da999-0e95-4b30-95c8-a0b92fc497f2",
                        "sourceText": "3. Percentage of subjects with numeric grade equal to or higher than 5 and percentage of subjects wi"
                      },
                      {
                        "id": "7aefed1e-1754-418e-bf36-cc3a3d80aaba",
                        "conditionType": "general",
                        "text": "4. Change in clinical laboratory test data from Baseline to end of study",
                        "footnoteId": "4499a344-3c64-462d-9aab-b6f0c41864a4",
                        "sourceText": "4. Change in clinical laboratory test data from Baseline to end of study"
                      },
                      {
                        "id": "c115f99f-3779-44f0-b9d6-d14c5ceac0a3",
                        "conditionType": "general",
                        "text": "5. Change in vital sign measurements from Baseline to end of study",
                        "footnoteId": "771ccb41-e178-4069-a4ae-3a5a27fb8a50",
                        "sourceText": "5. Change in vital sign measurements from Baseline to end of study"
                      },
                      {
                        "id": "60c10e28-e713-40ed-a228-a62ac4ccca32",
                        "conditionType": "general",
                        "text": "6. Change in electrocardiograms (ECGs) from Baseline to end of study",
                        "footnoteId": "2c33dbf3-6df8-4a03-a700-035bd11c31cf",
                        "sourceText": "6. Change in electrocardiograms (ECGs) from Baseline to end of study"
                      },
                      {
                        "id": "3cf35b70-055b-4464-95ce-31b1f7430492",
                        "conditionType": "general",
                        "text": "7. Subject is not considered by the investigator to be an unsuitable candidate to receive ABBV-951 for any reason. Disease Activity",
                        "footnoteId": "7d528954-0984-4bae-bceb-8519b170de5b",
                        "structuredCondition": "investigator.assessment == suitable",
                        "appliesToActivityIds": [
                          "26f7aad7-771c-4e3c-b6dd-cc4f06f63e75"
                        ],
                        "sourceText": "7. Subject is not considered by the investigator to be an unsuitable candidate to receive ABBV-951 f"
                      },
                      {
                        "id": "40479a40-c0be-4082-b2f4-1570a769015b",
                        "conditionType": "general",
                        "text": "8. Subject must have a diagnosis of levodopa-responsive idiopathic PD.",
                        "footnoteId": "92d6dd22-d177-4964-beba-b21f076fd3da",
                        "structuredCondition": "subject.diagnosis == 'levodopa-responsive idiopathic PD'",
                        "appliesToActivityIds": [
                          "Enrollment"
                        ],
                        "sourceText": "8. Subject must have a diagnosis of levodopa-responsive idiopathic PD."
                      },
                      {
                        "id": "52121c6a-a6ce-437f-9f57-100551695b72",
                        "conditionType": "timing_before",
                        "text": "9. Subject must meet the following disease activity criteria:  Must be taking a regimen of oral medications for PD that has remained unchanged for at least 30 days before commencing ABBV-951 (rescue medications taken \"as needed\" may be disregarded when assessing whether the regimen of oral medications has remained unchanged); this regimen must include levodopa-containing formulations such as CD/LD IR (e.g., Sinemet, Madopar), CD/LD-CR (e.g., Sinemet controlled release [CR]), CD/LD extended release (e.g., Rytary), CD/LD/entacapone (e.g., Stalevo).  Must have a recognizable/identifiable \"Off\" and \"On\" state (motor fluctuations) as established through investigator observation and confirmed by PD diary entries recorded during the concordance test performed during the Screening Period.b",
                        "footnoteId": "bc67a517-1704-4f3a-a6f7-b39cc2e623b4",
                        "structuredCondition": "medication.PD_regimen.stable_duration >= P30D && subject.motor_fluctuations == confirmed",
                        "appliesToActivityIds": [
                          "7ccdbc5c-d7a2-434d-93e8-7b90f8f92fcb",
                          "Concordance test"
                        ],
                        "sourceText": "9. Subject must meet the following disease activity criteria:  Must be taking a regimen of oral med"
                      }
                    ],
                    "endpointAlgorithms": [
                      {
                        "id": "21875b0b-c9e7-4923-9c7b-8ee50ebf7007",
                        "name": "Primary: Adverse Event Incidence",
                        "endpointType": "Primary",
                        "inputs": [
                          "AE",
                          "SAE",
                          "AESI"
                        ],
                        "timeWindow": {
                          "reference": "First infusion to end of study",
                          "duration": "P52W"
                        },
                        "algorithm": "(Count of subjects with >= 1 event / Total subjects in Safety Analysis Set) * 100",
                        "successCriteria": "Descriptive summary of percentage of subjects with AEs, SAEs, and AESIs",
                        "sourceText": "Percentage of subjects with adverse events (AEs) and serious adverse events (SAEs) during the study; Percentage of subjects with AEs of special interest (AESIs) during the study"
                      },
                      {
                        "id": "1317959c-6079-45be-a1e0-fbddffd0681b",
                        "name": "Primary: Infusion Site Tolerability",
                        "endpointType": "Primary",
                        "inputs": [
                          "Infusion Site Evaluation Scale numeric grade",
                          "Infusion Site Evaluation Scale letter grade"
                        ],
                        "timeWindow": {
                          "reference": "Any time during study",
                          "duration": "P52W"
                        },
                        "algorithm": "Percentage of subjects with numeric grade >= 5 OR letter grade >= D",
                        "successCriteria": "Descriptive summary of high-grade site reactions",
                        "sourceText": "Percentage of subjects with numeric grade equal to or higher than 5 and percentage of subjects with letter grade equal to or higher than D on the Infusion Site Evaluation Scale at any time during the "
                      },
                      {
                        "id": "5894b017-a5c6-4543-b142-650ca7d69c39",
                        "name": "Primary: Safety Parameter Change from Baseline",
                        "endpointType": "Primary",
                        "inputs": [
                          "Clinical laboratory data",
                          "Vital signs",
                          "ECG"
                        ],
                        "timeWindow": {
                          "reference": "Baseline to end of study",
                          "duration": "P52W"
                        },
                        "algorithm": "Post-baseline value - Baseline value",
                        "successCriteria": "Descriptive statistics (mean, SD, min, median, max) of change",
                        "sourceText": "Change in clinical laboratory test data from Baseline to end of study; Change in vital sign measurements from Baseline to end of study; Change in electrocardiograms (ECGs) from Baseline to end of stud"
                      },
                      {
                        "id": "926c22b9-7d8e-4d6e-a493-a24cf4e7552b",
                        "name": "Secondary: Normalized Daily Off/On Time",
                        "endpointType": "Secondary",
                        "inputs": [
                          "PD Diary Off time",
                          "PD Diary On time",
                          "Total diary hours"
                        ],
                        "timeWindow": {
                          "reference": "Baseline to end of study",
                          "duration": "P52W"
                        },
                        "algorithm": "(Reported hours / Total diary hours) * 24 - Baseline normalized value",
                        "successCriteria": "Paired-sample t-test for change from Baseline",
                        "sourceText": "Average normalized daily \"Off\" time and \"On\" times as assessed by the PD Diary"
                      },
                      {
                        "id": "e9b9a26d-ce11-4193-bb79-bbc5ceae0df8",
                        "name": "Secondary: PD Symptom Severity (MDS-UPDRS)",
                        "endpointType": "Secondary",
                        "inputs": [
                          "MDS-UPDRS Parts I-IV total scores"
                        ],
                        "timeWindow": {
                          "reference": "Baseline to end of study",
                          "duration": "P52W"
                        },
                        "algorithm": "End of study score - Baseline score",
                        "successCriteria": "Paired-sample t-test for change from Baseline",
                        "sourceText": "PD symptoms as assessed by the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Parts I-IV"
                      },
                      {
                        "id": "f8505bc0-fae2-4461-8c9d-55eb2326823b",
                        "name": "Secondary: Quality of Life and Sleep",
                        "endpointType": "Secondary",
                        "inputs": [
                          "PDSS-2 score",
                          "PDQ-39 score",
                          "EQ-5D-5L score"
                        ],
                        "timeWindow": {
                          "reference": "Baseline to end of study",
                          "duration": "P52W"
                        },
                        "algorithm": "End of study score - Baseline score",
                        "successCriteria": "Paired-sample t-test for change from Baseline",
                        "sourceText": "Sleep symptoms as assessed by the PD Sleep Scale-2 (PDSS-2); Quality of life as assessed by the PD Questionnaire-39 items (PDQ-39); Health-related quality of life as assessed by the EuroQol 5-dimensio"
                      }
                    ],
                    "derivedVariables": [
                      {
                        "id": "a9de07eb-b8bb-4d9c-a89e-ca03bd710f7a",
                        "name": "Percentage of subjects with adverse events (AEs)",
                        "variableType": "Categorical",
                        "sourceVariables": [
                          "Adverse Event (AE) occurrence"
                        ],
                        "derivationRule": "(Number of subjects with at least one AE / Total number of subjects) * 100",
                        "baselineDefinition": "Not applicable",
                        "analysisWindow": "Up to 52 weeks",
                        "imputationRule": "None specified",
                        "unit": "%"
                      },
                      {
                        "id": "1ac46b70-d6bf-4290-afe1-72928ff0b613",
                        "name": "Percentage of subjects with Infusion Site Evaluation Scale numeric grade >= 5",
                        "variableType": "Categorical",
                        "sourceVariables": [
                          "Infusion Site Evaluation Scale numeric grade"
                        ],
                        "derivationRule": "(Number of subjects with numeric grade >= 5 at any time / Total number of subjects) * 100",
                        "baselineDefinition": "Not applicable",
                        "analysisWindow": "Any time during the study",
                        "imputationRule": "None specified",
                        "unit": "%"
                      },
                      {
                        "id": "13dee3c4-9f90-4ee4-8c52-2383afce9bb0",
                        "name": "Change in clinical laboratory test data from Baseline",
                        "variableType": "ChangeFromBaseline",
                        "sourceVariables": [
                          "Clinical laboratory test values"
                        ],
                        "derivationRule": "End of study value - Baseline value",
                        "baselineDefinition": "Last value prior to initial study drug administration",
                        "baselineVisit": "Baseline",
                        "analysisWindow": "End of study (Week 52)",
                        "imputationRule": "None specified",
                        "unit": "Variable per test"
                      },
                      {
                        "id": "62ade9b5-ef97-49aa-9597-be9242da1996",
                        "name": "Change in vital sign measurements from Baseline",
                        "variableType": "ChangeFromBaseline",
                        "sourceVariables": [
                          "Vital sign measurements"
                        ],
                        "derivationRule": "End of study value - Baseline value",
                        "baselineDefinition": "Last value prior to initial study drug administration",
                        "baselineVisit": "Baseline",
                        "analysisWindow": "End of study (Week 52)",
                        "imputationRule": "None specified",
                        "unit": "Variable per measurement"
                      },
                      {
                        "id": "91945575-644d-468f-8335-8af3f21fc340",
                        "name": "Average normalized daily Off time",
                        "variableType": "ChangeFromBaseline",
                        "sourceVariables": [
                          "PD Diary Off time"
                        ],
                        "derivationRule": "(End of study normalized Off time) - (Baseline normalized Off time)",
                        "baselineDefinition": "Assessed via PD Diary prior to treatment",
                        "baselineVisit": "Baseline",
                        "analysisWindow": "End of study (Week 52)",
                        "imputationRule": "None specified",
                        "unit": "Hours"
                      },
                      {
                        "id": "4eb3a9c5-71e5-455d-bf4f-31d7a9643671",
                        "name": "Change in MDS-UPDRS Parts I-IV",
                        "variableType": "ChangeFromBaseline",
                        "sourceVariables": [
                          "MDS-UPDRS score"
                        ],
                        "derivationRule": "End of study total score - Baseline total score",
                        "baselineDefinition": "Last assessment prior to treatment",
                        "baselineVisit": "Baseline",
                        "analysisWindow": "End of study (Week 52)",
                        "imputationRule": "None specified",
                        "unit": "Score"
                      },
                      {
                        "id": "3d13340c-839e-46e8-9ffc-52cb8e61b46b",
                        "name": "Change in PDSS-2",
                        "variableType": "ChangeFromBaseline",
                        "sourceVariables": [
                          "PDSS-2 score"
                        ],
                        "derivationRule": "End of study total score - Baseline total score",
                        "baselineDefinition": "Last assessment prior to treatment",
                        "baselineVisit": "Baseline",
                        "analysisWindow": "End of study (Week 52)",
                        "imputationRule": "None specified",
                        "unit": "Score"
                      },
                      {
                        "id": "b7c81d90-7745-4ea7-817a-f657b2c6a5d8",
                        "name": "Change in PDQ-39",
                        "variableType": "ChangeFromBaseline",
                        "sourceVariables": [
                          "PDQ-39 score"
                        ],
                        "derivationRule": "End of study total score - Baseline total score",
                        "baselineDefinition": "Last assessment prior to treatment",
                        "baselineVisit": "Baseline",
                        "analysisWindow": "End of study (Week 52)",
                        "imputationRule": "None specified",
                        "unit": "Score"
                      },
                      {
                        "id": "c93153ac-4a50-4edc-9e16-68254ed3b11b",
                        "name": "Change in EQ-5D-5L",
                        "variableType": "ChangeFromBaseline",
                        "sourceVariables": [
                          "EQ-5D-5L score"
                        ],
                        "derivationRule": "End of study total score - Baseline total score",
                        "baselineDefinition": "Last assessment prior to treatment",
                        "baselineVisit": "Baseline",
                        "analysisWindow": "End of study (Week 52)",
                        "imputationRule": "None specified",
                        "unit": "Score"
                      },
                      {
                        "id": "8d06517d-c1b4-4513-b8c2-6b4e44cc715a",
                        "name": "Change in PKG wearable device assessments",
                        "variableType": "ChangeFromBaseline",
                        "sourceVariables": [
                          "Tremor",
                          "Bradykinesia",
                          "Dyskinesia",
                          "Daytime somnolence",
                          "Impulsive behaviors"
                        ],
                        "derivationRule": "Week 26 value - Baseline value",
                        "baselineDefinition": "6-Day Monitoring Period prior to Visit 3",
                        "baselineVisit": "Visit 3",
                        "analysisWindow": "Week 26",
                        "imputationRule": "None specified",
                        "unit": "Variable per metric"
                      }
                    ],
                    "stateMachine": {
                      "id": "1df0077b-2ecb-47bb-ac8e-c49566378290",
                      "initialState": "Screening",
                      "terminalStates": [
                        "Early Termination",
                        "Completed"
                      ],
                      "states": [
                        "Screening",
                        "Monitoring Period",
                        "Treatment Optimization",
                        "Treatment Maintenance",
                        "Follow Up",
                        "Early Termination"
                      ],
                      "transitions": [
                        {
                          "fromState": "Screening",
                          "toState": "Monitoring Period",
                          "trigger": "Progress to Monitoring Period"
                        },
                        {
                          "fromState": "Monitoring Period",
                          "toState": "Treatment Optimization",
                          "trigger": "Progress to Treatment Optimization"
                        },
                        {
                          "fromState": "Treatment Optimization",
                          "toState": "Treatment Maintenance",
                          "trigger": "Progress to Treatment Maintenance"
                        },
                        {
                          "fromState": "Treatment Maintenance",
                          "toState": "Follow Up",
                          "trigger": "Progress to Follow Up"
                        },
                        {
                          "fromState": "Monitoring Period",
                          "toState": "Early Termination",
                          "trigger": "Subject exits to Early Termination"
                        },
                        {
                          "fromState": "Treatment Optimization",
                          "toState": "Early Termination",
                          "trigger": "Subject exits to Early Termination"
                        },
                        {
                          "fromState": "Treatment Maintenance",
                          "toState": "Early Termination",
                          "trigger": "Subject exits to Early Termination"
                        }
                      ],
                      "epochIds": {
                        "Screening": "SCREENING",
                        "Monitoring Period": "MONITORING_PERIOD",
                        "Treatment Optimization": "TREATMENT_OPTIMIZATION",
                        "Treatment Maintenance": "TREATMENT_MAINTENANCE",
                        "Follow Up": "FOLLOW_UP",
                        "Early Termination": "EARLY_TERMINATION"
                      }
                    },
                    "dosingRegimens": [
                      {
                        "id": "e5217fcd-44ee-460b-9b08-7dde00be85dd",
                        "treatmentName": "Therapy",
                        "frequency": "QD",
                        "route": "Oral",
                        "startDay": 1,
                        "doseLevels": [
                          {
                            "amount": 100.0,
                            "unit": "mg"
                          },
                          {
                            "amount": 25.0,
                            "unit": "mg"
                          },
                          {
                            "amount": 10.0,
                            "unit": "mg"
                          },
                          {
                            "amount": 84.0,
                            "unit": "mg"
                          }
                        ],
                        "sourceText": "se a. Apomorphine and ergot dopamine agonists (lisuride, bromocriptine, cabergoline, etc.) are NOT allowed. b. Approved in Japan. c. Approved in the United States. Table 7. Allowed Rescue Medications/"
                      },
                      {
                        "id": "520fe3f7-0270-4980-9751-8e056c1f3ce8",
                        "treatmentName": "ABBV-951 (carbidopa phosphate/levodopa phosphate [CDP/LDP])",
                        "frequency": "Continuous",
                        "route": "SC",
                        "startDay": 1,
                        "doseLevels": [
                          {
                            "amount": 50.0,
                            "unit": "mg/mL",
                            "description": "Concentration of carbidopa phosphate"
                          },
                          {
                            "amount": 200.0,
                            "unit": "mg/mL",
                            "description": "Concentration of levodopa phosphate"
                          }
                        ],
                        "durationDescription": "52 weeks",
                        "titrationSchedule": "Individualized delivery covering a wide range of levodopa doses; includes loading dose and continuous infusion rates based on Levodopa Equivalent Dose.",
                        "doseModifications": [
                          "Loading dose followed by continuous infusion",
                          "Infusion rate adjusted based on individual patient needs"
                        ]
                      },
                      {
                        "id": "810076a7-9b04-426c-8ec0-a393dac4c536",
                        "treatmentName": "Levodopa-carbidopa intestinal gel (LCIG / CLES)",
                        "frequency": "Continuous",
                        "route": "",
                        "startDay": 1,
                        "durationDescription": "Not specified for this study arm"
                      }
                    ],
                    "visitWindows": [
                      {
                        "id": "134fb483-e680-4eb2-9e02-a960746063ae",
                        "visitName": "Screening Visit 1",
                        "targetDay": -42,
                        "windowBefore": 0,
                        "windowAfter": 32,
                        "isRequired": true,
                        "visitNumber": 1,
                        "epoch": "Screening"
                      },
                      {
                        "id": "ac105517-a698-460e-ba51-b45f362cc99e",
                        "visitName": "Screening",
                        "targetDay": -14,
                        "windowBefore": 7,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 2,
                        "sourceText": "The Screening Period may be extended up to a total of 90 days for extenuating circumstances, e.g., supply constraints. b. The Monitoring Period can occur any time before V3, as long as it lasts for 6 "
                      },
                      {
                        "id": "47536397-9a9a-42b8-9394-6dad72fb7645",
                        "visitName": "Screening Visit 2",
                        "targetDay": -10,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 2,
                        "epoch": "Screening"
                      },
                      {
                        "id": "6fc744de-a50d-4fc4-a11d-93ef4ae43ca2",
                        "visitName": "Monitoring Period",
                        "targetDay": -6,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 2.5,
                        "epoch": "Screening"
                      },
                      {
                        "id": "56ed456e-fbd7-499c-b253-c60a49da79a0",
                        "visitName": "Early Termination",
                        "targetDay": null,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 5,
                        "sourceText": "To assess the local and systemic safety and tolerability of ABBV-951 delivered as a CSCI for 24 hours daily for up to 52 weeks. Secondary"
                      },
                      {
                        "id": "b9b36511-5cca-4950-aaa4-77185ebd8865",
                        "visitName": "Baseline",
                        "targetDay": 0,
                        "windowBefore": 1,
                        "windowAfter": 1,
                        "isRequired": true,
                        "visitNumber": 6,
                        "sourceText": "Change in clinical laboratory test data from Baseline to end of study 5. Change in vital sign measurements from Baseline to end of study"
                      },
                      {
                        "id": "2ed074f8-7a6f-45cd-8632-ef77a701af7b",
                        "visitName": "end of study",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 7,
                        "isRequired": true,
                        "visitNumber": 7,
                        "sourceText": "Change in clinical laboratory test data from Baseline to end of study 5. Change in vital sign measurements from Baseline to end of study"
                      },
                      {
                        "id": "d7bd37d3-5f2b-4973-a254-97c4607ac6f2",
                        "visitName": "Visit 3",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 8,
                        "epoch": "Treatment",
                        "sourceText": "The Monitoring Period can occur any time before V3, as long as it lasts for 6 consecutive days. PD Diaries will also be collected for at least 2 consecutive days during the Monitoring Period. In count"
                      },
                      {
                        "id": "a675ebf8-0f1f-440a-b702-e32364df3764",
                        "visitName": "end of Treatment",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 9,
                        "sourceText": "infusion (end of Treatment Period). 22. If male and sexually active with female partner(s) of childbearing potential, subject must agree, from Day 1 (V3) through 30 days after the end of the infusion "
                      },
                      {
                        "id": "b6fe0993-91cf-45c2-85f0-c6e37d6c1d70",
                        "visitName": "Visit 12",
                        "targetDay": 1,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 10,
                        "targetWeek": 39,
                        "sourceText": "Week 39 (V12) Week 52 (V13) or in case of premature discontinuation. All visits, apart from the Screening visits (V1 and V2) and V3 (Day 1), will be allowed a window of"
                      },
                      {
                        "id": "deefdd3c-86f4-4695-b753-03c88c8bcdbb",
                        "visitName": "Visit 4",
                        "targetDay": 2,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 11,
                        "targetWeek": 1,
                        "sourceText": "Day 2 (V4) Week 1 (V5) Week 2 (V6)"
                      },
                      {
                        "id": "21f57b69-48c2-403f-a520-acbce7fa5911",
                        "visitName": "Visit 6",
                        "targetDay": 8,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 12,
                        "targetWeek": 2,
                        "sourceText": "Week 2 (V6) Week 3 (V7) Week 4 (V8)"
                      },
                      {
                        "id": "9fa15e80-ad4f-4601-a9fe-a1efaf439337",
                        "visitName": "Visit 7",
                        "targetDay": 15,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": false,
                        "visitNumber": 13,
                        "targetWeek": 3,
                        "sourceText": "Week 3 (V7) Week 4 (V8) The investigator may perform unscheduled visits to make any needed adjustments within the 4-week"
                      },
                      {
                        "id": "cfcce98e-8516-49a6-9cc2-66e1ad1c3df8",
                        "visitName": "Visit 8",
                        "targetDay": 22,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": false,
                        "visitNumber": 14,
                        "targetWeek": 4,
                        "sourceText": "Week 4 (V8) The investigator may perform unscheduled visits to make any needed adjustments within the 4-week Optimization Period."
                      },
                      {
                        "id": "f278ed44-a6a5-4824-b63b-77e4cedbb0e1",
                        "visitName": "Visit 9",
                        "targetDay": 36,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 15,
                        "targetWeek": 6,
                        "sourceText": "Week 6 (V9) Week 13 (V10) Week 26 (V11)"
                      },
                      {
                        "id": "1ea05b11-4b63-4b2d-8696-d167dbf9009a",
                        "visitName": "Visit 10",
                        "targetDay": 85,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 16,
                        "targetWeek": 13,
                        "sourceText": "Week 13 (V10) Week 26 (V11) Week 39 (V12)"
                      },
                      {
                        "id": "9ec973c6-d528-4db6-a7b8-f265076970c3",
                        "visitName": "Visit 11",
                        "targetDay": 176,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": false,
                        "visitNumber": 17,
                        "targetWeek": 26,
                        "sourceText": "completion of Week 26 (V11); thereafter, wearing of the PKG-watch will be optional. The Monitoring Period consists of at least 6 consecutive days during the Screening Period (prior to V3) where subjec"
                      },
                      {
                        "id": "3adc18c5-2c6f-41fc-885c-93346839998e",
                        "visitName": "Week 39",
                        "targetDay": 267,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 18,
                        "targetWeek": 39,
                        "sourceText": "Week 39 (V12) Week 52 (V13) or in case of premature discontinuation. All visits, apart from the Screening visits (V1 and V2) and V3 (Day 1), will be allowed a window of"
                      },
                      {
                        "id": "08ac9a35-7780-4e60-9f1a-4ed1246d3733",
                        "visitName": "Week 52",
                        "targetDay": 358,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 19,
                        "targetWeek": 52,
                        "epoch": "Treatment",
                        "sourceText": "Week 52 (V13) or in case of premature discontinuation. All visits, apart from the Screening visits (V1 and V2) and V3 (Day 1), will be allowed a window of ± 3 days."
                      },
                      {
                        "id": "91e6ea4c-d566-4acd-81d9-0c4afd7cecbd",
                        "visitName": "Follow-up",
                        "targetDay": 365,
                        "windowBefore": 7,
                        "windowAfter": 7,
                        "isRequired": true,
                        "visitNumber": 20,
                        "sourceText": "applicable), treatment, and follow-up per standard practice. The subject should be referred to a dermatologist within 2 business days after the photographs are taken. The dermatologic visit should be "
                      }
                    ]
                  }
                }
              },
              {
                "id": "8fb243ea-6644-4a48-88da-97c4b3cba2a8",
                "url": "https://protocol2usdm.io/extensions/x-soaFootnotes",
                "valueString": "[\"a. The Screening Period may be extended up to a total of 90 days for extenuating circumstances, e.g., supply constraints.\", \"b. The Monitoring Period can occur any time before V3, as long as it lasts for 6 consecutive days. PD Diaries will also be collected for at least 2 consecutive days during the Monitoring Period.\", \"a. GFR will be calculated one time at Screening Visit 1 (V1) according to the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation.\", \"b. Special laboratory tests to detect vitamin deficiencies, i.e., vitamin B12, vitamin B6, folic acid, homocysteine, and MMA levels will be performed at Screening Visit 1 (V1), on Day 1 (V3), and at Week 6 (V9), Week 26 (V11), and Week 52 (V13).\", \"a. Subjects with a low vitamin B12 or low-normal vitamin B12 and high MMA plasma level may undergo supplemental vitamin therapy.\", \"b. The PD diary concordance test may be omitted for subjects previously enrolled in Study M15-739, for whom recognizable/identifiable \\\"Off\\\" and \\\"On\\\" state (motor fluctuations) have been already established and confirmed.\", \"c. Subjects with evidence of transient skin conditions such as recent sunburn or open wound that resolved within the Screening Period are eligible for enrollment.\", \"p. 4 of 46 OPERATIONS MANUAL FOR CLINICAL STUDY PROTOCOL M15-741 VERSION 7.0 CONFIDENTIAL INFORMATION No use or disclosure outside AbbVie is permitted without prior written authorization from AbbVie. 4.2 REPORTING ADVERSE EVENTS AND INTERCURRENT ILLNESSES 37 4.3 PRODUCT COMPLAINT REPORTING 39 5 COUNTRY-SPECIFIC REQUIREMENTS 39 5.1 SAMPLE RETENTION REQUIREMENTS 39 5.2 SUSAR REPORTING 39 5.3 TREATMENT AFTER END OF STUDY 40 6 REFERENCES 40 LIST OF APPENDICES APPENDIX A. NEUROLOGY LABORATORY GRADING 41 APPENDIX B. CRITERIA FOR POTENTIALLY CLINICALLY SIGNIFICANT VITAL SIGN VALUES AND WEIGHT VALUES 46 Page 65 of 107 --- Page 66 ---\", \"0. = not at all, rarely\", \"1. Percentage of subjects with adverse events (AEs) and serious adverse events (SAEs) during the study\", \"2. Percentage of subjects with AEs of special interest (AESIs) during the study\", \"3. Percentage of subjects with numeric grade equal to or higher than 5 and percentage of subjects with letter grade equal to or higher than D on the Infusion Site Evaluation Scale at any time during the study\", \"4. Change in clinical laboratory test data from Baseline to end of study\", \"5. Change in vital sign measurements from Baseline to end of study\", \"6. Change in electrocardiograms (ECGs) from Baseline to end of study\", \"7. Subject is not considered by the investigator to be an unsuitable candidate to receive ABBV-951 for any reason. Disease Activity\", \"8. Subject must have a diagnosis of levodopa-responsive idiopathic PD.\", \"9. Subject must meet the following disease activity criteria: \\uf0b7 Must be taking a regimen of oral medications for PD that has remained unchanged for at least 30 days before commencing ABBV-951 (rescue medications taken \\\"as needed\\\" may be disregarded when assessing whether the regimen of oral medications has remained unchanged); this regimen must include levodopa-containing formulations such as CD/LD IR (e.g., Sinemet, Madopar), CD/LD-CR (e.g., Sinemet controlled release [CR]), CD/LD extended release (e.g., Rytary), CD/LD/entacapone (e.g., Stalevo). \\uf0b7 Must have a recognizable/identifiable \\\"Off\\\" and \\\"On\\\" state (motor fluctuations) as established through investigator observation and confirmed by PD diary entries recorded during the concordance test performed during the Screening Period.b\"]",
                "instanceType": "ExtensionAttribute"
              }
            ],
            "administrations": [
              {
                "id": "8ca5c4de-15db-4c3d-8c09-a8dbdd3296d6",
                "name": "Therapy Administration",
                "instanceType": "Administration",
                "dose": "100.0 mg / 25.0 mg / 10.0 mg / 84.0 mg",
                "doseFrequency": "QD",
                "route": {
                  "id": "b706e7e8-02b1-4e73-aa00-0107f35cd434",
                  "code": "Oral",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Oral",
                  "instanceType": "Code"
                },
                "description": "se a. Apomorphine and ergot dopamine agonists (lisuride, bromocriptine, cabergoline, etc.) are NOT allowed. b. Approved in Japan. c. Approved in the United States. Table 7. Allowed Rescue Medications/"
              },
              {
                "id": "a3bdd3c5-d5c6-4a54-9e68-900a0d03ae4a",
                "name": "ABBV-951 (carbidopa phosphate/levodopa phosphate [CDP/LDP]) Administration",
                "instanceType": "Administration",
                "dose": "50.0 mg/mL / 200.0 mg/mL",
                "doseFrequency": "Continuous",
                "route": {
                  "id": "d40c21f1-1955-49ea-a5fe-7e5de9918cff",
                  "code": "SC",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "SC",
                  "instanceType": "Code"
                },
                "duration": "52 weeks"
              },
              {
                "id": "c2029e64-15ef-487e-ac17-93e286afeb45",
                "name": "Levodopa-carbidopa intestinal gel (LCIG / CLES) Administration",
                "instanceType": "Administration",
                "doseFrequency": "Continuous",
                "route": {
                  "id": "9391db7e-b4c3-4218-a156-614bae6e177a",
                  "code": "",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "",
                  "instanceType": "Code"
                },
                "duration": "Not specified for this study arm"
              }
            ]
          }
        ],
        "titles": [
          {
            "id": "19853676-f64b-4990-9f55-086cbbbb906a",
            "text": "STUDY M15-741",
            "type": {
              "id": "d9229e53-71a5-43a9-a1d1-0efc78ef6da8",
              "code": "Official Study Title",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Official Study Title",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          }
        ],
        "studyIdentifiers": [
          {
            "id": "1c8a245d-81b6-417c-b4f0-e671f7688656",
            "text": "M15-741",
            "instanceType": "StudyIdentifier",
            "scopeId": "7434d6b5-0716-44bf-bf5b-210f91359954",
            "type": {
              "code": "C132351",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Sponsor Protocol Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "969fd885-d928-4593-9afc-69abb3879cd7",
            "text": "2018-002144-85",
            "instanceType": "StudyIdentifier",
            "scopeId": "bcfcf6b6-abfd-4518-8d53-be5fd67da3e2",
            "type": {
              "code": "C98714",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Clinical Trial Registry Identifier",
              "instanceType": "Code"
            }
          }
        ],
        "organizations": [
          {
            "id": "7434d6b5-0716-44bf-bf5b-210f91359954",
            "name": "AbbVie",
            "type": {
              "id": "d5b1f167-4788-4431-b9d0-d8fcc7cb59f0",
              "code": "C54086",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Pharmaceutical Company",
              "instanceType": "Code"
            },
            "identifier": "AbbVie",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "bcfcf6b6-abfd-4518-8d53-be5fd67da3e2",
            "name": "EudraCT",
            "type": {
              "id": "1e9a3fe7-372d-486a-ae7f-f503ddc95e07",
              "code": "C19326",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Healthcare Facility",
              "instanceType": "Code"
            },
            "identifier": "EudraCT",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "7434d6b5-0716-44bf-bf5b-210f91359954",
            "name": "University of Alabama at Birmingham - Main /ID# 207996",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "1",
            "type": {
              "id": "c4bfbb6b-674d-4a35-88b1-5ed84110bcc5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "bcfcf6b6-abfd-4518-8d53-be5fd67da3e2",
            "name": "Banner Sun Health Res Inst /ID# 208811",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "2",
            "type": {
              "id": "f2c672be-e01f-48e1-bb6f-6bfcdbdee244",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c55ec53a-b9df-4fe6-bca5-bc53bfb7f9fd",
            "name": "The Parkinson's & Movement Disorder Institute - Fountain Valley /ID# 216126",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "3",
            "type": {
              "id": "9e257378-3382-4590-a245-9ca744432a36",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "83e047a3-beaf-4e08-a9cb-dd8d91af9e75",
            "name": "University of Colorado Hospital /ID# 207968",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "4",
            "type": {
              "id": "6a5f5cba-d936-42b5-a00b-54a4c6b4a901",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ef6c8805-c7a5-45b4-a7fc-682cc9d6d059",
            "name": "Parkinson's Disease and Movement Disorders Center of Boca Raton /ID# 207677",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "5",
            "type": {
              "id": "3a4bcd75-25c1-4c6b-8d66-486041fdefa5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "86958804-5977-4d0a-882f-d01b8fb7e53e",
            "name": "Northwestern University Feinberg School of Medicine /ID# 208812",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "6",
            "type": {
              "id": "75994b2e-30b7-425e-b508-391174876ddf",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ec676ada-7f29-47d3-b803-a38d8fbf4ef5",
            "name": "Indiana Clinical Research Cent /ID# 207952",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "7",
            "type": {
              "id": "669e228d-c0a0-404e-b331-a21be4c84dbe",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5e138da0-8f5a-4809-bb21-941c1ecf8344",
            "name": "Univ Kansas Med Ctr /ID# 208963",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "8",
            "type": {
              "id": "8b8dcbea-6c4f-45ab-aba1-3f5aaff19ac7",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "87a95830-5cce-4cfc-8c41-e4588cad4de8",
            "name": "University of Kentucky Chandler Medical Center /ID# 207603",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "9",
            "type": {
              "id": "254db42f-eb11-4f4a-874e-5fe4ccdb6d72",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "82d5bf91-77e8-4843-bb82-7ea8f059a2bd",
            "name": "Massachusetts General Hospital /ID# 207993",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "10",
            "type": {
              "id": "52b4ad07-a066-494e-be0d-fa57ec5d38f5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "30bf0cd7-43f9-4d96-84f9-f8c6ca02f0c6",
            "name": "Health Partners /ID# 207950",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "11",
            "type": {
              "id": "80e84bb1-6558-4ed4-9e89-ffe8f3bd3663",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "264effc5-97cd-409a-a171-745a3bb30c56",
            "name": "University of Missouri /ID# 209043",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "12",
            "type": {
              "id": "8eb87669-0b56-4918-a900-dba133c0f6ca",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ac0f72c5-96b1-449a-85dc-c28621e8cad2",
            "name": "Washington University-School of Medicine /ID# 207525",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "13",
            "type": {
              "id": "f735e7e5-e311-48ee-8a2d-d121a41cf801",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "84d316fe-86be-429b-854e-4af1abc1df8b",
            "name": "Dartmouth-Hitchcock Medical Center /ID# 207972",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "14",
            "type": {
              "id": "b9526cc8-8abf-43e3-82f5-c3f958fdf189",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "640a4f32-04fd-403f-bff1-1c56529436ca",
            "name": "Wake Radiology UNC REX Healthcare - Raleigh Office /ID# 209784",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "15",
            "type": {
              "id": "f1b14574-876c-4cec-b098-65492f522c80",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d57cc2a9-8a65-4f34-9d1a-9d7d427dfe6e",
            "name": "Legacy Medical Group - Neurology /ID# 208031",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "16",
            "type": {
              "id": "33f45cdd-3bd5-435f-8983-897f6acae642",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2e69bb53-209b-4e91-87cd-25766988e0ec",
            "name": "Prisma Health Cancer Institute-Faris Road /ID# 207650",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "17",
            "type": {
              "id": "f39b2052-f516-4bc3-848e-9ac08752b4cc",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "03a92cb4-104e-4f29-beca-d8a0d1173ba9",
            "name": "Neurology Consultants of Dallas - LBJ Fwy /ID# 207619",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "18",
            "type": {
              "id": "72dc733a-652a-450b-b3b3-77b4d3b65d7b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "30374b69-16d6-4525-84b8-3d0f09ffd855",
            "name": "Baylor College of Medicine /ID# 207620",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "19",
            "type": {
              "id": "050ebcfe-ada9-44ad-a489-481e6d99fd6e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "6a8e3aee-0766-41ad-bb0e-29b635b196ef",
            "name": "Central Texas Neurology Consul /ID# 216918",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "20",
            "type": {
              "id": "82ba3f50-0ddb-449a-bf32-8f6998d7893d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4a2ee87f-c63a-4b1b-9624-ebdba4388891",
            "name": "Univ Texas HSC San Antonio /ID# 208958",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "21",
            "type": {
              "id": "d4ccd891-9ea0-47af-9868-3318c44df22b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "43cfbc6b-543c-439c-903a-39b1d57014b4",
            "name": "Booth Gardner Parkinson's Care Center /ID# 208026",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "22",
            "type": {
              "id": "b1941de2-f35b-4029-937f-b025765fbf52",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3240fe16-8988-4dfd-8f53-fa0ec21c57ac",
            "name": "Inland Northwest Research /ID# 208122",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "23",
            "type": {
              "id": "275ab180-b194-4c65-ad91-9fbe95f4990e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "dd492a0f-f6d2-48df-ae02-ac73144c15a5",
            "name": "Medical College of Wisconsin /ID# 207999",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "24",
            "type": {
              "id": "9dd7d0ba-0660-41b2-b468-bb6dae142cf0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b9c2bfcc-3cab-492f-b7f9-5f2ba8d74c35",
            "name": "Concord Repatriation General Hospital /ID# 207628",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "25",
            "type": {
              "id": "77b66e69-2b8b-40c3-a1f3-063baac7e218",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "14cf444d-a912-41f3-98b0-750e100265e4",
            "name": "Westmead Hospital /ID# 207633",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "26",
            "type": {
              "id": "dc57af49-322f-4f56-89a5-e84dad648f34",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2e03abaa-8d0c-42a3-8cd2-d20f079b7699",
            "name": "Royal Adelaide Hospital /ID# 207634",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "27",
            "type": {
              "id": "a6f9c3ac-111d-4fb6-8a8a-18c367b44653",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "737b74f0-0be7-422d-b0b1-b9598dc1274c",
            "name": "Alfred Health /ID# 207632",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "28",
            "type": {
              "id": "30991d76-894f-4e3e-b6fc-34a3a3c4f508",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a9e26b5a-5d62-4fd6-aa46-575dd7020ed5",
            "name": "Perron Institute /ID# 207627",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "29",
            "type": {
              "id": "2e87231b-f872-40dc-9763-cf16552c750e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5fbdb37c-54d2-427c-b1ab-f624caa961ec",
            "name": "Universitair Ziekenhuis Leuven /ID# 209058",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "30",
            "type": {
              "id": "2a25baec-c180-4ebd-832d-e303c03b1e76",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a4e0eb7a-6eab-4ff3-8e4a-6d5c79d90b0a",
            "name": "AZ Sint-Jan Brugge /ID# 208178",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "31",
            "type": {
              "id": "6f098b0a-1a68-441b-9a57-6b8652abeb6b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ea7183a9-4054-4198-9b2d-692a8a7ec3e4",
            "name": "Groupe Sante CHC - Clinique du MontLegia /ID# 208177",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "32",
            "type": {
              "id": "aad6462b-25d7-436b-af3b-37da9cb719bd",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "bed04777-9399-4a83-86da-7b3fce6a6c3c",
            "name": "University of Calgary - Movement Disorders Clinic /ID# 207342",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "33",
            "type": {
              "id": "cd720e83-f973-4984-a6a3-c0361ab7b133",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "cb4b6d97-f316-45f6-85fc-5f6d0f86999e",
            "name": "Centre de Recherche St-Louis /ID# 207344",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "34",
            "type": {
              "id": "aea2f0f4-498c-4508-8a2d-1ebf1090d52b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9724128f-55ae-48c2-a513-4b18d18f0ecd",
            "name": "Bispebjerg and Frederiksberg Hospital /ID# 207669",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "35",
            "type": {
              "id": "d03d40ab-a12c-42bc-95f4-810f029c6fde",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0fc6b0ef-6f83-4f63-8419-1e2ac84d537a",
            "name": "Aarhus University Hospital /ID# 207668",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "36",
            "type": {
              "id": "abe1d1b2-748b-4b1c-bea8-8736f521827e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b7431738-be60-4731-9a3d-c2d171c0ffd7",
            "name": "Odense University Hospital /ID# 207871",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "37",
            "type": {
              "id": "7792006c-6dbc-4d19-8861-187b7d3d2b09",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "29a571bc-0ae4-49c1-ae9a-9fdbac85a16a",
            "name": "Universitaetsklinikum Ulm /ID# 208602",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "38",
            "type": {
              "id": "7a75cd8e-db75-486c-b932-5cc21c338e94",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "6186a5e7-43c8-42a8-8542-d3c8085cb470",
            "name": "Kliniken Beelitz GmbH /ID# 208600",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "39",
            "type": {
              "id": "e6c796f1-f12c-4e33-867f-1eb568dfd1bc",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9a61c7bf-b2d9-4733-ab65-295f30c7e2cd",
            "name": "InnKlinikum Haag /ID# 208601",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "40",
            "type": {
              "id": "dddd18ca-7b4c-4c5d-b76e-104a321d4732",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a6d5b182-c91c-45dc-af38-274c4eab5734",
            "name": "IRCCS Centro Neurolesi Bonino Pulejo /ID# 207975",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "41",
            "type": {
              "id": "adc7b8b3-e44a-41b8-a417-961a95bc12ba",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1ab0a55e-a98f-4460-b333-baed83dc5b01",
            "name": "Fondazione IRCCS Istituto Neurologico Carlo Besta /ID# 207955",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "42",
            "type": {
              "id": "5d3d6c37-3d91-465b-b47d-0245593cd1dc",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0a157b28-8eb5-423e-b810-753859fddbdb",
            "name": "Azienda Ospedaliera di Padova /ID# 208077",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "43",
            "type": {
              "id": "c388f297-9eb0-46f6-ba9e-0bcf66232ed0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "40f413cc-de0b-470c-a23c-35d773aad0fa",
            "name": "National Hospital Organization Asahikawa Medical Center /ID# 210914",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "44",
            "type": {
              "id": "0987e1c5-f0c6-41c6-83ef-00b6c6f845a8",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ed47e89f-1017-4cf3-984b-e8f3d65e64f9",
            "name": "National Hospital Organization Utano National Hospital /ID# 210912",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "45",
            "type": {
              "id": "8951e1f2-4b91-461d-aa95-405aab74741f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1f39651f-0422-4aa3-8632-245c46acb371",
            "name": "Osaka University Hospital /ID# 210913",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "46",
            "type": {
              "id": "a2bba927-1797-4e26-8b78-cff6095455db",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c591a659-a3dc-4a8c-acc0-3c223354bfeb",
            "name": "Juntendo University Hospital /ID# 210915",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "47",
            "type": {
              "id": "fd1bd554-95ee-4069-96d8-c9ae6b8526e4",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d3065f02-8a4c-43ff-a388-b08913c44124",
            "name": "National Center of Neurology and Psychiatry /ID# 210911",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "48",
            "type": {
              "id": "9df9e5cb-ef4c-4164-89b4-f09639f67713",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "56f62344-c001-4f82-9b53-6122ab6b81b3",
            "name": "Erasmus Medisch Centrum /ID# 208168",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "49",
            "type": {
              "id": "90f94366-6acf-4195-92a5-5dd1e459cfe9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7c9def2a-bebc-4186-a831-a27e8361cc18",
            "name": "St. Antonius Ziekenhuis /ID# 208529",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "50",
            "type": {
              "id": "041647e2-9fdc-426a-a8df-1cc78ed408f6",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "65c3cfac-86e5-4369-8942-dd0bb9d1a2bb",
            "name": "Academician I.P. Pavlov First St. Petersburg State Medical University /ID# 216303",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "51",
            "type": {
              "id": "126766e5-3527-45e5-8db5-1c9b9a80d187",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c94a0640-0c37-44a2-b70c-2b67b5776aec",
            "name": "City Clinical Hospital #40 /ID# 216301",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "52",
            "type": {
              "id": "36677289-631f-4661-948f-8f7572dac8cd",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d7d28906-62ea-407e-b515-c2cf1bd6a57c",
            "name": "Hospital General Universitario de Elche /ID# 209777",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "53",
            "type": {
              "id": "c99f24a7-d385-4ecb-af4b-3f874b2cc144",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a24b5fa1-679d-4f89-b953-b3ce38e80fa6",
            "name": "Hospital Universitario de Bellvitge /ID# 209539",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "54",
            "type": {
              "id": "202ef1b2-4fd7-40c6-a77c-b6b72f2c91e9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5a727d38-4b7a-4459-852c-4a082438caef",
            "name": "Hospital Universitario A Coruna - CHUAC /ID# 212147",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "55",
            "type": {
              "id": "6595773b-9221-4cab-9125-3af93aba8efa",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9c395492-e103-4e64-97c6-566d0c66b336",
            "name": "Hospital Santa Creu i Sant Pau /ID# 208240",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "56",
            "type": {
              "id": "df2fa1a1-a4c7-403d-8ccd-e60d7ecbe36d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "81cc8476-6fa6-4769-9832-45ccaff9e0b1",
            "name": "Hospital Universitario Virgen de las Nieves /ID# 208242",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "57",
            "type": {
              "id": "f6fc31ed-08b9-4885-866a-438b702a611e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "fb6c64b8-4467-4c7a-af94-fccaa5fc494b",
            "name": "Hospital Universitario Ramon y Cajal /ID# 208241",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "58",
            "type": {
              "id": "f1cfe542-cc0d-4b5a-a9e7-d43c70d1a8a3",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4e8aeb78-98fb-47e6-a09a-4675320ba90b",
            "name": "Hospital Universitario Virgen del Rocio /ID# 208239",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "59",
            "type": {
              "id": "401ae88b-b13b-4427-b5c7-cfdfa48e6cce",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c70a0e5e-898a-47a2-8e14-2bca89b21f36",
            "name": "Skane University Hospital Lund /ID# 207811",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "60",
            "type": {
              "id": "c336f159-6812-420f-862c-f3142104afdb",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4ad3f0d1-375b-40f0-b355-2c3ffc22e77a",
            "name": "Centrum for neurologi /ID# 207716",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "61",
            "type": {
              "id": "eec6d0c0-de9b-4291-8bff-d0e4e6e2ff39",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b8bd693d-4880-4b74-bfef-6f59377a2e52",
            "name": "Sahlgrenska University Hospital /ID# 207718",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "62",
            "type": {
              "id": "10773c44-eab9-427f-a4fd-0816d99ce987",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9ebb33f6-cc2b-4c15-8a4e-899c807d282f",
            "name": "NHS Tayside /ID# 209242",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "63",
            "type": {
              "id": "df8338b6-1cdc-45d6-a05e-427d5d2a7db3",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "65b76bba-421a-41cc-a0da-92ccf4ec2362",
            "name": "King's College Hospital NHS Foundation Trust /ID# 208413",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "64",
            "type": {
              "id": "a5e08f9e-23c1-479e-b0d3-91b2c22da0f0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "84e0f61b-d56e-4f56-8e5d-82354ede98f2",
            "name": "University Hospital Plymouth NHS Trust /ID# 208447",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "65",
            "type": {
              "id": "6edfde3b-d4c0-46e2-97d8-2c28d874da28",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          }
        ],
        "studyPhase": {
          "id": "c3c94672-ed54-4edb-abc4-ad9ec774d792",
          "code": "NotApplicable",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "NotApplicable",
          "instanceType": "Code"
        },
        "eligibilityCriterionItems": [
          {
            "id": "14d17986-e18e-42db-bdbc-6b493aaf7dc9",
            "name": "Informed Consent Understanding",
            "text": "Subject must be able to understand the nature of the study and have had the opportunity to have any questions answered by the investigator.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "0e12b510-9dd8-4a9e-88a7-b7df70799447",
            "name": "Informed Consent Signature",
            "text": "Subject, if judged by the investigator to have decision making capacity, must voluntarily sign and date an informed consent form approved by an independent ethics committee (IEC)/institutional review board (IRB), prior to initiation of any study-specific procedures.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "80fa8a05-5d5c-4845-b057-2deeb59c16ff",
            "name": "Age Requirement",
            "text": "Subject must be an adult male or female, 30 years of age, or older.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "2c407aad-11fd-418a-8d1d-0254ae5e4168",
            "name": "Compliance",
            "text": "Subject is willing and able to comply with procedures required in this protocol.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "66b729bd-50e8-4fc6-b5d0-5cdd925b16a5",
            "name": "Vitamin B12 Levels",
            "text": "Subject does not have a low vitamin B12 level (< 200 pg/mL); or does not have low-normal vitamin B12 level (< 300 pg/mL) with elevated methylmalonic acid (MMA > 0.41 µmol/L) at Screening Visit 1 (V1).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "41803854-3c11-4261-80ae-7107f0f639dd",
            "name": "Cognitive Function",
            "text": "Subject has normal cognitive function (Mini-Mental State Examination [MMSE] score of 24 or greater). Subjects with mild cognitive impairment (MMSE score of 19 – 23 inclusive) may be enrolled if in the investigator's opinion, are able to adhere to all study requirements. Subjects with moderate or severe impairment (MMSE scores of 18 or below) may not be enrolled.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "c35f50e9-726a-4f45-84db-31996d19fb29",
            "name": "Investigator Suitability",
            "text": "Subject is not considered by the investigator to be an unsuitable candidate to receive ABBV-951 for any reason.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "6681a2aa-374d-42a8-9dce-9a6974267c9a",
            "name": "Parkinson's Diagnosis",
            "text": "Subject must have a diagnosis of levodopa-responsive idiopathic PD.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "102a173e-24bc-448e-8a3d-3eb28757a87a",
            "name": "Disease Activity and Medication",
            "text": "Subject must meet the following disease activity criteria: Must be taking a regimen of oral medications for PD that has remained unchanged for at least 30 days before commencing ABBV-951; this regimen must include levodopa-containing formulations such as CD/LD IR, CD/LD-CR, CD/LD extended release, CD/LD/entacapone. Must have a recognizable/identifiable \"Off\" and \"On\" state (motor fluctuations) as established through investigator observation and confirmed by PD diary entries recorded during the concordance test performed during the Screening Period.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "310f8e99-dc00-42a3-9125-60a23b2141ce",
            "name": "Off Time Requirement",
            "text": "Must be judged to be inadequately controlled by current therapy in the opinion of the investigator and experience a minimum of 2.5 hours of \"Off\" time per day as assessed by PD Diary prior to Day 1 (V3). Subjects who have received DBS therapy are eligible for the study, provided they are considered stable, are still levodopa responsive, and meet all other eligibility criteria.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "25e99789-e458-421a-8c29-c40bb794f4b0",
            "name": "Skin Conditions Exclusion",
            "text": "Subject does not have a history of significant skin conditions or disorders (e.g., psoriasis, atopic dermatitis) or evidence of recent sunburn, acne, scar tissue, tattoo, open wound, branding, or colorations that in the investigator's opinion would interfere with the infusion of study drug or could interfere with study assessments.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "e8004d64-9d49-445c-8a11-2e5b27899bfa",
            "name": "Substance Abuse Exclusion",
            "text": "Subject does not have a recent (within 6 months prior to study drug administration) history of drug or alcohol abuse that could preclude adherence to the protocol in the opinion of the investigator.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "ecb4c3c6-0f46-4da0-8596-28ca28eaf151",
            "name": "Suicidal Ideation Exclusion",
            "text": "Subject does not have significant current suicidal ideation within 1 year prior to study drug administration as evidenced by answering \"yes\" to questions 4 or 5 on the suicidal ideation portion of the Columbia-Suicide Severity Rating Scale (C-SSRS) completed at either screening visit, or any history of suicide attempts within the last 2 years.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "3a0f9b1c-8494-4e25-95f4-c60ad8c592f7",
            "name": "Psychotic Episodes Exclusion",
            "text": "Subject does not have a history or presence of psychotic episodes that in the investigator's judgment are not adequately controlled by second generation (atypical) antipsychotics and that could preclude adherence to the protocol.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "d56ccff6-a37e-4178-a4be-310c0a2d1ed3",
            "name": "Unstable Medical Conditions Exclusion",
            "text": "Subject does not have other clinically significant unstable medical conditions or any other reason that the investigator determines would interfere with the subject's participation in this study or would make the subject an unsuitable candidate to receive study drug.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "0f63fd19-358e-4c54-9580-ed13641a32b3",
            "name": "Allergic Reaction Exclusion",
            "text": "Subject does not have a history of allergic reaction or significant sensitivity to levodopa or constituents of the study drug (and its excipients) and/or other products in the same class.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "2907bb0f-57c9-4aec-8cd9-793244624841",
            "name": "Levodopa Contraindications Exclusion",
            "text": "Subject does not have any known medical condition for which levodopa is contraindicated (e.g., suspicious undiagnosed melanoma, narrow-angle glaucoma, severe heart failure, severe cardiac arrhythmia, pheochromocytoma, untreated hyperthyroidism, or Cushing's syndrome and other circumstances where adrenergics are contraindicated).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "232dae9e-8576-4fac-8d06-b14060499cda",
            "name": "Blood Donation Exclusion",
            "text": "Subject has not donated or lost 550 mL or more blood volume (including plasmapheresis) or received a transfusion of any blood product within 8 weeks prior to initial study drug administration.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "d2d2f6fa-45a9-47a4-9177-57e83e60450d",
            "name": "COVID-19 Exclusion",
            "text": "Subject has no known active COVID-19 infection. Subject must not have signs/symptoms associated with COVID-19 infection or known exposure to a confirmed case of COVID-19 infection during 14 days prior to Screening.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "fc85a01b-26d1-4e47-be23-5d566f76b55f",
            "name": "Pregnancy Test Requirement",
            "text": "If female of childbearing potential, subject must have a negative serum pregnancy test at Screening Visit 1 (V1) and a negative urine pregnancy test on Day 1 (V3) prior to the start of the infusion of study drug.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "bf4769e9-be24-48c5-88c8-96a4a2237299",
            "name": "Female Contraception",
            "text": "If female, subject must be either postmenopausal, OR permanently surgically sterile OR for women of childbearing potential (WOCBP) practicing at least 1 protocol-specified method of birth control, that is effective from Day 1 (V3) through at least 30 days after the end of the infusion (end of Treatment Period).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "717ad803-8376-47d2-b8e1-e104e15ae1e5",
            "name": "Male Contraception",
            "text": "If male and sexually active with female partner(s) of childbearing potential, subject must agree, from Day 1 (V3) through 30 days after the end of the infusion of study drug, to practice protocol-specified contraception.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "64322fe7-dca1-4af8-88f1-fe801a2f58f7",
            "name": "Pregnancy/Breastfeeding Exclusion",
            "text": "If female, subject is not pregnant, breastfeeding, or considering becoming pregnant or donating eggs during the study or within 30 days after the end of the infusion of study drug.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "7a9efe64-de08-4337-9437-03e0ecb0c93c",
            "name": "Male Procreation Exclusion",
            "text": "If male, subject is not considering fathering a child or donating sperm during the study or within 30 days after the end of the infusion of study drug (end of Treatment Period).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "16c5dcdc-86c8-4150-b51d-9684abc15766",
            "name": "Investigational Product Exclusion",
            "text": "Subject has not received an investigational product other than ABBV-951 within a time period equal to 5 half-lives, if known, or within 6 weeks, whichever is longer, prior to study drug administration.",
            "instanceType": "EligibilityCriterionItem"
          }
        ],
        "studyInterventions": [
          {
            "id": "fb166c65-2cac-4d31-84f9-5c337d57a16b",
            "name": "ABBV-951",
            "type": {
              "id": "af9f8e8a-bc58-4440-9910-0e28879b6aab",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "role": {
              "id": "0fa8fe7f-d72a-428e-a788-a9027f398157",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Soluble formulation of carbidopa phosphate and levodopa phosphate (CDP/LDP) for continuous subcutaneous infusion (CSCI).",
            "productIds": [
              "b503d3b2-9812-4bd6-a6e3-3fa67c9b4c77"
            ],
            "administrationIds": [
              "8a565cbb-5df1-4f73-8653-e63649124e07",
              "b769bf41-ddab-49dc-800d-e7d985b6d12f"
            ]
          },
          {
            "id": "7375e347-15c3-44ed-ad18-85a06a14f2a4",
            "name": "LD+DDCI",
            "type": {
              "id": "4e1bfe7c-aed8-40cc-a574-b582d78f7d40",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "role": {
              "id": "c44184c9-3df4-405e-b2e0-6daf45f69909",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Oral loading dose of levodopa and DOPA decarboxylase inhibitor (e.g., Sinemet, Madopar) administered at treatment initiation.",
            "productIds": [
              "8339d0fc-406e-4a9d-9fa8-ba66f103237c"
            ],
            "administrationIds": [
              "d0552f6c-f4d7-4cda-9443-d1bd8f0dcefd"
            ]
          },
          {
            "id": "8e379d9f-b40a-4e9f-85ab-159debd31837",
            "name": "Oral LD+DDCI IR",
            "type": {
              "id": "799c7d02-ba10-4749-bca3-98a716dd22ad",
              "code": "C54125",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Rescue Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "7cce8f14-b9c5-43a2-9316-27b694052700",
              "code": "C54125",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Rescue Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Immediate-release tablets (e.g., Sinemet 25/100) for rapid deterioration of motor symptoms or pump malfunction.",
            "productIds": [
              "d80e0cc5-23ae-43dd-86b1-bd4a998139fb"
            ],
            "administrationIds": [
              "7e1ae532-40f1-4205-8eea-f4a1e04eb122"
            ]
          },
          {
            "id": "5e5e0cdc-c1ab-4856-8f75-852b6f52cd6c",
            "name": "Levodopa inhalation powder",
            "type": {
              "id": "79c37ac4-9b78-4eff-b0f8-f172ae81a514",
              "code": "C54125",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Rescue Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "85e2d236-3ba5-4b97-ac7a-8ce1e38e33f2",
              "code": "C54125",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Rescue Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Inhaled levodopa (e.g., Inbrija) for serious medical need or pump malfunction."
          },
          {
            "id": "b1721e0a-cc14-4350-9944-40e36e6d3264",
            "name": "Non-ergolinic dopamine agonists",
            "type": {
              "id": "3621632b-3f75-4b98-8b68-a35c132d0b43",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "8fd3ad1e-d222-4ce8-9d7e-7d6146c13135",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted medications such as pramipexole, ropinirole, or rotigotine."
          },
          {
            "id": "d41023ef-acb0-492f-b63f-d4daf53261e8",
            "name": "Selective MAO-B inhibitors",
            "type": {
              "id": "8d1cdd90-db1b-46d4-b947-f6115708ee6b",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "1e9b5fee-90cb-44ad-aafc-cd0fdf71cfec",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted medications such as rasagiline or selegiline."
          },
          {
            "id": "ce6e592e-4960-4531-8f00-fe9769320f2c",
            "name": "Amantadine",
            "type": {
              "id": "ef634f78-141a-4769-99e1-9f85d9cc78ba",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "68525872-f838-407d-938a-2af1dfdd3593",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted IR and ER formulations."
          },
          {
            "id": "7b6d688d-35e8-4791-825e-57464e59b937",
            "name": "Safinamide",
            "type": {
              "id": "0e9efdfa-cb11-4d59-9488-0f862a5451d7",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "93dfce5d-ff34-4e5a-9250-762e93dae88c",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted concomitant therapy."
          },
          {
            "id": "6c68f56f-49f4-4588-8e55-a441b77c45c9",
            "name": "Zonisamide",
            "type": {
              "id": "ddb145b1-01ae-4536-8a45-690a4b6f1235",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "cd457b46-0a3b-4da0-9563-38e91d3c5636",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted concomitant therapy (approved in Japan)."
          },
          {
            "id": "6005217c-3c3d-4f0a-94a1-ae58461565fd",
            "name": "Istradefylline",
            "type": {
              "id": "00000618-1386-4678-85bc-6b20bff759f6",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "c848c353-0f28-48c4-bc24-f737e83bd6f9",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted concomitant therapy (approved in US/Japan)."
          },
          {
            "id": "f820e7d2-4e20-497c-9069-6631e6cd5189",
            "name": "Apomorphine",
            "type": {
              "id": "1013dc4d-118c-41c2-ae6e-e239425e5470",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "role": {
              "id": "662e67aa-ac2c-46d2-b192-14d4ef68bfb1",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Must be washed out (30 days for CSCI, 12 hours for other forms) prior to ABBV-951."
          },
          {
            "id": "083a1fc7-9dd7-4f69-9792-62ebd3928624",
            "name": "COMT inhibitors",
            "type": {
              "id": "b3006dc3-6426-4ae2-976c-71e79be38be7",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "role": {
              "id": "26ebd767-7a13-431b-845c-75e01ad86b4d",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Must be washed out for at least 12 hours before initiation (e.g., entacapone, tolcapone, opicapone)."
          }
        ],
        "administrableProducts": [
          {
            "id": "b503d3b2-9812-4bd6-a6e3-3fa67c9b4c77",
            "name": "ABBV-951 solution for infusion",
            "administrableDoseForm": {
              "id": "6e2c1ac9-9dda-479c-be70-e7c36247afb8",
              "code": "C42986",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Solution",
              "instanceType": "Code",
              "standardCode": {
                "id": "886c4332-b72b-4635-ba11-8e1be88197cd",
                "code": "C42986",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Solution",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "6b18a28e-931c-4429-8a29-ed06d94d6823",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "12/240 mg/mL",
            "substanceIds": [
              "11e2aac5-ab79-42a4-84d6-17e6d8dabd92"
            ],
            "manufacturer": "AbbVie"
          },
          {
            "id": "8339d0fc-406e-4a9d-9fa8-ba66f103237c",
            "name": "Sinemet 25/100",
            "administrableDoseForm": {
              "id": "b2fe6efc-f919-42da-a64d-57edb52281c0",
              "code": "C42998",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Tablet",
              "instanceType": "Code",
              "standardCode": {
                "id": "20e50d7a-b727-40b2-b4e8-5e56ba6045b5",
                "code": "C42998",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Tablet",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "64fff498-917c-4ec9-a9e1-258b7368f4bd",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "25 mg carbidopa / 100 mg levodopa",
            "substanceIds": [
              "6ec947dc-04ff-4b8a-b736-569aed0d471f"
            ],
            "manufacturer": "Not specified"
          },
          {
            "id": "d80e0cc5-23ae-43dd-86b1-bd4a998139fb",
            "name": "Inbrija",
            "administrableDoseForm": {
              "id": "8f59d034-3e8d-4238-b931-c7cb3b17751c",
              "code": "C42970",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Powder",
              "instanceType": "Code",
              "standardCode": {
                "id": "2bd1ace6-80d7-431a-9ffe-8ddb0cd4b1ed",
                "code": "C42970",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Powder",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "3499f77b-ccdd-46bf-9ebf-b3888ac759b3",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "84 mg",
            "manufacturer": "Not specified"
          }
        ],
        "narrativeContents": [
          {
            "id": "a9e7149a-5b9f-49bf-bc9d-904735c30cec",
            "name": "SYNOPSIS",
            "text": "SYNOPSIS",
            "order": 0,
            "instanceType": "NarrativeContent",
            "sectionNumber": "1",
            "sectionTitle": "SYNOPSIS",
            "sectionType": {
              "id": "982e7b68-6b42-4e79-a3cd-8ae6d7e3dfb0",
              "code": "Synopsis",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Synopsis",
              "instanceType": "Code"
            }
          },
          {
            "id": "ae23d124-bda6-4060-b620-e8aa6111aed2",
            "name": "INTRODUCTION",
            "text": "INTRODUCTION",
            "order": 1,
            "instanceType": "NarrativeContent",
            "sectionNumber": "2",
            "sectionTitle": "INTRODUCTION",
            "sectionType": {
              "id": "d74c8a8d-4fbd-4dca-a6df-aac2ada2d0ac",
              "code": "Introduction",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Introduction",
              "instanceType": "Code"
            },
            "childIds": [
              "093efd06-3c0d-4b0f-b630-ec92989be2cc",
              "dd4965ec-e192-43b0-9583-86ac320c10a8"
            ]
          },
          {
            "id": "ee249dc2-ece0-42c6-8ba3-b304663f1c57",
            "name": "STUDY OBJECTIVES AND ENDPOINTS",
            "text": "STUDY OBJECTIVES AND ENDPOINTS",
            "order": 2,
            "instanceType": "NarrativeContent",
            "sectionNumber": "3",
            "sectionTitle": "STUDY OBJECTIVES AND ENDPOINTS",
            "sectionType": {
              "id": "489506ed-3447-41ef-a06e-c13ebf2e302f",
              "code": "Objectives",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Objectives",
              "instanceType": "Code"
            },
            "childIds": [
              "6ebd4cbf-f88c-4ddb-aa45-154ef5b3b172",
              "12093016-f6af-41a5-b553-f3c020aa0d3d",
              "eaa98a9d-4a88-4347-a41a-de44cc6af382",
              "d00d888a-4de3-47a0-8458-8311e906499e",
              "b0f7d405-f74a-4523-af42-89f44ee609f6"
            ]
          },
          {
            "id": "866a2d10-3f43-462f-bc2a-1e3983e5f936",
            "name": "INVESTIGATIONAL PLAN",
            "text": "INVESTIGATIONAL PLAN",
            "order": 3,
            "instanceType": "NarrativeContent",
            "sectionNumber": "4",
            "sectionTitle": "INVESTIGATIONAL PLAN",
            "sectionType": {
              "id": "3ab3d436-487f-4049-b29e-9c783ac4b058",
              "code": "Study Design",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Design",
              "instanceType": "Code"
            },
            "childIds": [
              "8a530766-e729-471e-b146-360b5f155b7b",
              "a3008aa2-8c4d-4f8c-91aa-5f0e5e7efc18",
              "f61ea622-5c71-4e12-a95b-d1b91fdc5d3b"
            ]
          },
          {
            "id": "4598bfb9-1060-4770-b5bd-71ad3dbb1ca2",
            "name": "STUDY ACTIVITIES",
            "text": "STUDY ACTIVITIES",
            "order": 4,
            "instanceType": "NarrativeContent",
            "sectionNumber": "5",
            "sectionTitle": "STUDY ACTIVITIES",
            "sectionType": {
              "id": "b2f7be88-0f6f-472e-9445-b0f8929cd8b0",
              "code": "Study Procedures",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Procedures",
              "instanceType": "Code"
            },
            "childIds": [
              "c5efa76c-312f-4244-b853-4b1255f0eb20",
              "03d30bac-5132-4deb-8558-5fc135cd2666",
              "673e4a65-f50d-4af1-924d-6ee818a7b24d",
              "e0b19e0e-4095-4417-aa82-5f11ce6550eb",
              "205c6499-92a2-4441-94f3-30a49e105d9d",
              "94b79950-f515-4e3c-bfa5-f364c151ebb5",
              "dfe01386-61d1-4183-8a81-654460105f39",
              "02bbd3e9-609b-4d1d-869a-2008c32137cf",
              "ee9a869f-4de7-4ee9-9505-c34eaa35bb5b"
            ]
          },
          {
            "id": "b08925b4-0f68-4065-aa2a-cd33ab4468cc",
            "name": "SAFETY CONSIDERATIONS",
            "text": "SAFETY CONSIDERATIONS",
            "order": 5,
            "instanceType": "NarrativeContent",
            "sectionNumber": "6",
            "sectionTitle": "SAFETY CONSIDERATIONS",
            "sectionType": {
              "id": "2ff7c91c-f2ea-470b-a73a-8abbb73c47fb",
              "code": "Safety",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Safety",
              "instanceType": "Code"
            },
            "childIds": [
              "f4945b61-8a8b-4b68-8b11-3cebb6f427e4"
            ]
          },
          {
            "id": "fc9b7b5c-fad3-4dc5-9f54-3e3dd34be0f7",
            "name": "STATISTICAL METHODS & DETERMINATION OF SAMPLE SIZE",
            "text": "STATISTICAL METHODS & DETERMINATION OF SAMPLE SIZE",
            "order": 6,
            "instanceType": "NarrativeContent",
            "sectionNumber": "7",
            "sectionTitle": "STATISTICAL METHODS & DETERMINATION OF SAMPLE SIZE",
            "sectionType": {
              "id": "823d3add-4ca0-4bf5-9c43-227fb51895c5",
              "code": "Statistics",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Statistics",
              "instanceType": "Code"
            }
          },
          {
            "id": "e8376e91-b038-4b81-8bdd-caac9e140391",
            "name": "STUDY SPECIFIC ABBREVIATIONS AND TERMS",
            "text": "STUDY SPECIFIC ABBREVIATIONS AND TERMS",
            "order": 7,
            "instanceType": "NarrativeContent",
            "sectionNumber": "APPENDIX A",
            "sectionTitle": "STUDY SPECIFIC ABBREVIATIONS AND TERMS",
            "sectionType": {
              "id": "caef4da6-a533-4e87-9202-afde08ad7290",
              "code": "Appendix",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Appendix",
              "instanceType": "Code"
            }
          },
          {
            "id": "ef66f0f0-3efc-4088-938b-5bb53a525964",
            "name": "RESPONSIBILITIES OF THE INVESTIGATOR",
            "text": "RESPONSIBILITIES OF THE INVESTIGATOR",
            "order": 8,
            "instanceType": "NarrativeContent",
            "sectionNumber": "APPENDIX B",
            "sectionTitle": "RESPONSIBILITIES OF THE INVESTIGATOR",
            "sectionType": {
              "id": "26a38ab1-d989-4115-b4d4-e3a246840bca",
              "code": "Appendix",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Appendix",
              "instanceType": "Code"
            }
          },
          {
            "id": "24f87ce0-e72d-4dfc-87a4-b736dbd8de25",
            "name": "LIST OF PROTOCOL SIGNATORIES",
            "text": "LIST OF PROTOCOL SIGNATORIES",
            "order": 9,
            "instanceType": "NarrativeContent",
            "sectionNumber": "APPENDIX C",
            "sectionTitle": "LIST OF PROTOCOL SIGNATORIES",
            "sectionType": {
              "id": "7d97716c-3696-495a-8aee-84def364ca2e",
              "code": "Appendix",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Appendix",
              "instanceType": "Code"
            }
          },
          {
            "id": "793c9d94-c4ab-43c4-9fb9-80d3ef5a6b20",
            "name": "ACTIVITY SCHEDULE",
            "text": "ACTIVITY SCHEDULE",
            "order": 10,
            "instanceType": "NarrativeContent",
            "sectionNumber": "APPENDIX D",
            "sectionTitle": "ACTIVITY SCHEDULE",
            "sectionType": {
              "id": "122d8682-7152-4ea4-b202-76dafaa22878",
              "code": "Appendix",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Appendix",
              "instanceType": "Code"
            }
          },
          {
            "id": "5cfec2b0-a68d-4a34-a5cc-7d95932fca2e",
            "name": "PROTOCOL SUMMARY OF CHANGES",
            "text": "PROTOCOL SUMMARY OF CHANGES",
            "order": 11,
            "instanceType": "NarrativeContent",
            "sectionNumber": "APPENDIX E",
            "sectionTitle": "PROTOCOL SUMMARY OF CHANGES",
            "sectionType": {
              "id": "36baa4a1-511a-4840-9c90-c056e4e495e7",
              "code": "Appendix",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Appendix",
              "instanceType": "Code"
            }
          },
          {
            "id": "7c96584c-ddc9-4b5a-a362-2305850a822a",
            "name": "OPERATIONS MANUAL",
            "text": "OPERATIONS MANUAL",
            "order": 12,
            "instanceType": "NarrativeContent",
            "sectionNumber": "APPENDIX F",
            "sectionTitle": "OPERATIONS MANUAL",
            "sectionType": {
              "id": "3f1c320d-c1f1-4374-b5d5-9bf444e5bf93",
              "code": "Appendix",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Appendix",
              "instanceType": "Code"
            }
          }
        ],
        "narrativeContentItems": [
          {
            "id": "093efd06-3c0d-4b0f-b630-ec92989be2cc",
            "name": "BACKGROUND AND RATIONALE",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.1",
            "sectionTitle": "BACKGROUND AND RATIONALE"
          },
          {
            "id": "dd4965ec-e192-43b0-9583-86ac320c10a8",
            "name": "BENEFITS AND RISKS TO SUBJECTS",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.2",
            "sectionTitle": "BENEFITS AND RISKS TO SUBJECTS"
          },
          {
            "id": "6ebd4cbf-f88c-4ddb-aa45-154ef5b3b172",
            "name": "OBJECTIVES",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "3.1",
            "sectionTitle": "OBJECTIVES"
          },
          {
            "id": "12093016-f6af-41a5-b553-f3c020aa0d3d",
            "name": "PRIMARY ENDPOINTS",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "3.2",
            "sectionTitle": "PRIMARY ENDPOINTS"
          },
          {
            "id": "eaa98a9d-4a88-4347-a41a-de44cc6af382",
            "name": "SECONDARY ENDPOINTS",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "3.3",
            "sectionTitle": "SECONDARY ENDPOINTS"
          },
          {
            "id": "d00d888a-4de3-47a0-8458-8311e906499e",
            "name": "EXPLORATORY ENDPOINT",
            "text": "",
            "order": 3,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "3.4",
            "sectionTitle": "EXPLORATORY ENDPOINT"
          },
          {
            "id": "b0f7d405-f74a-4523-af42-89f44ee609f6",
            "name": "EXPLORATORY RESEARCH: BIOMARKER RESEARCH ENDPOINTS",
            "text": "",
            "order": 4,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "3.5",
            "sectionTitle": "EXPLORATORY RESEARCH: BIOMARKER RESEARCH ENDPOINTS"
          },
          {
            "id": "8a530766-e729-471e-b146-360b5f155b7b",
            "name": "OVERALL STUDY DESIGN AND PLAN",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.1",
            "sectionTitle": "OVERALL STUDY DESIGN AND PLAN"
          },
          {
            "id": "a3008aa2-8c4d-4f8c-91aa-5f0e5e7efc18",
            "name": "DISCUSSION OF STUDY DESIGN",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.2",
            "sectionTitle": "DISCUSSION OF STUDY DESIGN"
          },
          {
            "id": "f61ea622-5c71-4e12-a95b-d1b91fdc5d3b",
            "name": "LOADING DOSE, CONTINUOUS INFUSION RATES, TITRATION, AND EXTRA DOSES",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.3",
            "sectionTitle": "LOADING DOSE, CONTINUOUS INFUSION RATES, TITRATION, AND EXTRA DOSES"
          },
          {
            "id": "c5efa76c-312f-4244-b853-4b1255f0eb20",
            "name": "ELIGIBILITY CRITERIA",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.1",
            "sectionTitle": "ELIGIBILITY CRITERIA"
          },
          {
            "id": "03d30bac-5132-4deb-8558-5fc135cd2666",
            "name": "CONTRACEPTION RECOMMENDATIONS",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.2",
            "sectionTitle": "CONTRACEPTION RECOMMENDATIONS"
          },
          {
            "id": "673e4a65-f50d-4af1-924d-6ee818a7b24d",
            "name": "PROHIBITED MEDICATIONS AND THERAPY",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.3",
            "sectionTitle": "PROHIBITED MEDICATIONS AND THERAPY"
          },
          {
            "id": "e0b19e0e-4095-4417-aa82-5f11ce6550eb",
            "name": "PRIOR AND CONCOMITANT THERAPY",
            "text": "",
            "order": 3,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.4",
            "sectionTitle": "PRIOR AND CONCOMITANT THERAPY"
          },
          {
            "id": "205c6499-92a2-4441-94f3-30a49e105d9d",
            "name": "WITHDRAWAL OF SUBJECTS AND DISCONTINUATION OF STUDY",
            "text": "",
            "order": 4,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.5",
            "sectionTitle": "WITHDRAWAL OF SUBJECTS AND DISCONTINUATION OF STUDY"
          },
          {
            "id": "94b79950-f515-4e3c-bfa5-f364c151ebb5",
            "name": "TEMPORARY SUSPENSION OF STUDY DRUG TREATMENT",
            "text": "",
            "order": 5,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.6",
            "sectionTitle": "TEMPORARY SUSPENSION OF STUDY DRUG TREATMENT"
          },
          {
            "id": "dfe01386-61d1-4183-8a81-654460105f39",
            "name": "FOLLOW-UP AFTER SUBJECT DISCONTINUATION OF STUDY DRUG OR FROM STUDY",
            "text": "",
            "order": 6,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.7",
            "sectionTitle": "FOLLOW-UP AFTER SUBJECT DISCONTINUATION OF STUDY DRUG OR FROM STUDY"
          },
          {
            "id": "02bbd3e9-609b-4d1d-869a-2008c32137cf",
            "name": "STUDY DRUG AND STUDY DEVICES",
            "text": "",
            "order": 7,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.8",
            "sectionTitle": "STUDY DRUG AND STUDY DEVICES"
          },
          {
            "id": "ee9a869f-4de7-4ee9-9505-c34eaa35bb5b",
            "name": "PROTOCOL DEVIATIONS",
            "text": "",
            "order": 8,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.9",
            "sectionTitle": "PROTOCOL DEVIATIONS"
          },
          {
            "id": "f4945b61-8a8b-4b68-8b11-3cebb6f427e4",
            "name": "COMPLAINTS AND ADVERSE EVENTS",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "6.1",
            "sectionTitle": "COMPLAINTS AND ADVERSE EVENTS"
          }
        ],
        "abbreviations": [
          {
            "id": "cf4df387-7c51-4b63-99be-37f0890c6ebb",
            "abbreviatedText": "EudraCT",
            "expandedText": "European Union Drug Regulating Authorities Clinical Trials",
            "instanceType": "Abbreviation"
          },
          {
            "id": "a801c1ce-d4b2-4a57-92eb-edc0b069ff72",
            "abbreviatedText": "M15-741",
            "expandedText": "Study Number",
            "instanceType": "Abbreviation"
          }
        ],
        "amendments": [
          {
            "id": "edcc88d1-2975-4d40-8520-b776d7330bdf",
            "number": "2.0",
            "name": "Amendment 2.0",
            "scope": {
              "id": "94771c4b-22e6-4086-8430-e435e32842c5",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "9923d9c1-9dda-48d1-9feb-8134dd947662",
              "code": {
                "id": "d77173e7-7f4b-45d6-98d1-2b0133f5f100",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "755b82e2-49a2-4400-b899-9547bbfc5439",
                "type": {
                  "id": "3ad60ebf-411a-4c66-8bee-fb8d400266d4",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Amendment 2.0 to the protocol",
            "effectiveDate": "2018-11-15",
            "previousVersion": "1.0",
            "newVersion": "2.0"
          },
          {
            "id": "4465062a-f3c6-4791-ba59-f9c3e5cd8396",
            "number": "3.0",
            "name": "Amendment 3.0",
            "scope": {
              "id": "96ccf80d-c747-4d9b-a4fd-abd9459b68ad",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "eb548032-7922-45b9-883a-63094b2e7251",
              "code": {
                "id": "4b4ee64f-c1a8-4ac1-ad6b-44e5b82c826b",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "1fe2756f-c0f8-405a-b6f9-d22b5d05e76a",
                "type": {
                  "id": "774c7c9d-3b52-4149-ae40-0e969888d85a",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Amendment 3.0 to the protocol",
            "effectiveDate": "2019-02-11",
            "previousVersion": "2.0",
            "newVersion": "3.0"
          },
          {
            "id": "0b2f92c8-c318-4aad-b78c-0ab9b7720cc1",
            "number": "3.1 (United States and Japan)",
            "name": "Amendment 3.1 (United States and Japan)",
            "scope": {
              "id": "04358261-d49f-41b6-a7b0-969a8a63f4b2",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "87538933-fa38-4a77-93f1-e4b3cd8edc51",
              "code": {
                "id": "fdb17405-7eab-4fd2-82fb-764d3e5b3e78",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "285acb3f-0201-4f6e-b609-bccac4a18732",
                "type": {
                  "id": "01d1e2cc-b649-4f17-8ed9-2e5df13080af",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Amendment 3.1 (United States and Japan) to the protocol",
            "effectiveDate": "2019-04-18",
            "previousVersion": "3.0",
            "newVersion": "3.1"
          },
          {
            "id": "61f95d59-5296-4fe8-93af-14b0fdfcec80",
            "number": "3.1.1 (United States and Japan)",
            "name": "Amendment 3.1.1 (United States and Japan)",
            "scope": {
              "id": "68a9b96b-d87d-432f-a159-7348e1a435de",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "4da32d8e-9686-4d99-ad42-267f6f4390a7",
              "code": {
                "id": "27c7cf91-05f7-43cd-8ccc-34da6536af64",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "2f29d241-7ae2-4737-ac3f-69f70d806a4b",
                "type": {
                  "id": "bdb68d43-7046-40a5-b192-56ccdb8994c2",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Amendment 3.1.1 (United States and Japan) to the protocol",
            "effectiveDate": "2019-04-26",
            "previousVersion": "3.1",
            "newVersion": "3.1.1"
          },
          {
            "id": "6de7dfa9-4f2c-477a-a689-618228131bba",
            "number": "4.0",
            "name": "Amendment 4.0",
            "scope": {
              "id": "58dfe22d-3182-4829-89ef-83db04b674a9",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "43066302-17cb-4591-996b-9a75c36713d7",
              "code": {
                "id": "d260c5d1-89c5-4868-b67f-ea736ce9ed26",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "0dddb64c-ac34-48fe-b4a4-c075e0800ac5",
                "type": {
                  "id": "7c9a6e22-26d9-44c9-ab46-04971f96caba",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Amendment 4.0 to the protocol",
            "effectiveDate": "2019-08-28",
            "previousVersion": "3.1.1",
            "newVersion": "4.0"
          },
          {
            "id": "b36308db-4068-4515-b6c9-316c7ca136bf",
            "number": "4.1 (Germany only)",
            "name": "Amendment 4.1 (Germany only)",
            "scope": {
              "id": "b8964cde-5f56-4577-b627-436c1b526496",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "dd37cc1a-551f-4f5b-8734-616d830dfc10",
              "code": {
                "id": "d09dd61b-e264-4a69-b5e1-bfbebb643217",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "c75a548b-7309-4e44-a0a9-3344740a5167",
                "type": {
                  "id": "cd912036-66ff-4e9f-9496-c30983c47dc8",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Amendment 4.1 (Germany only) to the protocol",
            "effectiveDate": "2020-01-02",
            "previousVersion": "4.0",
            "newVersion": "4.1"
          },
          {
            "id": "ffa49276-58c8-4668-87b5-944dced81c2b",
            "number": "5.0",
            "name": "Amendment 5.0",
            "scope": {
              "id": "941077e5-a463-4fc0-87a6-112b1e34c014",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "085bc7fc-fa25-4e8a-84a9-6ea7a966402f",
              "code": {
                "id": "41b53b11-a815-4a22-9edf-ea0fb89b3a79",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "dce39af3-ca61-4b6d-b9da-da495b5e7226",
                "type": {
                  "id": "706b357c-8680-4905-8d31-a2dc117c3611",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Amendment 5.0 to the protocol",
            "effectiveDate": "2020-03-02",
            "previousVersion": "4.1",
            "newVersion": "5.0"
          },
          {
            "id": "987f28ae-4b03-4662-8dc8-8bae298f7303",
            "number": "6.0",
            "name": "Amendment 6.0",
            "scope": {
              "id": "ea76a6c8-4c50-4bb1-8f62-1d9ffa2cd6eb",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "5985d875-9608-424d-b3ea-df5ef802121d",
              "code": {
                "id": "5e738003-387e-4535-ad85-ec86678e0c04",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "63d12275-c222-4896-bd7f-e7e7ab1b676a",
                "type": {
                  "id": "beef3600-1e57-4aeb-a809-e624584964ed",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Amendment 6.0 to the protocol",
            "effectiveDate": "2020-04-09",
            "previousVersion": "5.0",
            "newVersion": "6.0"
          },
          {
            "id": "52398247-a9c8-4f31-9746-9819e2ec059f",
            "number": "6.1 (Sweden only)",
            "name": "Amendment 6.1 (Sweden only)",
            "scope": {
              "id": "8f0531dc-74ab-4b50-920e-701ddaa872c7",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "8264eaee-2603-4602-9b1d-b9a28b29a59d",
              "code": {
                "id": "6910b6a4-614a-4cb7-bc14-edd48a1deffe",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "327a6a7b-a623-4bb0-8dd5-785bca43de4d",
                "type": {
                  "id": "edbbef28-5e4c-4faa-bf54-b33d1a487b43",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Amendment 6.1 (Sweden only) to the protocol",
            "effectiveDate": "2020-06-11",
            "previousVersion": "6.0",
            "newVersion": "6.1"
          },
          {
            "id": "95bea075-b7f3-42d2-aec1-5222d82e9d6d",
            "number": "6.2 (Germany only)",
            "name": "Amendment 6.2 (Germany only)",
            "scope": {
              "id": "1bd018dc-1979-472f-b579-030b9730fbff",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "ec9c8133-5171-4d5b-a26a-52011067973a",
              "code": {
                "id": "28c388bd-e50e-4b02-9577-2f42955b34aa",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "e4534572-120e-4f8f-9867-1c301fb53578",
                "type": {
                  "id": "6102224b-7383-4403-8384-90194628e937",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Amendment 6.2 (Germany only) to the protocol",
            "effectiveDate": "2020-06-11",
            "previousVersion": "6.0",
            "newVersion": "6.2"
          },
          {
            "id": "faa31bef-bc58-4d69-b466-a7eedc3eb464",
            "number": "6.1.1 (Sweden only)",
            "name": "Amendment 6.1.1 (Sweden only)",
            "scope": {
              "id": "28759964-11fe-46ac-b8c4-62e3e45717ba",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "1b45452a-e35a-419f-91d9-14de9589ba05",
              "code": {
                "id": "bf0cb7b0-6c1b-4b41-b9f7-36871f4b845a",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "1bb2b4ad-4434-4252-82c7-69909799436d",
                "type": {
                  "id": "c9be9f65-f3b8-4c2a-a279-4ed60f9a5a6d",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Amendment 6.1.1 (Sweden only) to the protocol",
            "effectiveDate": "2020-09-08",
            "previousVersion": "6.1",
            "newVersion": "6.1.1"
          },
          {
            "id": "bedd4360-92d0-49aa-9570-0731909c1ece",
            "number": "6.1.1.1 (Sweden only)",
            "name": "Amendment 6.1.1.1 (Sweden only)",
            "scope": {
              "id": "aa6b6359-32bc-4bc2-92fa-f78f4b28c4df",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "e9ada072-a3e3-42c3-bc1f-09a2abb6945e",
              "code": {
                "id": "5f742fc5-a86d-405a-a690-98b6ecec2aac",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "f0fa3323-05fc-4b03-8664-84cd25155141",
                "type": {
                  "id": "a3151ef4-1e79-47ae-8c45-09449150749b",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Amendment 6.1.1.1 (Sweden only) to the protocol",
            "effectiveDate": "2020-11-20",
            "previousVersion": "6.1.1",
            "newVersion": "6.1.1.1"
          },
          {
            "id": "33cd9cba-bc40-462b-b360-183c7cbbcb10",
            "number": "7.0",
            "name": "Amendment 7.0",
            "scope": {
              "id": "a714a5ed-8302-4f3d-a639-80279f72b59a",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "c64bdc22-fb0f-40a4-8134-0c9d612d44bf",
              "code": {
                "id": "7fac9e9b-c8da-4d02-b7e8-d29dac31761c",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "22a2eec2-f6b1-48b7-b5c7-437e9d5a5a7f",
                "type": {
                  "id": "80db123b-0509-475e-b95a-30a81dd62e85",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The purpose of this version is to correct minor clerical errors for consistency throughout the protocol and incorporate necessary protocol modifications due to the COVID-19 pandemic, as well as other changes including sample size estimation updates to accommodate participation of additional countries and gain additional safety data.",
            "reasonIds": [
              "fa694a73-2b6f-4b03-8155-12976625e85e",
              "05dd5a10-ade9-4a83-bde5-d98ad290ecb6",
              "0e3fd4e8-7ffc-448d-929e-6b14d5038672",
              "0de17171-979b-4e9c-a245-77fa154bd4a9"
            ],
            "previousVersion": "6.1.1.1",
            "newVersion": "7.0"
          }
        ],
        "medicalDevices": [
          {
            "id": "0671cdf0-3dbf-4362-8e5e-d9bb7a639541",
            "name": "Ambulatory pump",
            "instanceType": "MedicalDevice",
            "label": "Infusion Pump",
            "description": "Programmable pump for continuous subcutaneous delivery of ABBV-951",
            "deviceType": {
              "id": "c87eb3dd-6d9a-40a5-995c-45b72d6e7244",
              "code": "Drug Delivery Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Drug Delivery Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "aadbd06e-12bd-4b65-8327-ca547a59e896",
            "name": "Infusion set",
            "instanceType": "MedicalDevice",
            "label": "Infusion Set",
            "description": "Tubing and cannula system for subcutaneous drug delivery",
            "deviceType": {
              "id": "c02366d6-f390-4612-a871-b1ac55c409ed",
              "code": "Drug Delivery Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Drug Delivery Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "0e779430-4708-4eeb-bc5f-2c44f2d48f90",
            "name": "Cannula",
            "instanceType": "MedicalDevice",
            "label": "Subcutaneous Cannula",
            "description": "Needle or cannula for subcutaneous access"
          },
          {
            "id": "7aa57bf2-0fbf-4754-a915-a4798dacb840",
            "name": "Parkinson's KinetiGraph / Personal KinetiGraph",
            "instanceType": "MedicalDevice",
            "label": "PKG",
            "description": "Wearable device for assessing PD symptoms like tremor and bradykinesia",
            "deviceType": {
              "id": "68188dc8-0727-478e-b2e6-e61cee9cd790",
              "code": "Wearable Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Wearable Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "8242fa58-5685-4c39-994b-afce2d68b0b8",
            "name": "Syringe",
            "instanceType": "MedicalDevice",
            "label": "Syringe",
            "description": "Used for holding and delivering the drug solution via the pump",
            "deviceType": {
              "id": "8910e3a6-f861-47d1-9948-093961b33c71",
              "code": "Drug Delivery Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Drug Delivery Device",
              "instanceType": "Code"
            }
          }
        ],
        "conditions": [
          {
            "id": "f9799fbc-cc38-4597-9511-75cbd7a1b2aa",
            "name": "Clinically Defined Off State",
            "instanceType": "Condition",
            "description": "Requirement for Day 1 initiation",
            "text": "No PD medications for at least 12 hours before initiation of study drug"
          },
          {
            "id": "675d8b81-0f30-4e84-8e61-f0fcade80cd5",
            "name": "Optimal Clinical Response",
            "instanceType": "Condition",
            "description": "Definition for titration success",
            "text": "Maximizing functional On time and minimizing the number of Off episodes and troublesome dyskinesia"
          },
          {
            "id": "589d5beb-1331-45cf-aa71-47884e315c2b",
            "name": "Suicidal Ideation Criteria",
            "instanceType": "Condition",
            "description": "Safety stopping criteria based on C-SSRS",
            "text": "Yes to question 4 or 5 on suicidal ideation or any positive response to suicidal behavior"
          }
        ],
        "studySites": [
          {
            "id": "592e5b37-f15e-4a6b-a780-dd07c5c5b4c8",
            "name": "University of Alabama at Birmingham - Main /ID# 207996",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "1",
            "organizationId": "7434d6b5-0716-44bf-bf5b-210f91359954",
            "country": "United States"
          },
          {
            "id": "ee250c6e-a270-4378-b2be-e75ce1e85ea4",
            "name": "Banner Sun Health Res Inst /ID# 208811",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "2",
            "organizationId": "bcfcf6b6-abfd-4518-8d53-be5fd67da3e2",
            "country": "United States"
          },
          {
            "id": "bed3d269-da24-4e88-8c2e-3f9b4e2f70f8",
            "name": "The Parkinson's & Movement Disorder Institute - Fountain Valley /ID# 216126",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "3",
            "organizationId": "c55ec53a-b9df-4fe6-bca5-bc53bfb7f9fd",
            "country": "United States"
          },
          {
            "id": "34fc6225-549d-4cda-a0f7-0c71593555ed",
            "name": "University of Colorado Hospital /ID# 207968",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "4",
            "organizationId": "83e047a3-beaf-4e08-a9cb-dd8d91af9e75",
            "country": "United States"
          },
          {
            "id": "1c86d6ce-68df-4e7c-aa46-651c8e359561",
            "name": "Parkinson's Disease and Movement Disorders Center of Boca Raton /ID# 207677",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "5",
            "organizationId": "ef6c8805-c7a5-45b4-a7fc-682cc9d6d059",
            "country": "United States"
          },
          {
            "id": "488c57d9-2b42-467c-bb1e-b6aba9c2163d",
            "name": "Northwestern University Feinberg School of Medicine /ID# 208812",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "6",
            "organizationId": "86958804-5977-4d0a-882f-d01b8fb7e53e",
            "country": "United States"
          },
          {
            "id": "92bcd0b0-fdec-444d-8c35-083859172a8f",
            "name": "Indiana Clinical Research Cent /ID# 207952",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "7",
            "organizationId": "ec676ada-7f29-47d3-b803-a38d8fbf4ef5",
            "country": "United States"
          },
          {
            "id": "c2c8c718-7882-40c9-9ee6-8a252bcc9974",
            "name": "Univ Kansas Med Ctr /ID# 208963",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "8",
            "organizationId": "5e138da0-8f5a-4809-bb21-941c1ecf8344",
            "country": "United States"
          },
          {
            "id": "a2ac5cc9-9d79-4f39-9d9c-5d588455c86e",
            "name": "University of Kentucky Chandler Medical Center /ID# 207603",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "9",
            "organizationId": "87a95830-5cce-4cfc-8c41-e4588cad4de8",
            "country": "United States"
          },
          {
            "id": "8e1729c4-ffc1-4a5f-ab11-abae760245a6",
            "name": "Massachusetts General Hospital /ID# 207993",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "10",
            "organizationId": "82d5bf91-77e8-4843-bb82-7ea8f059a2bd",
            "country": "United States"
          },
          {
            "id": "417680d3-2d96-4de2-8ccd-3d340a7e8b02",
            "name": "Health Partners /ID# 207950",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "11",
            "organizationId": "30bf0cd7-43f9-4d96-84f9-f8c6ca02f0c6",
            "country": "United States"
          },
          {
            "id": "5442cd19-12ac-4453-a43d-a7469969283b",
            "name": "University of Missouri /ID# 209043",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "12",
            "organizationId": "264effc5-97cd-409a-a171-745a3bb30c56",
            "country": "United States"
          },
          {
            "id": "fd530b9b-1322-4ed6-895b-02822ddba7a9",
            "name": "Washington University-School of Medicine /ID# 207525",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "13",
            "organizationId": "ac0f72c5-96b1-449a-85dc-c28621e8cad2",
            "country": "United States"
          },
          {
            "id": "8ab9110a-e218-4254-b909-9a85a5bfc9fe",
            "name": "Dartmouth-Hitchcock Medical Center /ID# 207972",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "14",
            "organizationId": "84d316fe-86be-429b-854e-4af1abc1df8b",
            "country": "United States"
          },
          {
            "id": "5dff6aa4-ccd7-46d6-8f7a-e4d407bdd6c6",
            "name": "Wake Radiology UNC REX Healthcare - Raleigh Office /ID# 209784",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "15",
            "organizationId": "640a4f32-04fd-403f-bff1-1c56529436ca",
            "country": "United States"
          },
          {
            "id": "44bb6227-7f0c-4a92-8109-ec040bf9e161",
            "name": "Legacy Medical Group - Neurology /ID# 208031",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "16",
            "organizationId": "d57cc2a9-8a65-4f34-9d1a-9d7d427dfe6e",
            "country": "United States"
          },
          {
            "id": "69975652-9416-46fa-9b2a-64b39e8c1d32",
            "name": "Prisma Health Cancer Institute-Faris Road /ID# 207650",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "17",
            "organizationId": "2e69bb53-209b-4e91-87cd-25766988e0ec",
            "country": "United States"
          },
          {
            "id": "a65776b6-613b-4dc0-a739-a5f6518366c7",
            "name": "Neurology Consultants of Dallas - LBJ Fwy /ID# 207619",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "18",
            "organizationId": "03a92cb4-104e-4f29-beca-d8a0d1173ba9",
            "country": "United States"
          },
          {
            "id": "524bdaba-55d2-4fa2-9812-a1d2216ba3f9",
            "name": "Baylor College of Medicine /ID# 207620",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "19",
            "organizationId": "30374b69-16d6-4525-84b8-3d0f09ffd855",
            "country": "United States"
          },
          {
            "id": "dcca642b-7283-4e17-b112-46b7ffc30b47",
            "name": "Central Texas Neurology Consul /ID# 216918",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "20",
            "organizationId": "6a8e3aee-0766-41ad-bb0e-29b635b196ef",
            "country": "United States"
          },
          {
            "id": "cf20ac37-7a24-4d2a-bbda-69f3a9782f14",
            "name": "Univ Texas HSC San Antonio /ID# 208958",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "21",
            "organizationId": "4a2ee87f-c63a-4b1b-9624-ebdba4388891",
            "country": "United States"
          },
          {
            "id": "81acf44d-f563-4c1d-9fa2-c5bc1bb6147c",
            "name": "Booth Gardner Parkinson's Care Center /ID# 208026",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "22",
            "organizationId": "43cfbc6b-543c-439c-903a-39b1d57014b4",
            "country": "United States"
          },
          {
            "id": "ba4e3b79-cbb6-46fc-8462-3d455e6ea993",
            "name": "Inland Northwest Research /ID# 208122",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "23",
            "organizationId": "3240fe16-8988-4dfd-8f53-fa0ec21c57ac",
            "country": "United States"
          },
          {
            "id": "794d5716-b096-43cb-84b5-e364890e9103",
            "name": "Medical College of Wisconsin /ID# 207999",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "24",
            "organizationId": "dd492a0f-f6d2-48df-ae02-ac73144c15a5",
            "country": "United States"
          },
          {
            "id": "c2e444e4-cf01-4db0-9743-9a82934e8182",
            "name": "Concord Repatriation General Hospital /ID# 207628",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "25",
            "organizationId": "b9c2bfcc-3cab-492f-b7f9-5f2ba8d74c35",
            "country": "Australia"
          },
          {
            "id": "e2b507b7-4e6e-4e79-adf7-03e09f5b483b",
            "name": "Westmead Hospital /ID# 207633",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "26",
            "organizationId": "14cf444d-a912-41f3-98b0-750e100265e4",
            "country": "Australia"
          },
          {
            "id": "64a2d91e-4aa1-4d8c-a012-02357e3195ba",
            "name": "Royal Adelaide Hospital /ID# 207634",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "27",
            "organizationId": "2e03abaa-8d0c-42a3-8cd2-d20f079b7699",
            "country": "Australia"
          },
          {
            "id": "ed2bd1ee-358b-46b3-a910-456918d23e85",
            "name": "Alfred Health /ID# 207632",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "28",
            "organizationId": "737b74f0-0be7-422d-b0b1-b9598dc1274c",
            "country": "Australia"
          },
          {
            "id": "cef346f0-d9b9-4313-b1bf-bbf2549c5893",
            "name": "Perron Institute /ID# 207627",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "29",
            "organizationId": "a9e26b5a-5d62-4fd6-aa46-575dd7020ed5",
            "country": "Australia"
          },
          {
            "id": "33ee52fc-e2b8-4b03-8c57-f3a959ab25c3",
            "name": "Universitair Ziekenhuis Leuven /ID# 209058",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "30",
            "organizationId": "5fbdb37c-54d2-427c-b1ab-f624caa961ec",
            "country": "Belgium"
          },
          {
            "id": "1238a3b9-1b48-45a8-b89d-a69c7120f743",
            "name": "AZ Sint-Jan Brugge /ID# 208178",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "31",
            "organizationId": "a4e0eb7a-6eab-4ff3-8e4a-6d5c79d90b0a",
            "country": "Belgium"
          },
          {
            "id": "63bec95f-8506-49d6-a3dc-6dfef90ced73",
            "name": "Groupe Sante CHC - Clinique du MontLegia /ID# 208177",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "32",
            "organizationId": "ea7183a9-4054-4198-9b2d-692a8a7ec3e4",
            "country": "Belgium"
          },
          {
            "id": "3190d574-f770-4f84-a513-6cb06ce1a774",
            "name": "University of Calgary - Movement Disorders Clinic /ID# 207342",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "33",
            "organizationId": "bed04777-9399-4a83-86da-7b3fce6a6c3c",
            "country": "Canada"
          },
          {
            "id": "0fb44112-8ee0-4c04-92ae-2f111b8e59f4",
            "name": "Centre de Recherche St-Louis /ID# 207344",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "34",
            "organizationId": "cb4b6d97-f316-45f6-85fc-5f6d0f86999e",
            "country": "Canada"
          },
          {
            "id": "b0923269-fb9d-4b03-9f02-66c2cbfcab94",
            "name": "Bispebjerg and Frederiksberg Hospital /ID# 207669",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "35",
            "organizationId": "9724128f-55ae-48c2-a513-4b18d18f0ecd",
            "country": "Denmark"
          },
          {
            "id": "cc89800c-9624-4abb-af37-2b259fb1542b",
            "name": "Aarhus University Hospital /ID# 207668",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "36",
            "organizationId": "0fc6b0ef-6f83-4f63-8419-1e2ac84d537a",
            "country": "Denmark"
          },
          {
            "id": "89a6bad7-bcc6-454a-bad8-c3ef40f85247",
            "name": "Odense University Hospital /ID# 207871",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "37",
            "organizationId": "b7431738-be60-4731-9a3d-c2d171c0ffd7",
            "country": "Denmark"
          },
          {
            "id": "8f6c1455-cfe0-4294-88fd-dff2331224a3",
            "name": "Universitaetsklinikum Ulm /ID# 208602",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "38",
            "organizationId": "29a571bc-0ae4-49c1-ae9a-9fdbac85a16a",
            "country": "Germany"
          },
          {
            "id": "5aa05de6-6e84-405d-a905-8f0441311dd1",
            "name": "Kliniken Beelitz GmbH /ID# 208600",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "39",
            "organizationId": "6186a5e7-43c8-42a8-8542-d3c8085cb470",
            "country": "Germany"
          },
          {
            "id": "75aac2b1-5ac8-433e-964e-e3f52d3ece54",
            "name": "InnKlinikum Haag /ID# 208601",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "40",
            "organizationId": "9a61c7bf-b2d9-4733-ab65-295f30c7e2cd",
            "country": "Germany"
          },
          {
            "id": "16deb24f-b775-41c2-9758-6526a52c4d4f",
            "name": "IRCCS Centro Neurolesi Bonino Pulejo /ID# 207975",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "41",
            "organizationId": "a6d5b182-c91c-45dc-af38-274c4eab5734",
            "country": "Italy"
          },
          {
            "id": "fae219c0-a6c8-470e-ba6d-f72932aab315",
            "name": "Fondazione IRCCS Istituto Neurologico Carlo Besta /ID# 207955",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "42",
            "organizationId": "1ab0a55e-a98f-4460-b333-baed83dc5b01",
            "country": "Italy"
          },
          {
            "id": "e9487727-0fab-4ea8-ac32-b7e398c03641",
            "name": "Azienda Ospedaliera di Padova /ID# 208077",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "43",
            "organizationId": "0a157b28-8eb5-423e-b810-753859fddbdb",
            "country": "Italy"
          },
          {
            "id": "873c5cc0-1ef0-4309-a3b7-b7c20a2fe057",
            "name": "National Hospital Organization Asahikawa Medical Center /ID# 210914",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "44",
            "organizationId": "40f413cc-de0b-470c-a23c-35d773aad0fa",
            "country": "Japan"
          },
          {
            "id": "8e99699e-7c0a-4d74-bd55-ecd56a1f8eb8",
            "name": "National Hospital Organization Utano National Hospital /ID# 210912",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "45",
            "organizationId": "ed47e89f-1017-4cf3-984b-e8f3d65e64f9",
            "country": "Japan"
          },
          {
            "id": "38df1e23-aa87-40b2-8908-6fae3f9e976a",
            "name": "Osaka University Hospital /ID# 210913",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "46",
            "organizationId": "1f39651f-0422-4aa3-8632-245c46acb371",
            "country": "Japan"
          },
          {
            "id": "b8baafc7-77c0-4b46-8251-c0af8c746b20",
            "name": "Juntendo University Hospital /ID# 210915",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "47",
            "organizationId": "c591a659-a3dc-4a8c-acc0-3c223354bfeb",
            "country": "Japan"
          },
          {
            "id": "c28b5ed3-e7c2-4746-b597-98de08689387",
            "name": "National Center of Neurology and Psychiatry /ID# 210911",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "48",
            "organizationId": "d3065f02-8a4c-43ff-a388-b08913c44124",
            "country": "Japan"
          },
          {
            "id": "b59a27ac-c6fe-4526-bad5-1ea572e23d9d",
            "name": "Erasmus Medisch Centrum /ID# 208168",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "49",
            "organizationId": "56f62344-c001-4f82-9b53-6122ab6b81b3",
            "country": "Netherlands"
          },
          {
            "id": "00f1ff7c-e112-464d-8368-ef2a9bee805a",
            "name": "St. Antonius Ziekenhuis /ID# 208529",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "50",
            "organizationId": "7c9def2a-bebc-4186-a831-a27e8361cc18",
            "country": "Netherlands"
          },
          {
            "id": "c425034e-086b-44fb-9db1-d2590a0c3aa3",
            "name": "Academician I.P. Pavlov First St. Petersburg State Medical University /ID# 216303",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "51",
            "organizationId": "65c3cfac-86e5-4369-8942-dd0bb9d1a2bb",
            "country": "Russia"
          },
          {
            "id": "8c33e38b-8177-41c4-b982-d07af95c8933",
            "name": "City Clinical Hospital #40 /ID# 216301",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "52",
            "organizationId": "c94a0640-0c37-44a2-b70c-2b67b5776aec",
            "country": "Russia"
          },
          {
            "id": "e0fbf448-1cc4-47a8-8d68-252ae04f1cec",
            "name": "Hospital General Universitario de Elche /ID# 209777",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "53",
            "organizationId": "d7d28906-62ea-407e-b515-c2cf1bd6a57c",
            "country": "Spain"
          },
          {
            "id": "1f04e4e6-e2bb-41c6-9a08-38fcc9765cbe",
            "name": "Hospital Universitario de Bellvitge /ID# 209539",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "54",
            "organizationId": "a24b5fa1-679d-4f89-b953-b3ce38e80fa6",
            "country": "Spain"
          },
          {
            "id": "09fafdd0-ac7c-4f8c-803e-6edde04b1621",
            "name": "Hospital Universitario A Coruna - CHUAC /ID# 212147",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "55",
            "organizationId": "5a727d38-4b7a-4459-852c-4a082438caef",
            "country": "Spain"
          },
          {
            "id": "ef751d81-2b03-4844-80c9-99b87596b15d",
            "name": "Hospital Santa Creu i Sant Pau /ID# 208240",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "56",
            "organizationId": "9c395492-e103-4e64-97c6-566d0c66b336",
            "country": "Spain"
          },
          {
            "id": "b5fae7ca-b964-4bd4-a690-9819eb497b12",
            "name": "Hospital Universitario Virgen de las Nieves /ID# 208242",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "57",
            "organizationId": "81cc8476-6fa6-4769-9832-45ccaff9e0b1",
            "country": "Spain"
          },
          {
            "id": "5cab407c-b738-48bb-9f5a-eba603725fe5",
            "name": "Hospital Universitario Ramon y Cajal /ID# 208241",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "58",
            "organizationId": "fb6c64b8-4467-4c7a-af94-fccaa5fc494b",
            "country": "Spain"
          },
          {
            "id": "1b4c80ef-16bd-4842-895e-045544213851",
            "name": "Hospital Universitario Virgen del Rocio /ID# 208239",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "59",
            "organizationId": "4e8aeb78-98fb-47e6-a09a-4675320ba90b",
            "country": "Spain"
          },
          {
            "id": "813bdca2-7d40-484a-ac42-7b0805a1eb16",
            "name": "Skane University Hospital Lund /ID# 207811",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "60",
            "organizationId": "c70a0e5e-898a-47a2-8e14-2bca89b21f36",
            "country": "Sweden"
          },
          {
            "id": "d779a978-4d25-44d8-b0c1-5eb396d9a238",
            "name": "Centrum for neurologi /ID# 207716",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "61",
            "organizationId": "4ad3f0d1-375b-40f0-b355-2c3ffc22e77a",
            "country": "Sweden"
          },
          {
            "id": "c110d613-3ef0-4a7a-be6d-b92ad7b674d3",
            "name": "Sahlgrenska University Hospital /ID# 207718",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "62",
            "organizationId": "b8bd693d-4880-4b74-bfef-6f59377a2e52",
            "country": "Sweden"
          },
          {
            "id": "67fad114-fea6-44b5-a89f-1dd400d544a1",
            "name": "NHS Tayside /ID# 209242",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "63",
            "organizationId": "9ebb33f6-cc2b-4c15-8a4e-899c807d282f",
            "country": "United Kingdom"
          },
          {
            "id": "2b11b0da-fdfb-4b0f-bd4e-6aa0a2d46bc9",
            "name": "King's College Hospital NHS Foundation Trust /ID# 208413",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "64",
            "organizationId": "65b76bba-421a-41cc-a0da-92ccf4ec2362",
            "country": "United Kingdom"
          },
          {
            "id": "73d3c23e-f89d-4886-a523-e21e71f98ea2",
            "name": "University Hospital Plymouth NHS Trust /ID# 208447",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "65",
            "organizationId": "84e0f61b-d56e-4f56-8e5d-82354ede98f2",
            "country": "United Kingdom"
          }
        ],
        "administrations": [
          {
            "id": "61572746-a4e5-4b24-b3a4-1812b6175ca4",
            "name": "Administration of Therapy",
            "description": "RouteOfAdministration.ORAL DosingFrequency.ONCE_DAILY",
            "instanceType": "Administration",
            "route": {
              "id": "00220d11-02be-4172-832f-cb3d68317a61",
              "code": "C38288",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Oral",
              "instanceType": "Code"
            }
          },
          {
            "id": "b769bf41-ddab-49dc-800d-e7d985b6d12f",
            "name": "Administration of ABBV-951 (carbidopa phosphate/levodopa phosphate [CDP/LDP])",
            "description": "RouteOfAdministration.SUBCUTANEOUS DosingFrequency.CONTINUOUS",
            "instanceType": "Administration",
            "route": {
              "id": "a8bcd5bd-3abf-48d5-ae70-766073614429",
              "code": "C38288",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "SC",
              "instanceType": "Code"
            }
          },
          {
            "id": "6a1444f4-55f1-47db-84b9-bab797a48943",
            "name": "Administration of Levodopa-carbidopa intestinal gel (LCIG / CLES)",
            "description": "RouteOfAdministration.UNKNOWN DosingFrequency.CONTINUOUS",
            "instanceType": "Administration",
            "route": {
              "id": "ef47cae4-c326-4ddf-88a3-9d9e309897b8",
              "code": "C38288",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "",
              "instanceType": "Code"
            }
          }
        ],
        "rationale": "Protocol version"
      }
    ],
    "name": "STUDY M15-741"
  },
  "administrations": [
    {
      "id": "8a565cbb-5df1-4f73-8653-e63649124e07",
      "name": "ABBV-951 Continuous Subcutaneous Infusion",
      "instanceType": "Administration",
      "dose": "0.17 to 1.04 mL/hr",
      "doseFrequency": "Continuous 24-hour daily",
      "route": {
        "id": "47f67ea9-28ba-4c69-be39-5867017cebcc",
        "code": "Subcutaneous",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Subcutaneous",
        "instanceType": "Code"
      },
      "duration": "52 weeks"
    },
    {
      "id": "d0552f6c-f4d7-4cda-9443-d1bd8f0dcefd",
      "name": "Oral Loading Dose",
      "instanceType": "Administration",
      "dose": "Habitual first morning dose of LD+DDCI",
      "doseFrequency": "Once at initiation",
      "route": {
        "id": "ff2c43f9-a44e-41fb-8d46-0d7b193a00d6",
        "code": "Oral",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Oral",
        "instanceType": "Code"
      },
      "duration": "Single dose"
    },
    {
      "id": "7e1ae532-40f1-4205-8eea-f4a1e04eb122",
      "name": "ABBV-951 Extra Dose",
      "instanceType": "Administration",
      "dose": "Preprogrammed volume",
      "doseFrequency": "As needed (bolus)",
      "route": {
        "id": "3a6b336a-7015-4870-87cd-29213b662ba9",
        "code": "Subcutaneous",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Subcutaneous",
        "instanceType": "Code"
      },
      "duration": "During treatment period"
    }
  ],
  "substances": [
    {
      "id": "11e2aac5-ab79-42a4-84d6-17e6d8dabd92",
      "name": "Carbidopa phosphate",
      "instanceType": "Substance",
      "description": "Prodrug of carbidopa"
    },
    {
      "id": "6ec947dc-04ff-4b8a-b736-569aed0d471f",
      "name": "Levodopa phosphate",
      "instanceType": "Substance",
      "description": "Prodrug of levodopa"
    }
  ],
  "studyDefinitionDocument": {
    "id": "c1aed092-6c7c-4785-9481-8adc077a72ef",
    "name": "STUDY M15-741",
    "documentType": "Protocol",
    "language": "en",
    "instanceType": "StudyDefinitionDocument",
    "version": "7.0",
    "versionDate": "Not specified",
    "contentIds": [
      "a9e7149a-5b9f-49bf-bc9d-904735c30cec",
      "ae23d124-bda6-4060-b620-e8aa6111aed2",
      "ee249dc2-ece0-42c6-8ba3-b304663f1c57",
      "866a2d10-3f43-462f-bc2a-1e3983e5f936",
      "4598bfb9-1060-4770-b5bd-71ad3dbb1ca2",
      "b08925b4-0f68-4065-aa2a-cd33ab4468cc",
      "fc9b7b5c-fad3-4dc5-9f54-3e3dd34be0f7",
      "e8376e91-b038-4b81-8bdd-caac9e140391",
      "ef66f0f0-3efc-4088-938b-5bb53a525964",
      "24f87ce0-e72d-4dfc-87a4-b736dbd8de25",
      "793c9d94-c4ab-43c4-9fb9-80d3ef5a6b20",
      "5cfec2b0-a68d-4a34-a5cc-7d95932fca2e",
      "7c96584c-ddc9-4b5a-a362-2305850a822a"
    ]
  },
  "geographicScope": {
    "id": "b97212eb-a2c3-4618-8e86-f63a46942d4c",
    "name": "Study Geographic Scope",
    "scopeType": "Global",
    "instanceType": "GeographicScope",
    "countryIds": [
      "14439bf3-2402-4ed0-838c-a0bfaae8c20b",
      "8dfdc406-1133-409e-8016-712cc1743922",
      "4a405b95-3d16-4d32-972d-a7470086a56e",
      "a0db6b96-92af-4148-a0d5-2dac8ad14b24"
    ]
  },
  "countries": [
    {
      "id": "14439bf3-2402-4ed0-838c-a0bfaae8c20b",
      "name": "United States",
      "instanceType": "Country",
      "code": "US"
    },
    {
      "id": "8dfdc406-1133-409e-8016-712cc1743922",
      "name": "Japan",
      "instanceType": "Country",
      "code": "JP"
    },
    {
      "id": "4a405b95-3d16-4d32-972d-a7470086a56e",
      "name": "Germany",
      "instanceType": "Country",
      "code": "DE"
    },
    {
      "id": "a0db6b96-92af-4148-a0d5-2dac8ad14b24",
      "name": "Sweden",
      "instanceType": "Country",
      "code": "SE"
    }
  ],
  "ingredients": [
    {
      "id": "55db29e0-0e54-472f-83dc-7a2b81ff3d4b",
      "name": "Carbidopa phosphate",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "CDP"
    },
    {
      "id": "1cd86cff-6a4a-46ae-8597-29b783eee606",
      "name": "Levodopa phosphate",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "LDP"
    },
    {
      "id": "c6dd383f-000d-47aa-9044-02a2f001f713",
      "name": "Carbidopa",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "CD"
    },
    {
      "id": "2039a319-813f-4461-b2b9-ff93797728be",
      "name": "Levodopa",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "LD"
    }
  ],
  "strengths": [
    {
      "id": "f2d47f96-7ffa-44c8-b440-96840980b522",
      "instanceType": "Strength",
      "value": 240,
      "unit": "mg/mL",
      "numerator": {
        "value": 240,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "mL"
      }
    },
    {
      "id": "1734a4e3-65e3-4a4e-911c-9f8088f355aa",
      "instanceType": "Strength",
      "value": 50,
      "unit": "mg/mL",
      "numerator": {
        "value": 50,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "mL"
      }
    },
    {
      "id": "be42550b-d593-4df0-a2c8-02cb5476018d",
      "instanceType": "Strength",
      "value": 200,
      "unit": "mg/mL",
      "numerator": {
        "value": 200,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "mL"
      }
    }
  ],
  "transitionRules": [
    {
      "id": "b40c2c7c-1e8a-41f9-85d0-c2385e9f9f9b",
      "name": "Screening to Treatment",
      "instanceType": "TransitionRule",
      "transitionType": "Epoch Transition",
      "fromElementId": "Screening",
      "toElementId": "Optimization",
      "text": "Investigator must confirm continued subject eligibility at V3 prior to enrollment"
    },
    {
      "id": "5dfa182a-cb8a-4ce8-9991-ea21c151e499",
      "name": "Optimization to Maintenance",
      "instanceType": "TransitionRule",
      "transitionType": "Epoch Transition",
      "fromElementId": "Optimization",
      "toElementId": "Maintenance",
      "text": "Transition occurs after Week 4 (V8) following dose optimization"
    },
    {
      "id": "4129510b-cc63-4848-b649-e4b6494e9f5d",
      "name": "Dose Adjustment",
      "instanceType": "TransitionRule",
      "transitionType": "Dose Modification",
      "text": "Adjust ABBV-951 infusion rate based on clinical response and tapering of concomitant PD meds"
    },
    {
      "id": "0e449d71-be2e-4f3d-b2e4-e9dcbdabd721",
      "name": "Rescue Therapy Trigger",
      "instanceType": "TransitionRule",
      "transitionType": "Rescue Therapy",
      "text": "Used in case of serious medical need or pump malfunction"
    }
  ],
  "documentContentReferences": [
    {
      "id": "7ba9e049-7a4a-402b-a076-e891d2b7ae8d",
      "name": "Eligibility Criteria Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "5.1",
      "sectionTitle": "ELIGIBILITY CRITERIA",
      "description": "Cross-reference to eligibility criteria from the Overall Study Design section."
    },
    {
      "id": "89cb24b5-bccd-41b6-8f09-4bc169e9d738",
      "name": "Safety Monitoring Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "3.11, 3.14, 3.15",
      "sectionTitle": "Operations Manual",
      "description": "Reference to clinical laboratory test results, ECGs, and vital signs in Appendix F."
    },
    {
      "id": "a373f03b-8900-4f42-9d3f-bb8be0e66714",
      "name": "Study Design Schematic",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "Figure 1",
      "sectionTitle": "Study Design Schematic",
      "description": "Internal link to the study design visual representation."
    },
    {
      "id": "051b836c-acbf-406c-8b9a-aa51fc94fb59",
      "name": "Prohibited Medications Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "5.3",
      "sectionTitle": "PROHIBITED MEDICATIONS AND THERAPY",
      "description": "Reference for details on discontinuing prohibited medications."
    },
    {
      "id": "dabb8011-bd7c-4b71-b416-c71f49e48297",
      "name": "Dose Conversion Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "4.2",
      "sectionTitle": "Discussion of Study Design",
      "description": "Reference to conversion algorithm based on Phase 1 studies."
    },
    {
      "id": "28d76821-88f1-4c25-8225-97cfbaa4a142",
      "name": "Infusion Site Evaluation Scale",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "3.6",
      "sectionTitle": "Operations Manual",
      "description": "Reference to the numeric grade scale for skin irritation in Appendix F."
    },
    {
      "id": "2578ba60-fd83-480a-807b-0ac8f2eb8746",
      "name": "Follow-up Information",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "5.7",
      "sectionTitle": "FOLLOW-UP AFTER SUBJECT DISCONTINUATION",
      "description": "Reference for additional information on post-treatment activities."
    }
  ],
  "commentAnnotations": [
    {
      "id": "f5692663-bd31-4db9-9d22-14c48fb5f320",
      "text": "The Screening Period may be extended up to a total of 90 days for extenuating circumstances, e.g., supply constraints.",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Figure 1. Study Design Schematic",
      "pageNumber": 11
    },
    {
      "id": "a44da079-caaa-4de3-99e8-da7f07c83974",
      "text": "As allowed by local regulations, subjects will receive the PKG-watch following Screening Visit 1 (V1) and will be required to wear it during the Monitoring Period.",
      "annotationType": "Note",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Figure 1. Study Design Schematic",
      "pageNumber": 11
    },
    {
      "id": "111b0207-bb07-43c8-b823-1ba38c21dc0a",
      "text": "Software version 'DL.v01.05' is installed on the pumps.",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Table 9. Identity of Study Devices",
      "pageNumber": 33
    },
    {
      "id": "32800b6f-0fa3-4c40-98c1-9a43cff15379",
      "text": "Subjects enrolled under protocol v6.0 (or after) will use the Neria Guard infusion set at the start of enrollment.",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Table 9. Identity of Study Devices",
      "pageNumber": 33
    }
  ],
  "studyDefinitionDocumentVersions": [
    {
      "id": "7238af31-047c-42bb-bc4d-4efca3cf9cb3",
      "versionNumber": "7.0",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2021-02-11",
      "description": "Current version identified in page headers and Appendix B."
    },
    {
      "id": "b52bf3fe-d750-4798-8db1-6e81cba1b1ff",
      "versionNumber": "6.0",
      "status": "Final",
      "instanceType": "StudyDefinitionDocumentVersion",
      "description": "Historical version referenced in Table 9 footnotes regarding subject enrollment transitions."
    }
  ],
  "studyAmendmentImpacts": [
    {
      "id": "5c4aedf3-3769-41ad-8fec-4609d0497f6e",
      "amendmentId": "b951f3ec-0d7e-45ae-8934-6253e184ffaa",
      "affectedSection": "Section 7 - Statistical Methods & Determination of Sample Size",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Sample size increased to approximately 240 subjects to accommodate more countries and higher dropout rates."
    },
    {
      "id": "5d38bacb-8054-45d7-b05b-4eed05b79cce",
      "amendmentId": "b951f3ec-0d7e-45ae-8934-6253e184ffaa",
      "affectedSection": "Section 5.1 - Eligibility Criteria",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Modified eligibility criteria to exclude subjects positive for COVID-19."
    },
    {
      "id": "fb398ca0-4b5f-49c8-a2d0-e588270682e0",
      "amendmentId": "b951f3ec-0d7e-45ae-8934-6253e184ffaa",
      "affectedSection": "Section 4.3 - Loading Dose, Continuous Infusion Rates, Titration, and Extra Doses",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Clarified flexibility in F3 infusion rate reduction beyond the standard 20% limit."
    },
    {
      "id": "caf0202f-e865-4960-8e0b-468c7632f4e8",
      "amendmentId": "b951f3ec-0d7e-45ae-8934-6253e184ffaa",
      "affectedSection": "Section 5.8 - Study Drug and Study Devices",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Added guidance on cannula length selection and infusion site rotation."
    },
    {
      "id": "6d18da54-2472-494e-8bcf-4401f39a840b",
      "amendmentId": "b951f3ec-0d7e-45ae-8934-6253e184ffaa",
      "affectedSection": "Section 6.1 - Complaints and Adverse Events",
      "impactLevel": "Administrative",
      "instanceType": "StudyAmendmentImpact",
      "description": "Updated reporting timeframe for product complaints to 24 hours."
    }
  ],
  "studyAmendmentReasons": [
    {
      "id": "48ae15f7-f88d-4fba-a6ec-4aeb603d7839",
      "amendmentId": "b951f3ec-0d7e-45ae-8934-6253e184ffaa",
      "reasonText": "Necessary protocol modifications due to the COVID-19 pandemic to minimize subject risk.",
      "category": "Safety",
      "isPrimary": true,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "56911e8e-dd22-44d8-83b9-6ad019e07609",
      "amendmentId": "b951f3ec-0d7e-45ae-8934-6253e184ffaa",
      "reasonText": "To mitigate the risk of muscle wall infiltration leading to pain and/or occlusion of the cannula.",
      "category": "Scientific",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "edf8a060-9c95-4de0-9ae5-dc74620f8a07",
      "amendmentId": "b951f3ec-0d7e-45ae-8934-6253e184ffaa",
      "reasonText": "To provide general guidance to investigators on possible causes and management of hallucinations/psychosis.",
      "category": "Scientific",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "0e0ee38f-67ee-4a68-8e87-cf35bb4b83eb",
      "amendmentId": "b951f3ec-0d7e-45ae-8934-6253e184ffaa",
      "reasonText": "To accommodate participation of additional countries and account for higher-than-expected dropout rate.",
      "category": "Operational",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    }
  ],
  "studyChanges": [
    {
      "id": "a5ca9bf2-0ef3-4d88-8f24-6dca7670d912",
      "amendmentId": "b951f3ec-0d7e-45ae-8934-6253e184ffaa",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "7.0",
      "beforeText": "null",
      "afterText": "Approximately 240 subjects",
      "summary": "Updated sample size estimation to 240 subjects."
    },
    {
      "id": "ff59f559-6e2d-4430-a66a-0ef68a088375",
      "amendmentId": "b951f3ec-0d7e-45ae-8934-6253e184ffaa",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "5.1",
      "beforeText": "null",
      "afterText": "Exclude subjects positive for COVID-19",
      "summary": "Added COVID-19 exclusion criteria."
    },
    {
      "id": "675dbea8-29f8-4c50-b1c3-2338ed902b1b",
      "amendmentId": "b951f3ec-0d7e-45ae-8934-6253e184ffaa",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "6.1",
      "beforeText": "null",
      "afterText": "24 hours",
      "summary": "Changed the reporting timeframe for product complaints to 24 hours."
    },
    {
      "id": "a76ea295-9fd2-4eb5-b190-3d6eb8391836",
      "amendmentId": "b951f3ec-0d7e-45ae-8934-6253e184ffaa",
      "changeType": "Deletion",
      "instanceType": "StudyChange",
      "sectionNumber": "Global",
      "beforeText": "caregivers",
      "afterText": "null",
      "summary": "Removed references to caregivers throughout protocol and Operations Manual."
    },
    {
      "id": "422c3d33-5ff0-49ee-abd3-eb8c52a25ffd",
      "amendmentId": "b951f3ec-0d7e-45ae-8934-6253e184ffaa",
      "changeType": "Clarification",
      "instanceType": "StudyChange",
      "sectionNumber": "4.3",
      "beforeText": "null",
      "afterText": "F3 infusion rate may be reduced beyond the 20% limit from the prescribed base infusion rate (F1) if medically necessary and only with approval from the AbbVie TA MD.",
      "summary": "Clarified F3 infusion rate reduction protocols."
    }
  ],
  "computationalExecution": {
    "ready": true,
    "supportedSystems": [
      "EDC",
      "ePRO",
      "CTMS",
      "RTSM"
    ],
    "validationStatus": "issues_found"
  }
}